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The prevalence of passive and active nicotine exposure among neonates, children and 
adolescents remains relatively high and varies among cultures and countries. Currently, there is 
ample evidence that a safe nicotine dose or level does not exist. For that, early exposure to any 
nicotine product is considered “catastrophic” to the children’s future and wellbeing. The cycle of 
nicotine addiction, relapse, and enduring health disparities remains unpreventable. This is 
majorly due to the incomplete understanding of nicotine-induced molecular signaling and 
mechanisms. Recently, the role of epigenetics in the developmental origin of diseases has been 
highlighted. With this in mind, this study aims to identify and validate the roles of particular 
epigenetics factors known as microRNAs in nicotine-induced early and late-onset diseases. Our 
workflow started with post-embryonic exposure to nicotine and was followed by global 
microRNA profiling across three generations. Based on the transcriptomic findings, we 
identified 14 transgenerational miRNAs that can serve as biomarkers for early parental nicotine 
exposure. Bioinformatics analysis coupled with a literature review allowed us to focus on three 
factors: mpk-1, sir-2.1, miR-80 for further validation. We were intrigued in finding a potential 
relationship among these factors (MS80) in mediating nicotine induced early and late-onset 
diseases. For that, we performed reverse genetics assays and tested their contribution to nicotine-
induced larval developmental delay, larval pharyngeal pumping inhibition, adult reproduction, 
adult mean lifespan, and adult germ line apoptosis. Our results showed that nicotine delayed 
development in an MS80 independent manner. Meanwhile, MS80 had a role in mediating 
nicotine-induced pharyngeal pumping inhibition. As for nicotine enduring effects, our data 
showed that post-embryonic nicotine exposure delayed the onset of reproduction without 
impacting fertility. This early exposure also had a negative effect on mean worm lifespan which 
was promoted by nicotine-induced upregulation of miR-80. In addition, our data also allowed us 
to infer that early nicotine exposure increases the ROS levels which trigger an organism level 
response that is mediated by MS80 to induce adult germ line apoptosis. Our study is the first to 
show the role of MS80 in intra and transgenerational inheritance of nicotine-induced effects. We 
also identified functional human homologs for cel-miR-80 in nicotine addiction and discussed 
the promising potential of manipulating MS80 to counteract nicotine-induced cellular and 
organismal damage during the early stages. Therefore, MS80 could be used as a prevention 
approach for nicotine-induced late-onset diseases. 
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Media and food 
NGM (Nematode Growth 
Medium) Agar 




Streptomycin (optional) 0.2g 
Distilled water 975ml 
Mix on shaker and autoclave at 121
o
C for 20 min 
Wait for it to cool till about 55
o
C (this is an important step before adding cholesterol) 
After cooling, add in the following order: 
Cholesterol (5mg/ml in ETOH) 1ml 
CaCl2 (1M) 1ml 
MgSO4 (1M) 1ml 
Potassium Phosphate (PH 6) 25ml 
Mix well (stir bar) and pour to the plates of interest using electronic pipette such that: 
3.5 cm plate 3ml 
6 cm plate 8-12 ml (depending on the petri dish brand) 
10 cm plate 23-30 ml (depending on the petri dish brand) 
After solidifying and cooling, seal them and put them at RT overnight. Next day, check for any 
possible contamination. If all is clear, stack the dishes in their original bag and place in the 4
o
C 
fridge for use later.  
Luria Broth (LB) For V=1L 
Tryptone 10g 
Yeast extract 5g 
NaCl 5g 
dH2O Up to 1L 
PH=7.5 Optional adjustment 
Autoclave and cool to 55
o
C before streptomycin (200mg) (Optional) 
LB medium (Solid) For V=1L 
Tryptone 10g 
Yeast extract 5g 
NaCl 10g 
Agar 10g 
dH2O  Up to 1L 
Autoclave 
 
OP50 Food stock for C. elegans 
Prepare 300 ml LB liquid medium (see recipe #) and wait for it to cool after autoclave. 
Inoculate with an OP50 pellet stored at -20
o
C. 
Place on a shaker (121 rpm) at 37
o




Transfer 10-12 ml of the grown bacterial solution to 25-30 Falcon tubes (15ml). 
Centrifuge at 3000 rpm for 20 minutes. 
Discard supernatant (usually just flip the tube and release liquid into the sink). 
Dry the tip of the tube with a tissue paper. 
Label the tubes, and store them at -20
o
C.  
To use the pellet, just add a certain number of M9 to it. It is better to measure the concentration 
of your bacteria before use.  
To do that, blank the spectrophotometer with M9. Add the same volume of the bacterial solution 
and measure the Absorbance (A) at λ=600nm. I usually have it b/t 1-2.  
For a 3.5 cm plate15µl OP50 solution. 
For a 6 cm plate 50-60µl OP50 solution. 





CaCl2 (1M) For a V=100ml 
CaCl2.2H2O 14.7g 
dH2O Up to 100ml 
Autoclave 
MgSO4 (1M) For a V=100ml 
MgSO4.7H2O 24.6g 
dH2O Up to 100ml 
Autoclave 
Potassium 
Phosphate (PH 6) 
For a V=1L 
KH2PO4 (1M) 118.3g (869ml) 
K2HPO4 (1M) 23g (132ml) 





Ethyl alcohol 10ml 
Do not autoclave 





Sometimes M9 clouds+turns whitish. This is due to the MgSO4.7H20. I 
made a 100mM stock (M=246.4755g/mol). For 1L M9, I take 10.14 ml. 





Synchronization solution and protocol 
1. Grow gravid worms (such that the worms are not so old and are laying fertilized eggs).  
2. Wash each plate with 3-5ml of M9 until most worms are collected into a 15ml Falcon 
tube.  
3. Centrifuge at 2000rpm for 2 min. 
4. Discard supernatant and add 5ml of M9. Mix a bit. 
5. Centrifuge at 2000rpm for 2 min.  
6. Discard supernatant. (If the supernatant is still unclear, then repeat the wash). 
7. Prepare a FRESH synchronization solution (with bleach added in the end). The recipe is 
as follows 
For V=25 ml  
Water 17.5ml 
NaOH 2.5ml 
Clorox bleach 5ml 
Note: If the bleach is scented, it might negatively affect the hatching of the eggs. In our 
lab, it seems that the bleach with the brand name (Top Job) is working for 
synchronization) 
Mix well  
8. For each 15ml Falcon tube, add 5ml of synchronization solution. 
9. Mix vigorously by shaking/vortexing intermittently.  
10. Check for the worm’s status as you shake. Shake for 5 minutes (8 minutes maximum). 
The adult worms should break open and dissolve, leaving only free eggs dispersed in 
solution.  
11. When ready, you have to work fast! 
12. Quickly centrifuge the eggs in bleach at 2000rpm for 2 min at RT. 
13. Remove supernatant. 
14. Add 5ml of M9, and centrifuge for 2 min at 2000rpm.  
15. Repeat this wash for 2 more times. 
16. After removing the M9 from the third wash, add another 5ml of M9 to disperse the eggs. 
Note: at this point, I usually smell the tube to see if there is still bleach in it. If so, I repeat 
the wash.  
17. Place the tube on a shaker (for aeration) overnight (12-18 hours) for the eggs to hatch to 
L1. 
18. Since there is no food in the tube, the larvae will be stuck at L1 no matter what time the 
eggs hatched. Thus the worms are synchronized. 
19. Next morning, centrifuge the tube, remove supernatant leaving about 100µl.  






MicroRNAs and nicotine: a double-edge sword 
Abstract 
Nicotine was first discovered in the 1560s and was introduced as a panacea. Unfortunately, 
increasing scientific evidence in the following decades proved that it is far from a miraculous 
drug as it harms every organ in the body and currently kills more than 480,000 individuals 
annually. Currently, there are no safe therapeutics for nicotine-related diseases among children 
and adolescents and this is partly because the molecular mechanisms for nicotine’s effects in 
different developmental stages remain unknown. Having said that, the roles of epigenetics 
factors like non-coding RNA in substance use disorders has increased tremendously in the last 
few years. We were interested in investigating the roles of one RNA species known as 
microRNAs in response to early nicotine exposure. We reviewed the miRNAs response to a 
variety of abused drugs and found global differential expressions across different studies on 
nicotine. We were intrigued to validate the roles of nicotine-responsive microRNAs in response 
to early nicotine exposure. For that, we employed the model organism C. elegans to perform our 
profiling and reverse genetics experiments. We took advantage of its life history traits concerned 
with the short generation time and transparent body as well as the high genome sequence 
homology with humans. We performed systemic miRNA profiling and used pharyngeal pumping 
and adult germ line apoptosis as proxies for early and late-onset diseases. In this chapter, we 
provided background information on the conservation of these physiological phenotypes to 
mammalian systems which allows for the extrapolations of our findings. 
Keywords: nicotine, epigenetics, microRNAs, C. elegans, MAPK, sirtuins, pharyngeal pumping, 





First line therapies for tobacco smoking cessation are nicotine-based. This only mitigates 
risks from other harmful chemicals in tobacco, but does not protect against nicotine addiction.  
Other non-nicotine based therapies like Bupropion (non-specific agent), Varenicline (nicotinic 
receptor partial agonist), Nortriptyline (affinity for multiple receptors), Clonidine (alpha2 -
noradrenergic agonist) also improved cessation rate. Unfortunately, benefits are countered by 
side-effects ranging from nausea and insomnia to serious cardiovascular events and even death. 
Due to these side effects, no nicotine-free treatments are FDA-approved for children or 
adolescents (Karpinski, Timpe, & Lubsch, 2010). This reinforces the cycle of addiction and/or 
predisposition to future health burdens which stresses on the importance of novel approaches that 
are both safe and effective.  
Addiction is complex arising from additive contribution of many genes (NIDA, 2014). 
This makes traditional gene therapy approaches far reaching. For that, epigenetic factors 
represent attractive candidates for treatment. We are particularly interested in microRNAs which 
are known to fine tune the expression of at least 50% of genes (Chekulaeva & Filipowicz, 2009). 
One miRNA can target hundreds of genes (Guo, Ingolia, Weissman, & Bartel, 2010), a property 
that can be exploited in polygenic disorders like addiction. Single as well as global miRNA 
expression profiling can be used in diagnostics as they represent physiological biomarkers. In 
addition, some miRNAs have become phase III medicines (e.g. NCT01200420 for hepatitis C) 





Experiments using cell lines, though informative, often don’t represent organism level 
responses. miRNAs and other signaling pathways can work in a non-cell-autonomous manner. 
On the other hand, gene manipulations coupled with imaging assays are often challenging in 
higher organisms. These challenges can be overcome by using the available genetics and 
behavioral tools in the model C. elegans. Using the worm, we will investigate the role a 
molecular network in mediating divergent and enduring impacts of early nicotine exposure.   
First we identified nicotine-linked microRNA transgenerational biomarkers using qRT-
PCR profiling. These microRNAs were used in bioinformatics analyses to predict gene targets 
and pathway enrichments (Chapter II). We integrated our bioinformatics predictions with a 
literature review and aimed to focus on three factors: mpk-1, sir-2.1, and miR-80 (Chapter III). 
Then, we employed reverse genetics to understand the role of those factors in nicotine-induced 
early (Chapter III) and late onset diseases (Chapter IV). Both larval growth rate and pharyngeal 
pumping rate were used as proxies for early onset phenotypes (Chapter III) while adult 
reproduction, lifespan, and germ line apoptosis were used as proxies for late onset endpoints 
(Chapter IV). Finally, we present our hypothesized model for nicotine-induced early and late-
onset complications and provide evidence of potential functional homologs in humans (Chapter 
IV). 
Significance 
Our findings allowed the i) identification of a molecular mechanism for direct and 
enduring effects of postembryonic nicotine exposure (i.e. adolescent neuromotor dysfunction vs. 




potentially safer therapeutics for early nicotine exposure, and (iii) the functional annotation of 
miR-80 in nicotine-SUD phenotype.  
Background 
Nicotine 
Nicotine was named after the French ambassador Jean Nicot who introduced it to Queen 
Catherine de Medicis as a panacea in 1560 (Cotton, 1998) (Figure1.1). Centuries later, this 
‘panacea’ kills more than 480,000 individuals annually (CDC, 2010a). According to World 
Health Organization (WHO), about half of the world’s children (~700 million) are exposed to 
nicotine directly by breathing tobacco-polluted air (WHO, 2007) or indirectly through 
absorption/adsorption of third hand smoke residing on surfaces (Martins-Green et al., 2014). 
More so, more than 50% of teenagers are active smokers in a number of developing countries 
(WHO, 2013) and waterpipe tobacco smoking (i.e. hookah) has increased dramatically among 
youth in developed countries like the United States (Soule, Lipato, & Eissenberg, 2015). The 
very first published report on the dangers of tobacco “snuff” was in 1761 by Dr. J. Hill (J. Hill, 
1761). Then, the first report on the adverse effects of environmental tobacco smoke on children’s 
health in 1967(Cameron, 1967) started a snowball which continues to grow with more evidence 
on the sensitivity for tobacco during early human development. It was concluded that “there is no 
threshold dose of environmental tobacco smoking below which an effect will not occur” (Corbo 
et al., 1996; Potera, 2010). Among the 4000 chemicals that constitute tobacco smoke, nicotine is 
the most addictive and is notorious for being a poison that affects every organ in the body and is 





Nicotine is a naturally occurring insecticide mainly found in tobacco leaves, but can also 
be found in small amounts in other common vegetables like eggplants and tomatoes (Domino , 
Hornbach , & Demana 1993) (Table 1.1). Nicotine has pKa of 8.0 and is considered a weak base. 
So, its absorption is dependent on the pH. For example, nicotine is ionized in acidic 
environments and is thus absorbed at a much slower rate through membranes. With this in mind, 
the routes of exposure are concomitant on the nicotine products.  Typically, nicotine is ionized in 
cigarettes which are slightly acidic and thus does not get absorbed in the buccal cavity of active 
smokers. A slower route of absorption is through the skin and is the basis for transdermal patches 
and for the occupational hazard for tobacco harvesters. On the other hand, nicotine is readily 
absorbed by the buccal cavity of passive smokers and pulmonary tract of passive and active 
smokers, respectively since it is unionized in the released smoke (N. L. Benowitz, Hukkanen, & 
Jacob, 2009). From the alveoli, nicotine gets absorbed to the pulmonary venous circulation, 
enters the heart and then to the arterial circulation which delivers nicotine to the brain faster than 
intravenous injection. Like an excited child in a state fair, nicotine rides all the brain tissue by 
stereoselectively binding to nicotinic acetylcholine receptors (nAChRs). Those ligand gated 
channels open and result in an influx of cations like calcium and sodium and influence 
intracellular signaling (N. L. Benowitz et al., 2009; Grando, 2014) and consequently impact 
tissue function and organism physiology and psychology. Thus, nicotine impacts the brain before 
reaching the liver and once it does, it is primary metabolized by cytochrome CYP2A6 and then 
by other enzymes resulting in around 16 additional metabolites, some of which are alkylating 
agents. More so, nicotine can also permeate the cell membranes directly (Nielsen & Rassing, 
2002) or via H+ gradient-dependent cation transport systems and then impact intracellular 




about 2 hours, nicotine also accumulates in different fluids such as saliva, gastric juice, fetal 
serum, amniotic fluid, and breast milk as well as body organs like the brain, blood, muscle, liver, 
kidney, spleen, and lungs. The arterial blood concentration of chronic smokers is about 100ng/ml 
and has been reported to be 10 folds higher in some situations (N. L. Benowitz et al., 2009).  
Nicotine-related diseases  
Nicotine is anorexic (H. Huang, Xu, & van den Pol, 2011; Mineur et al., 2011; 
Rubinstein & Low, 2011) and exposure during the perinatal period is associated with higher risks 
of sudden infant death syndrome (SID), low birth weight, decreased head circumference, as well 
as a developmental delay in genitals, skeletal muscle (Gyekis, Anthony, Foreman, Klein, & 
Vandenbergh, 2010) and secondary spinal motor neurons (Kawakita A, Sato K, Makino H, 
Ikegami H, & Takayama S, 2008; Svoboda, Vijayaraghavan, & Tanguay, 2002). Other nicotine-
associated complications include respiratory infections, otitis media, asthma, childhood cancer, 
hearing loss, dental caries, metabolic syndromes, conduct disorder, attention-deficit/hyperactivity 
disorder, poor academic achievement, and cognitive impairment, tachycardia and fetal hypoxia, 
fatal cardiac arrhythmias (R. Chen, Clifford, Lang, & Anstey, 2013; Cook & Strachan, 1997; 
DiFranza, Aligne, & Weitzman, 2004; Ey et al., 1995; Haberg, Stigum, Nystad, & Nafstad, 2007; 
Liebrechts-Akkerman et al., 2011; Owen et al., 1993; Strachan & Cook, 1998; Zhou et al., 2014). 
The vulnerability to nicotine changes with age, but the mechanisms and the developmental origin 
of these health problems remain unknown and therefore late-onset diseases are not preventable. 
As mentioned earlier, nicotine is an agonist for acetylcholine receptors. The latter are also 
present on surfaces on non-neuronal cells and play important roles in cellular homeostasis. 
Nicotine binding to those receptors on non-neuronal cells can lead to cell division, arrest, or 




interferes with the normal signaling and can result in pathologies such as cancers (Grando, 2014),  
neurodegeneration (Durazzo, Mattsson, & Weiner, 2014; Fredriksson & Archer, 2004; Hernan, 
Takkouche, Caamano-Isorna, & Gestal-Otero, 2002; James, 2013; Smith, Dwoskin, & Pauly, 
2010; Wei, Alberts, & Li, 2014; Zhou et al., 2014), and apoptosis in cardiovascular (L. Wang et 
al., 2014), pulmonary (Demiralay, Gursan, & Erdem, 2006), and pancreatic tissue (Bruin, 
Gerstein, Morrison, & Holloway, 2008; Bruin, Kellenberger, Gerstein, Morrison, & Holloway, 
2007). Exposure to nicotine is also linked to diabetes, obesity, reduced fertility, etc. (Bruin, 
Gerstein, & Holloway, 2010). 
Nicotine, MAPK and Sirtuins 
Mitogen activated protein kinases (MAPK) signaling pathway is one of the most ancient 
and conserved signaling among eukaryotes. It is considered one of the central hubs that have a 
role in many functions like the regulation of gene expression, metabolism, cell division, survival, 
differentiation, and cell death. There are four conventional MAPKs (i.e. ERK1/2, p38, JUN1/2/3, 
ERK5) that are comprised of a Ser/Thr kinase domain flanked by an N and C-terminal regions of 
variable lengths. Each of the four groups is composed of a three module kinase such that the 
signal is relayed from the extracellular environment to a GTP-binding protein which triggers a 
sequential activation starting by MAPK, to MAPKK, and then MAPKK (Figure 1.2).  MAPK 
signaling is enriched in nicotine disorders as noted in KARG (Knowledgebase for Addiction 
Related Gene) (C. Y. Li, Mao, & Wei, 2008). In particular, the ERK module was the first to be 
cloned and is among the most studied pathway (Cargnello & Roux, 2011). Commonly abused 
drugs modify ERK1/2 in critical neuro-regions related to reinforcement (Zamora-Martinez & 
Edwards, 2014). Nicotine was consistently shown to activate ERK1/2 in lung cancer cells 




nasopharyngeal carcinoma cells (Shi et al., 2012), mouse primary cortical neurons (Steiner, 
Heath, & Picciotto, 2007), bovine adrenal chromaffin cells (Sugano et al., 2006), spinal cord 
neurons (Toborek et al., 2007), human bronchial epithelial cells (Tsai et al., 2006) and vascular 
smooth muscle cells (Di Luozzo et al., 2005). On the other hand, it was downregulated in 
nicotine-treated cardiomyoctes (L. Wang et al., 2014).  
Sirtuins are NAD-dependent class III protein and histone deacetylases that are universally 
found from bacteria to humans (Colak et al., 2011). It mediates different stress responses and is 
involved in lifespan extension in some organisms (Howitz et al., 2003). They are highly involved 
in cellular and organismal energy metabolism and are therefore responsive to caloric restriction 
by insulin signaling-dependent and independent mechanisms (X. Li & Kazgan, 2011). In 
addition, sirtuins contribute to and regulate the epigenetics signature of the genome and impact 
chromatin remodeling which results in global changes in gene expression. They have also been 
shown to be implicated in cardiovascular disease, cancer, neuronal function and 
neurodegenerative diseases (Nakagawa & Guarente, 2011) (Figure1.3). SIRT1 (silent 
information regulator) is one of the seven sirtuins and is the best and most studied (Colak et al., 
2011). Nicotine reduced SIRT1 expression in A/J mice lungs (Iskandar et al., 2013), mouse 
neural stem cells (H. Lee et al., 2014), and cultured mouse embryos (Lin et al., 2012). Cigarette 
smoking also downregulated SIRT1in the mice lungs (Hwang, Sundar, Yao, Sellix, & Rahman, 
2014) and in (Hwang, Yao, Caito, Sundar, & Rahman, 2013), lung epithelial cells, endothelial 
cells, and macrophages (Arunachalam, Yao, Sundar, Caito, & Rahman, 2010; Hwang et al., 2013; 
S. R. Yang et al., 2007). On the other hand, nicotine upregulated SIRT1 expression in human 




airway epithelial cells, but its downregulation was confined to cancerous lung tissue from 
smokers (Beane et al., 2012). 
Nicotine and miRNAs 
Consistent with the hypothesis of “developmental origins of adult health and disease” 
(DOHaD), early nicotine exposure increases the risks and occurrences of late-onset diseases. 
Epigenetics alterations have been shown to occur in children exposed to nicotine in utero (Breton 
et al., 2009) and were proposed to mediate consequential late-onset diseases. Epigenetic and non-
genetic factors that influence intra and transgenerational inheritance include microRNAs. 
Though a very recent field, it significantly contributed to the epigenetic-based DOHaD data gap 
(Haugen, Schug, Collman, & Heindel, 2015). This is supported by evidence that showed changes 
of microRNA profiles in smokers’ sperm samples (Marczylo, Amoako, Konje, Gant, & 
Marczylo, 2012). Moreover, our lab recently identified nicotine-responsive microRNAs that are 
consistently or specifically altered across three generations (F. A. Taki, Pan, Lee, & Zhang, 2014; 
F. A. Taki, X. Pan, & B. Zhang, 2013).We also performed a metaanalysis based on 118 studies 
concerned with microRNAs in drugs of abuse, including nicotine (F. A. Taki, Pan, & Zhang, 
2015). We will discuss our analyses on nicotine in the following sections. 
microRNAs: definition and biogenesis 
Ever since their initial discovery in C. elegans in 1993 (R. C. Lee, Feinbaum, & Ambros, 
1993), microRNAs have become universal molecules among eukaryotes. Due to their 
conservation and significant abundance (i.e. up to 50,000 copies/cell), miRNAs are considered to 
have significant biological roles. Indeed, with a deceptive size of 22 nucleotides, miRNAs fine 




pathways (B. Zhang, Wang, & Pan, 2007). Initially, miRNAs were discovered as central hubs in 
development (e.g. let-7, lin-4) with strong phenotypic consequences. Soon thereafter, research 
uncovered their pleiotropic nature and contribution to a variety of conserved phenomena which 
include, but are not limited to, aging, cancer, metabolism, cell fate and differentiation, and neuro- 
and cardiovascular physiologies and disorders. Fourteen years later, Sathyan et al. uncovered a 
role of miRNAs as mediators of alcohol’s teratogenic effects (Sathyan, Golden, & Miranda, 2007) 
and was followed with a burst in research on a variety of drugs of abuse and model organisms. 
Currently, miRNAs are known to protect from or promote substance use disorders (SUDs) and 
thus serve as attractive tools for therapeutic and/or diagnostic purposes.  
    Adopting miRNAs in the biomedical field necessitates understanding their biogenesis, 
regulation, and mode of action. Recently, a number of reviews have elegantly summarized the 
latest findings on miRNA-related mechanisms ((Fiore, Khudayberdiev, Saba, & Schratt, 2011; 
Ha & Kim, 2014; Leung & Sharp, 2010; Vidigal & Ventura, 2014; Wilczynska & Bushell, 2015). 
Briefly, miRNA-sequences are generally dispersed in coding (e.g. ORF) or non-coding regions 
(e.g. introns) (Ha & Kim, 2014). RNA pol II/III transcribe the DNA sequence to a capped and a 
potentially polyadenylated primary miRNA transcript (Pfeffer et al., 2005). This pri-miRNA 
transcript is about 1000 nucleotides in length and is comprised of one to several stem-loop 
structures, each of which is flanked by single stranded segments. Cleavage takes place at the 
intersection with flanking sites by an RNaseIII enzyme known as DROSHA (V. N. Kim, 2005). 
The liberated ~60-70 nt stem-loop molecule gives rise to a precursor miRNA (pre-miRNA) that 
is transported from the nucleus via Ran-GTP exportin5 complex. Further processing occurs in 
the cytoplasm by another RNaseIII enzyme known as Dicer which cleaves the pre-miRNA loop 




to give rise to a guide strand which joins argonautes in a complex with TNRC6A–C (GW182) 
and other proteins to form miRISC (miRNA RNA interference complex). To find a specific 
target sequence, miRNAs act as guides that direct the interference machinery to MREs 
(microRNA response elements) residing in 3’-UTRs (B. Zhang et al., 2007), 5’ UTR, or even 
ORF of a target mRNA (Stroynowska-Czerwinska, Fiszer, & Krzyzosiak, 2014). With such 
proximity, miRISCs were traditionally thought to silence genes through two general models: 
translational repression and/or mRNA decay. On the translational level, miRISC could compete 
with eIF4E and therefore prevent the recruitment of the translational machinery (Mathonnet et al., 
2007). More so, miRISC could disrupt the sequential order of events at translational initiation by 
interacting with eIF6 (Chendrimada et al., 2007; Fabian & Sonenberg, 2012). On the other hand, 
destabilization of the mRNA could directly be due to miRNA-induced decapping and/or 
deadenylation (Behm-Ansmant et al., 2006). So, miRNA-dependent mRNA destabilization could 
be direct or indirect (translational repression) and has been shown to promote a dominant 
irreversible suppression (Bazzini, Lee, & Giraldez, 2012; Carthew & Sontheimer, 2009; 
Eichhorn et al., 2014). Meanwhile, miRISC could delay translation by holding a transcript in 
custody, after which it can be released to resume expression in response to certain cues (Kundu, 
Fabian, Sonenberg, Bhattacharyya, & Filipowicz, 2012). All in all, the maturation of a functional 
miRNA requires such canonical or other non-canonical pathways to fine-tune gene expression (F. 
A. Taki et al., 2015) (Figure 1.3).  
miRNA nomenclature 
Animal miRNA nomenclature includes the host species (i.e. first three letters), miR-, and 
a number. The latter is based on the order of discovery. However, interspecies miRNAs with 




high degree of homology (≥ 70%) are often not annotated with similar nomenclature. For 
example, cel-miR-58 family (cel-miR-58, cel-miR80, cel-miR-81, cel-miR-82, cel-miR-1018, 
cel-miR-1022) in C. elegans is homologous to dme-bantam and miR-306* in drosophila as well 
as mir-450b-3p in humans (Ibanez-Ventoso, Vora, & Driscoll, 2008). In addition, miRNA guide 
strands were distinguished from the passenger strand that was identified as miRNA* (e.g. 
miR_St, miR-as). This is based on the relative abundance of the miRNA strand. Unfortunately, 
due to some data gaps in abundance data, miRNA are sometimes referred to as miR-5p and miR-
3p. This is problematic because the duplex strands are not completely identical and have 
different target sets (Ambros et al., 2003; Kozomara & Griffiths-Jones, 2014). Since studies 
usually refer to miRNAs by their names, rather than their stable accession number or sequence, it 
is a challenge to perform meta-analyses to identify commonly altered miRNAs across species in 
response to one or more drugs of abuse. Therefore, some biologically significant miRNAs might 
be missed due to differences in nomenclature. 
Complexity of miRNA regulation and functional validation 
Most miRNA mutants are phenotypically ‘normal’. This has prompted not only skeptics, 
but also leaders in the field to declare that “most miRNAs are individually not essential for 
development or viability” (Alvarez-Saavedra & Horvitz, 2010; Miska et al., 2007).  Nevertheless, 
recent research highlighted the complexity of miRNA-dependent regulation. miRNA profiles are 
specific to treatment, exposure duration, cell compartments, cell, tissue, organ types, 
developmental period, physiological state and history, environment, ethnicity, genetic 
polymorphism, species, etc… Thus, when assessing their functions, miRNAs should be studied 
as a system in a dynamic transcriptome. If we consider miRNAs as one non-linear system, then a 




system as a whole (Rickles, Hawe, & Shiell, 2007). miRNAs are "epitranscriptional regulators" 
(G. W. Dorn, 2013; Y. Hu et al., 2012) interacting directly with only a subset of master 
regulators of gene expression (e.g. transcription factors (Matkovich, 2014)) which amplify the 
initial modest signal. Thus, initial conditions shape a miRNA mosaic which in turn works as a 
system to canalize sensitive biological events (e.g. cell cycle, differentiation) (G. W. Dorn, 2nd, 
2012). So, one setting encompasses not a single, but a repertoire of miRNAs which contribute to 
large scale and multi-level impacts (e.g. transcript, protein levels).  
The vagueness of miRNA behavior stems from: i) dynamic regulation of miRNA 
biogenesis, ii) versatility of miRISC gene regulation, iii) synergism vs. antagonism with other 
RNA (e.g. circRNA, lncRNA) and RNP (e.g. HuR), iv) ambiguity in miRNA-target binding sites 
(e.g. 3’/5’ UTR, ORF), v) context-dependent modes of target regulation (e.g. mRNA decay or 
translational repression), vi) shifts between activation and repression of target expression, vii) 
target diversity for a single miRNA, viii) miRNA redundancy for a single target (Breving & 
Esquela-Kerscher, 2010), and ix) reversed regulatory outcomes as a function of miRNA 
competition (Nyayanit & Gadgil, 2015). With this in mind, it is a challenge to dissect miRNA 
pathways or to deduce causal relationships. In fact, as the complexity of a system increases, our 
ability to precisely predict its behavior decreases (Ripoli, Rainaldi, Rizzo, Mercatanti, & Pitto, 
2010; Zadeh, 1973). This concept can be applied to miRNAs in conferring robustness in noisy, 
crowded, and chaotic living systems in response to fluctuating signals (Ripoli et al., 2010). 
Interestingly, we found support for this idea in our meta-analysis. Morphine induces miR-23b 
through MOR, which in turn is targeted by miR-23b through a negative loop while its antagonist 
also upregulated miR-23b in cells in a MOR-dependent and - independent manner (Q. Wu, 




directional changes, yet shared common target. Therefore, the directions of miRNA targets could 
not be anticipated (Eipper-Mains et al., 2011). In addition, many candidate targets will be missed 
when considering only inversely expressed miRNAs. In addition, choosing miRNAs with highest 
differential changes is not necessarily the best route as critical drug-induced miRNAs might 
undergo modest shifts in expression levels due to their abundant nature. Sometimes two 
opposing miRNAs like miR-21 (anti-apoptotic) and miR-335 (pro-apoptotic) have the same 
directional change in response to a drug like alcohol, yet the net effect was proliferation (Sathyan 
et al., 2007). Noteworthy, some targets are commonly regulated by different miRNAs with 
opposite expression levels. So, direction of change of potential targets can’t be anticipated 
(Eipper-Mains et al., 2011).  
The miRNA response to drugs of abuse has been well elucidated across many biological 
systems ((Chandrasekar & Dreyer, 2009, 2011; Hollander et al., 2010; Jadhav et al., 2013; 
Pietrzykowski et al., 2008; Rajasethupathy et al., 2009; Saba et al., 2012; Schaefer et al., 2010). 
Most of the studies focused on alcohol (41%) followed by tobacco/nicotine (20%), stimulants 
(17%), opioids (13%), anesthetics (6%), and lastly cannabinoids (3%). Tobacco/nicotine was the 
only group that had a higher percentage of studies reporting global downregulation (~50%) of 
miRNAs (Figure 1.5A). Nevertheless, global upregulation was still reported in about 33% of the 
tobacco/nicotine studies while 17% reported equal distribution of miRNA expression levels 
(Figure 1.5B). Interestingly, tobacco/nicotine affected the highest percentage of miRNAs (13%) 
relative to the other drugs of abuse (Figure 1.6). Only 2 out of 205 miRNAs were consistently 
upregulated in response to nicotine. These were let-7 family, and miR-21 (Table 1.3). In addition, 
let-7 was also repeatedly reported to be downregulated by nicotine, while miR-125b and miR-




A comprehensive list of miRNA-dependent mechanisms are summarized in (Table 1.5). 
For example, nicotine affected miRNAs involved in stem cell regeneration and cellular 
proliferation in human periodontal ligament-derived stem cells (Ng et al., 2013), human gastric 
adenocarcinoma (Shin et al., 2011) and bronchial epithelial cells (Kassie, Jarcho, & Endalew, 
2010). It also antagonized the effects of alcohol on select miRNAs in fetal mouse cerebral 
cortical neural precursors (Balaraman, Winzer-Serhan, & Miranda, 2012b) and affected miRNA 
mediators of neuroplasticity in rat adrenal pheochromocytoma (W. Huang & Li, 2009).  In 
higher organisms, nicotine affected miRNAs involved in atrial remodeling in canines (Shan et al., 
2009). miR-21 served a protective role in mice and human tissue for AAA (Abdominal Aortic 
Aneurysm) disease in response to nicotine (Maegdefessel et al., 2012). Recently, we showed that 
post-embryonic nicotine exposure altered global miRNA expression profiles upon direct nicotine 
exposure (F. A. Taki et al., 2013) and this effect was transgenerational (F. A. Taki et al., 2014).  
Are they a cause or a side-effect (symptom) of SUD (Substance Use Disorder)? 
Substance use disorder is a broad term that describes a variety of effects. Determining 
whether miRNA dysfunction causes or results from SUD has been recognized as a conundrum 
(Fiore et al., 2011). It is best to tackle this question relative to a phenotype of interest. Even then, 
it is difficult to determine sequence of events, as miRNAs sometimes act as a double-edged 
sword. For example, HIV infection can alter miRNAs like miR-9 which can make CNS neurons 
susceptible to methamphetamine addiction (Tatro et al., 2013). On the other hand, cocaine 
downregulates anti-HIV miRNAs like miR-155 and miR-125b, thereby enhancing HIV 
replication (Mantri, Pandhare Dash, Mantri, & Dash, 2012; Napuri et al., 2013). This is mainly 
because they are involved in auto-regulatory loops. For example, morphine activates MOR 




2013) and miR-23b (Q. Wu et al., 2009), both of which target MOR itself at its 3’ UTR. 
Meanwhile, not all DA-responsive miRNAs are pathogenic, but instead some have a protective 
role. For example, nicotine potentiated the increase of miR-21 in AAA (Abdominal Aortic 
Aneurysm) mice models. miR-21 is usually described as an oncomir (Medina, Nolde, & Slack, 
2010), yet in the context of AAA disease, it protected from aortic expansion due to increased 
smooth muscle cell proliferation. When AAA mice received both nicotine and anti-miR-21, they 
died due to the rupture of enlarged aortic wall (Maegdefessel et al., 2012).  
Meanwhile, the regulation of miRNA levels is not limited to transcription, but can also 
happen at any of the steps during biogenesis (e.g. DROSHA, DGCR8, XPO5, RAN, DICER1, 
TARBP2, AGO1, AGO2, GEMIN3, GEMIN4 (Gedik et al., 2014)). Drugs can affect 
Drosha/Pacha microprocessor or dicer enzyme, which subsequently alters the production of 
precursor miRNA (pre-miRNA) or mature miRNAs, respectively. Some drugs have been shown 
to affect argonautes which consequently alter the activity of miRISC complex. For example, 
Gedik et al. reported AGO1 rs595961, AGO2 rs4961280 G alleles and GEMIN4 rs910924 T-
alleles to affect the susceptibility to alcohol dependence (AD) in a Turkish population (Gedik et 
al., 2014). In addition, an increase in Drosha, Dicer and Ago2 was observed in zebrafish treated 
with cocaine (Lopez-Bellido, Barreto-Valer, Sanchez-Simon, & Rodriguez, 2012). Alcohol also 
increased Drosha in the dorsal hippocampus of rats, while it increased Drosha and Dicer in the 
dorsal and ventral hippocampus (Prins, Przybycien-Szymanska, Rao, & Pak, 2014). These 
changes might result in non-specific miRNA alterations and thus it is easier to consider them as 
side-effects of drug exposure, assuming that select miRNAs themselves are not direct co-targets. 
Noteworthy, current technical advancements and tools do allow for the diagnosis of miRNA 




antisense oligonucleotides can be used to manipulate pri-miRNAs, pre-miRNAs, or mature 
miRNAs. Complete or conditional knock outs can be established for any gene of interest 
involved in the biogenesis pathway (e.g. Drosha, Dicer) (McNeill & Van Vactor, 2012). Taken 
collectively, we refer to the description by Li, & van der Vaart which considered miRNAs as 
middlemen for addiction ‘tug of war’ between motivation-based learning versus counteractive 
neuronal homeostasis (M. D. Li & van der Vaart, 2011).   
microRNA transport 
Recently, miRNAs have been reported to have extra/inter-cellular and even between 
individuals (e.g. placenta, lactation) shuttling through vesicles including exosomes, apoptotic 
bodies, RNA binding proteins, and lipoproteins (Boon & Vickers, 2013; H. J. Lee, 2014; Rayner 
& Hennessy, 2013). Not all extracellular miRNAs are byproducts of cell damage or rupture. 
Others are nevertheless absent in the parent cell as they are destined to be secreted after 
transcription. For example, miR-122 was downregulated in liver tissue, but upregulated in 
exosome fractions as well as in the serum of alcohol liver disease models (Bala et al., 2012). 
Interestingly, treating SIV-infected SH-SY5Y neuronal cells with morphine did not affect 
PDGF-B chain levels. However, Hu et al. elegantly showed that morphine potentiated SIV-
mediated neuronal apoptosis by downregulating tropic factor PDGF-B chain in neurons in a cell 
non-autonomous manner. This required exosome-dependent shuttling of miR-29b from 
astrocytes to exert its action on PDGF-B in the neurons (G. Hu et al., 2012). Thus, miRNAs can 
also serve as signaling molecules involved in orchestrating organism level communications and 
processes. This raises an issue with analyses that try to exclude predicted miRNA targets that are 
not co-expressed within tissue of interest. Meanwhile, it adds another challenge to target 




nuclear and cytoplasmic miRNA fractions. Indeed, miRNAs have also been shown to have a 
nuclear presence (Roberts, 2014). Thus, those miRNAs might be shuttled back and forth between 
the cytoplasm and the nucleus to silence nascent transcripts (Benhamed, Herbig, Ye, Dejean, & 
Bischof, 2012; Liang, Zhang, Zen, Zhang, & Chen, 2013), to mediate epigenetic remodeling (D. 
H. Kim, Saetrom, Snove, & Rossi, 2008) at promoters of gene and/or other non-coding RNAs, 
and to perform other roles that are not yet identified. Current research has not yet accounted for 
predicting and validating miRNAs as transcriptional regulators of other miRNAs (Liang et al., 
2013; Tang et al., 2012). Collectively, miRNAs can serve as diagnostic markers (e.g. salivary 
miRNAs for oral diseases (H. J. Lee, 2014)) and therapeutic agents (Dreyer, 2010; Eipper-Mains, 
Eipper, & Mains, 2012; Jadhav et al., 2013; Pietrzykowski, 2010) for nicotine-induced diseases. 
Caenorhabditis elegans 
C. elegans (Phylum Nematoda: Family Rhabditidae) is a free-living nematode that was 
first isolated by Maupus in 1990 (Maupus, 1990). Soon thereafter, it was established as a 
genetics model organism by Sydney Brenner (S. Brenner, 1974). It is our preferred model due its 
short generation time of about 2-3 days at 20 °C. Eggs hatch to L1 larvae of about 250 µm and 
go through four larval stages before molting to adulthood (1mm) (Z.F. Altun & D.H. Hall, 2009) 
(Table 1.6). Spermatogenesis occurs in late L4 stage (L'Hernault, 2006) and is followed by 
oogenesis in young adult hermaphrodites. Thus, we considered the L1 to L3/L4 molt period to 
model post-embryonic development (i.e. lacking differentiated gametes). The self-fertilizing 
hermaphrodites lay around 300 eggs which can increase to around 1000 eggs after mating. With 
this in mind, the occurrence of males in an N2 population is about 0.1% (Ward & Carrel, 1979). 
This increases in response to stressful conditions like starvation, crowding, shifts in temperatures. 




used as tools to introduce alleles of interest in cross linking experiments (McGraw-Hill-Higher-
Education, 2011).  
Despite being a simple multicellular organism, the worm enables studying complex 
behavior and syndromes. It has been used in many recent phenology studies (McGary et al., 2010; 
van der Velde et al., 2014) to understand human maladies like cancer (Cha, Datla, Hollis, Kimble, 
& Lee, 2012; Kirienko, Mani, & Fay, 2010; Kobet et al., 2014), ageing (Honda, Honda, Narici, 
& Szewczyk, 2014), development (Hubbard, Korta, & Dalfo, 2013; Pilon, 2014; Schaedel, 
Gerisch, Antebi, & Sternberg, 2012), addiction (Feng et al., 2006; Sellings et al., 2013; F. Taki, 
X. Pan, & B. Zhang, 2013; F. A. Taki et al., 2014; F. A. Taki et al., 2013; Zhu, Zhang, & Li, 
2014) and other cardiovascular (Diomede et al., 2014; Epstein & Benian, 2012) and 
neurodegenerative diseases like Alzheimer’s (Ewald & Li, 2009) and Huntington (Voisine et al., 
2007). As the first multicellular organism to have its nervous system delineated, the worm with 
its 302 neurons offers an attractive platform to understand universal phenomenon like sleep (Cho 
& Sternberg, 2014; A. J. Hill, Mansfield, Lopez, Raizen, & Van Buskirk, 2014) and pain (Riera 
et al., 2014) research. Each neuron can be labelled by a specific marker which facilitates 
identification and tracking. More so, neuron ablations are non-lethal in the worm under standard 
laboratory conditions (Riddle, Blumenthal, & B.J., 1997), a characteristic that is challenging 
and/or ethically controversial in higher organisms.  
Research on the worm has received much attention in the biomedical field especially 
after two Nobel Prize awards in medicine and physiology in 2002 and 2006. This is due to the 
conservation of major signaling pathways as well as high genome homology (~80%) with 
humans (Carroll, Dougherty, Ross-Macdonald, Browman, & FitzGerald, 2003; Consortium, 




annotation. With this in mind, we took advantage of C. elegans having only 1/6
th
 of the total 
number of miRNAs relative to humans (Kozomara & Griffiths-Jones, 2014).  Such a feature 
enables us to perform systematic profiling using gold-standard single-plex qRT-PCR. Another 
advantage of using C. elegans in drugs of abuse research is that we can control for the effects of 
conditioning. In other words, drug addiction is also impacted by social and habitual cues that 
enhance the urge to abuse. Thus, it becomes challenging to dissociate those cues from the direct 
physiological and pharmacological effects of the drug (N. L. Benowitz, 2009). So, treating the 
worms with nicotine will allow us to focus on the molecular basis of the drug-induced effects.  
Drug absorption in the worm 
1. Under normal conditions, the average time for residence of a bacterium in the worm 
intestine is less than two minutes (McGhee, 2007).  
2. The pH levels estimated in C. elegans intestine is about 3.59 (Chauhan, Orsi, Brown, 
Pritchard, & Aylott, 2013) in comparison to the human blood and intestines of which 
pH ranges from 6 to 7.4 (Fallingborg, 1999). This impacts the efficiency of nicotine 
absorption since it is a weak base that is ionized in acidic environments (i.e. worm’s 
intestine) and is assimilated at a much slower rate (N. L. Benowitz, 2009). 
3. Previous studies that exposed worms to about 2% alcohol showed that the inner 
concentration was comparable to 0.1% human blood alcohol levels (Davis, Li, & 
Rankin, 2008). It is noteworthy to mention that alcohol readily permeates the cuticle 
in C. elegans (Mitchell et al., 2007) and in spite of this property, a 20 fold decrease 
was still observed between external and internal environments. Meanwhile, the 
cuticle is a barrier for nicotine (Ruiz-Lancheros, Viau, Walter, Francis, & Geary, 




4. The bioavailability of the drug (i.e. nicotine) is affected by the method of exposure. 
The worm’s metabolic rate is proportional to the drug dose and reaches its peak after 
8-12 hours of exposure. Also, the concentration of the drug decreases with time and is 
impacted by whether the food supplied is killed versus living bacteria. In addition, 
drugs infused to solid NGM media which is seeded with living bacteria resulted in the 
second lowest absorption rate in the worm (Zheng, Ding, Li, Wu, & Luo, 2013). The 
latter was our method of exposure and therefore together with the ionized state of 
nicotine in the worm’s acidic intestine and rapid digestive and metabolic rates of the 
worm, the inner nicotine concentration is expected to more than 20 folds lower than 
the nicotine concentration in the medium.  
Pharynx and heart 
C. elegans is a filter feeder which takes up food from the environment to the pharynx 
before being transported to the intestines. The pharynx is not directly exposed to the environment 
because its lumen is lined with the cuticle that connects to the epidermis. The pharynx is divided 
into three main parts: corpus, isthmus, and terminal bulb. Food is passed along through two 
actions known as pumping and peristalsis. The former depends on the consecutive contraction 
and relaxation of the radial muscles, respectively. This is followed by an intermittent peristalsis 
that moves partially broken food from the anterior isthmus to the terminal bulb. Food is then 
subjected to further crushing by the grinder in the terminal bulb before being passed to the 
intestines.  Noteworthy, the grinder movement is proportional to terminal bulb contraction and 
relaxation and is used as a proxy to count pumping rate in our pumping assay. A single “pump” 
corresponds to an action potential that depends on five ion channels: nAChR, low and high-




potassium channel (Avery & You, 2012; Mango, 2007). So, despite having different purposes, 
processing the different signals for a synchronized action is physiologically similar to the human 
heart as will be discussed below.  
Though the pharynx and the heart are not derived from the same germ line origin 
(ectoderm vs mesoderm, respectively), they are considered to be similar by convergent evolution 
(Mango, 2007). Both are tube-like structures, with a lumen lined with binucleated muscle cells. 
More so, both undergo autonomous rhythmic pumping which can occur even without nervous 
input. However, neurons are required for efficient functioning (e.g. feeding) (Avery & You, 
2012). The pharynx serves as a simple platform to understand how environmental stimuli are 
received by neuro-signaling pathways which in turn relay the signal to motor function.  Thus the 
frequencies of both pumping and peristalsis, described above, are outputs of endogenous and 
exogenous signals that trigger neuro-muscular interactions (Song & Avery, 2013).  
Germline apoptosis 
Development is a balance between programmed cell growth and death (i.e. apoptosis). 
The latter is important to maintain homeostasis, and eliminate aberrant, damaged or harmful cells. 
The dysregulation of apoptosis is associated with many human diseases (Kam & Ferch, 2000). 
For example, inhibition of apoptosis is a hallmark of cancer, while excessive apoptosis is 
associated with heart and some neurodegenerative diseases like Alzheimer’s as well as diabetes 
if it occurred in pancreatic beta-islet cells. Apoptosis was first discovered in C. elegans which 
resulted in the first Nobel Prize. The worm undergoes two types of apoptosis: physiological and 
stress induced. The former progresses independently from environmental cues and follows a 




hand, apoptosis in other germ cells is not encoded, but instead reflects the worm’s life history 
and experiences (Gartner A., Boag P. R., & B., 2008). Hence stress-induced germ cell apoptosis 
represents a highly tractable system to study apoptosis for prognostic, diagnostics, as well we 
therapeutic purposes. Below, I will briefly provide an overview of germ cell development and 
physiology that are relevant to our experimental design as well as apoptosis assay. 
Germ cells differentiate around the four-cell stage during embryogenesis. However, 
further differentiation of the somatic gonad is coupled with that of germ cells and occurs post-
embryonically. Those germ cell precursors require signaling and nutrients from the forming 
somatic gonad for subsequent steps. The process starts in mid-L1 until L3 stage where a somatic 
“niche” is formed from 12 cells: 2 distal tip cells (DTCs) and 10 proximal cells. This represents 
the backbone for subsequent bursts in germ and somatic cell proliferation and marks the 
beginning of sex determination. As worms grow to L4 and young adult stage, events continue to 
be spatiotemporal starting from DTC-dependent germ cells mitosis which then transition to 
meiosis around gonad loop region. This is the site of apoptosis and is known as the death loop. 
Until this point, germ cells are syncytial and share a cytoplasm during the pachytene stage. Thus, 
it is hypothesized that apoptosis would not only eliminate faulted germ cells, but they would also 
provide nutrients to the qualified cells through the shared cytoplasm (Hubbard & Greenstein, 
2005). Interestingly, MAPK pathway represents a common factor that controls both the 
progression beyond pachytene as well as the apoptosis rate. Thus, decreased MAPK signaling is 
proportional to pachytene arrest, decrease in apoptosis, as well as a decrease in fertility. Hence, it 
is important to note that apoptosis does not always correlate with fertility, and in fact has been 




How to differentiate the developmental (normal and physiological) apoptosis from the 
stress-induced apoptosis? Both types of apoptotic cells are restricted to pachytene cells (i.e. death 
loop region) in C. elegans and are morphologically indistinguishable. However, they are 
triggered by different molecular pathways. Stressors can be further categorized into either 
genotoxic or non-genotoxic, both of which have different upstream apoptotic signal transducers. 
Signaling vie cep-1 (i.e. P53 tumor suppressor) and egl-1 (BH3-only protein) is required for 
genotoxic apoptosis, but is not required for non-mutagenic agents/events. While physiological 
apoptosis represents the baseline, an increase in apoptotic count can be linked to worm exposure 
in comparison to those control worms at similar developmental stages (e.g. young vs. old) 
(Gartner A. et al., 2008).  
Hypotheses and objectives 
Previously, our lab performed a systematic and detailed behavioral analysis in C. elegans 
larvae. Nicotine treatment was limited to the early larval stages in the parental worms. However, 
I have found that those behavioral changes were not restricted to the parents, but also extended to 
offspring and grand-offspring generations (F. Taki et al., 2013). Based on these preliminary 
results, I hypothesized that (i) post-embryonic nicotine exposure impacts microRNA profiles 
across generations and that (ii) some microRNAs mediate nicotine-induced early-onset and 
late-onset diseases. To test the hypotheses, I performed the following aims. First, I identified a 
transgenerational effects on specific microRNA pathways. Then, I examined the molecular 
mechanisms for the intragenerational inheritance of the damages induced by nicotine.  
 Aim I: To identify nicotine-responsive microRNAs that are consistently altered in more 




o Objective 1: To perform global microRNA profiling for parent (F0), offspring 
(F1), and grand-offspring (F2) worm generations using single-plex qRTPCR. 
o Objective 2: To identify miRNA-enriched biological networks in response to 
early nicotine exposure based on microRNA-target enrichment and bioinformatics 
functional annotation. This sets the basis for investigating the MS80 (mpk-1, sir-
2.1, and miR-80) pathway. 
 Aim II: To examine the roles of MS80 (mpk-1, sir-2.1, miR-80) in nicotine-induced 
early-onset phenotypes (Chapter III). 
o Objective 1: To investigate the role of MS80 in nicotine-induced developmental 
arrest. This was based on reverse genetics, treatment with antagonists, imageJ 
software and microscopic analyses. 
o Objective 2: To investigate the role of MS80 in nicotine-induced pharyngeal 
pumping inhibition. This was based on reverse genetics, treatment with inhibitors, 
and behavioral analysis.  
 Aim III: To validate the role of MS80 (mpk-1, sir-2.1, miR-80) in nicotine-induced late-
onset diseases (Chapter IV). 
o Objective 1: To examine the effects of post-embryonic nicotine exposure on adult 
reproduction, lifespan, and germ line apoptosis. This involved reproduction and 
lifespan assays, and staining and counting apoptotic cells.  
o Objective 2: Investigate the role of MS80 in nicotine-induced adult germ line 
apoptosis. This was based on reverse genetics, treatment with inhibitors, SYTO12 




 Aim IV: To deduce a possible functional relationship among mpk-1, sir-2.1, and miR-80 
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Table 1.3: A list of miRNAs reported to be upregulated in at least two DA (F. A. Taki et al., 2015). 
 
Drugs total microRNAs 
Alcohol, Anesthetics, Opioids, Stimulants, 
Tobacco/nicotine 
1 let-7 
Alcohol, Cannabinoids, Stimulants, Tobacco/nicotine 4 miR-152 
  miR-27a 
  miR-125b 
  miR-194 
Alcohol, Opioids, Stimulants, Tobacco/nicotine 2 miR-9 
  miR-1 
Alcohol, Anesthetics, Stimulants, Tobacco/nicotine 2 miR-212 
  miR-328 
Alcohol, Cannabinoids, Opioids, Tobacco/nicotine 4 miR-335 
  miR-29c 
  miR-21 
  miR-15b 
Alcohol, Anesthetics, Opioids, Tobacco/nicotine 1 miR-132 
Alcohol, Anesthetics, Opioids, Stimulants 1 miR-124 
Alcohol, Anesthetics, Cannabinoids, Opioids 1 miR-29b 
Alcohol, Stimulants, Tobacco/nicotine 6 miR-199a-3p 
  miR-18a 
  miR-196b 
  miR-26b 
  miR-542-3p 
  miR-451 
Alcohol, Cannabinoids, Tobacco/nicotine 5 miR-221 
  miR-642 
  miR-19b 
  miR-24 
  miR-141 
Alcohol, Opioids, Tobacco/nicotine 5 miR-192 
  miR-137 
  miR-365 
  miR-7 
  miR-29a 
Alcohol, Anesthetics, Tobacco/nicotine 3 miR-222 
  miR-92a 
  miR-301a 
Alcohol, Cannabinoids, Stimulants 4 miR-665 




Table 1.3: A list of miRNAs reported to be upregulated in at least two DA (F. A. Taki et al., 2015). 
 
Drugs total microRNAs 
  miR-431 
  miR-27b 
Alcohol, Anesthetics, Stimulants 3 miR-375 
  miR-144 
  miR-34b 
Alcohol, Anesthetics, Cannabinoids 1 miR-139-5p 
Cannabinoids, Stimulants, Tobacco/nicotine 2 miR-218 
  miR-135a 
Cannabinoids, Opioids, Tobacco/nicotine 2 miR-20a 
  miR-224 
Anesthetics, Opioids, Tobacco/nicotine 1 miR-211 
Anesthetics, Cannabinoids, Stimulants 1 miR-376a 
Alcohol, Tobacco/nicotine 18 miR-188 
  miR-503 
  miR-351 
  miR-139-3p 
  miR-200c 
  miR-26a 
  miR-30e 
  miR-181b 
  miR-203 
  miR-30d 
  miR-93 
  miR-132_St 
  miR-135b 
  miR-374b 
  miR-18a_St 
  miR-27a_St 
  miR-25 
  miR-140_St 
Alcohol, Stimulants 11 miR-153 
  miR-125b-3p 
  miR-708 
  miR-523 
  miR-369-5p 
  miR-28_St 
  miR-196a 
  miR-32 




Table 1.3: A list of miRNAs reported to be upregulated in at least two DA (F. A. Taki et al., 2015). 
 
Drugs total microRNAs 
  miR-130b 
  miR-181a 
Alcohol, Cannabinoids 21 miR-93_St 
  miR-125a-3p 
  miR-200a 
  miR-376c 
  miR-145 
  miR-339-5p 
  miR-379 
  miR-10b 
  miR-370 
  miR-183 
  miR-323-3p 
  miR-322 
  miR-10a 
  miR-26b_St 
  miR-30e-3p 
  miR-101 
  miR-149 
  miR-215 
  miR-99a 
  miR-130a 
  miR-1195 
Alcohol, Opioids 4 miR-103 
  miR-122 
  miR-302b 
  miR-107 
Alcohol, Anesthetics 10 miR-136-5p 
  miR-181a-5p 
  miR-34a 
  miR-146a 
  miR-221-3p 
  miR-124-5p 
  miR-214 
  miR-488-3p 
  miR-138-5p 
  miR-30e-5p 
Stimulants, Tobacco/nicotine 7 miR-30c 
  miR-126_St 




Table 1.3: A list of miRNAs reported to be upregulated in at least two DA (F. A. Taki et al., 2015). 
 
Drugs total microRNAs 
  miR-148a 
  miR-15a 
  miR-331-3p 
  miR-16 
Cannabinoids, Tobacco/nicotine 7 miR-186 
  miR-183_St 
  miR-106b 
  miR-362-3p 
  miR-96 
  miR-23a 
  miR-543 
Anesthetics, Tobacco/nicotine 1 miR-9_St 
Cannabinoids, Stimulants 4 miR-383 
  miR-409-3p 
  miR-20a_St 
  miR-374 
Anesthetics, Stimulants 2 miR-34c 
  miR-129 
Cannabinoids, Opioids 5 miR-142-3p 
  miR-499 
  miR-154 
  miR-331 
  miR-539 
Anesthetics, Cannabinoids 2 miR-487b 
  miR-495 







Table 1.4: A list of miRNAs reported to be downregulated in at least two DA (F. A. Taki et al., 
2015). 
 
Drugs total microRNA(s) 
Alcohol, Anesthetics, Stimulants, Tobacco/nicotine 2 miR-200a 
  miR-200b 
Alcohol, Stimulants, Tobacco/nicotine 6 miR-192 
  miR-128a 
  miR-223 
  miR-124a 
  miR-99a 
  let-7 
Alcohol, Cannabinoids, Tobacco/nicotine 2 miR-210 
  miR-374 
Alcohol, Anesthetics, Tobacco/nicotine 2 miR-152 
  miR-10b 
Alcohol, Cannabinoids, Stimulants 1 miR-335-5p 
Alcohol, Opioids, Stimulants 3 miR-181b 
  miR-382 
  miR-155 
Alcohol, Anesthetics, Stimulants 2 miR-183 
  miR-200c 
Alcohol, Cannabinoids, Opioids 1 miR-182 
Alcohol, Anesthetics, Opioids 1 miR-296 
Opioids, Stimulants, Tobacco/nicotine 2 miR-150 
  miR-125b 
Anesthetics, Stimulants, Tobacco/nicotine 1 miR-429 
Alcohol, Tobacco/nicotine 21 miR-342-5p 
  miR-193b 
  miR-98 
  miR-100 
  miR-30a 
  miR-30a-5p 
  miR-101a 
  miR-362 
  miR-30C 
  miR-19b 
  miR-335 
  miR-29c 
  miR-21 
  miR-19a 




Table 1.4: A list of miRNAs reported to be downregulated in at least two DA (F. A. Taki et al., 
2015). 
 
Drugs total microRNA(s) 
  miR-186 
  miR-352 
  miR-301a 
  miR-622 
  miR-26a 
  miR-449b 
Alcohol, Stimulants 6 miR-212 
  miR-29b 
  miR-154 
  miR-124 
  miR-181a 
  miR-127 
Alcohol, Cannabinoids 4 miR-499 
  miR-324-5p 
  miR-27a_St 
  miR-10b_St 
Alcohol, Opioids 3 miR-606 
  miR-572 
  miR-184 
Alcohol, Anesthetics 3 miR-203 
  miR-206 
  miR-871 
Stimulants, Tobacco/nicotine 3 miR-31 
  miR-99b_St 
  miR-125a-5p 
Cannabinoids,  Tobacco/nicotine 6 miR-762 
  miR-223_St 
  miR-708 
  miR-423-5p 
  miR-500 
  miR-1226_St 
Opioids, Tobacco/nicotine 4 miR-1915 
  miR-99b 
  miR-146a 
  miR-149 
Anesthetics, Tobacco/nicotine  2 miR-224 
  miR-1 




Table 1.4: A list of miRNAs reported to be downregulated in at least two DA (F. A. Taki et al., 
2015). 
 
Drugs total microRNA(s) 
Opioids, Stimulants 3 miR-28 
  miR-410 
  miR-133b 
Anesthetics, Stimulants 6 miR-144 
  miR-451 
  miR-143 
  miR-199a-5p 
  miR-34c 
  miR-370 
Anesthetics, Cannabinoids 1 miR-340-3p 






















Table 1.5: A summary of 118 studies on miRNAs in response to seven categories of drugs of abuse (F. A. 

































Figure 1.1: Jean Nicot presenting the tobacco plant to Queen Catherine de Medicis and the Grand Prior of 













Figure 1.2: (A) MAPK signaling cascades (Cargnello & Roux, 2011). (B) Functions of ERK isoforms in 
























Figure 1.5: (A) Distribution of miRNA studies among DA (Drugs of Abuse). (B) Frequencies of studies 








Figure 1.6: (A) The % of differential miRNAs as a function of DA from 54 global profiling studies (73 
different treatment conditions). Note that Opioids had only 1 profiling study and therefore was not 
included in the analysis. ANOVA followed by post-Hoc pairwise comparisons was performed with 
p<0.05. Different letters denote statistically significant differences. (B) Total number (#) of miRNAs 
reported to be differential (Left axis) and the (%) of miRNAs reported to be up or down-regulated (right 
axis) in response to a DA in all 118 studies. Chi square test was used to compare the difference between 




Tri-generational microRNA profile shifts in response to parental post-embryonic nicotine 
exposure 
Abstract 
Early developmental stages are highly sensitive to stress and it has been reported that pre-
conditioning with tobacco smoking during adolescence predisposes those youngsters to become 
smokers as adults. However, the molecular mechanisms of nicotine-induced transgenerational 
consequences are unknown. In this study, we genome-widely investigated the impact of nicotine 
exposure on small regulatory microRNAs (miRNAs) and its implication on health disorders at a 
transgenerational level. Our results demonstrated that nicotine exposure, even at the low dose, 
affected the global expression profiles of miRNAs not only in the treated worms (F0 parent 
generation) but also in two subsequent generations (F1 and F2, children and grandchildren).  
Some miRNAs were commonly affected by nicotine across two or more generations while others 
were specific to one. The general miRNA patterns followed a “two-hit” model as a function of 
nicotine exposure and abstinence. Target prediction and pathway enrichment analyses showed 
daf-4, daf-1, fos-1, cmk-1, and unc-30 to be potential effectors of nicotine addiction. These genes 
are involved in physiological states and phenotypes that were consistent with previously 
published nicotine induced behavior. Our study offered new insights and further awareness on 
the transgenerational effects of nicotine exposed during the vulnerable post-embryonic stages, 
and identified new biomarkers for nicotine addiction.  






40% of children have been estimated to be exposed to nicotine and up to 60% of 
teenagers were reported to be active smokers in some developing countries in 2010 (WHO, 
2012). Whether actively or passively taken, tobacco smoke causes damage to every organ in the 
body. High death rates and increased economic burden have triggered a lot of policies and 
research on tobacco-related diseases. Despite its known health risks, tobacco abusers are 
entrapped in a vicious cycle of drug dependence. Among the 4000 chemicals in tobacco, nicotine 
is one of the primarily addictive components mediating continuous smoking relapses throughout 
an individual’s lifetime (CDC, 2010a; USDHHS, 1988). Early developmental periods are known 
to be highly sensitive and vulnerable to stress. Children who are exposed to smoke are more 
susceptible to become smokers during adulthood (Kandel & Chen, 2000; Slotkin, 2002). 
Numerous studies have reported the effects of nicotine (Neal L. Benowitz, 1988; Counotte et al., 
2009; Dani & Heinemann, 1996; Feng et al., 2006; Samaha, Yau, Yang, & Robinson, 2005; 
Sobkowiak, Kowalski, & Lesicki, 2011; Thomas, Welsh, Galvez, & Svoboda, 2009; Wada et al., 
1989) which focused on the exposed generation. Other studies investigated the effects of nicotine 
during prenatal and perinatal periods (Ajarem & Ahmad, 1998; El Marroun et al., 2014; 
Holloway, Cuu, Morrison, Gerstein, & Tarnopolsky, 2007; Maritz, 2013). However, to our 
knowledge, the transgenerational effect of nicotine exposed strictly till adolescence has not been 
reported. Our recent studies show that nicotine exposure caused significant behavioral changes in 
C. elegans (F. Taki et al., 2013). However, the molecular mechanisms of nicotine-induced 
transgenerational consequences are not known. Therefore, elucidating the molecular regulatory 
mechanism for such phenotypes is essential for developing new approaches for monitoring and 




Research on nicotine was based on many biological organisms (rats, mice, flies, fishes, 
and worms) (Matta et al., 2007) that modeled different aspects of nicotine-induced behavior like 
sensitization, tolerance, withdrawal, and reinforcement. We employed the nematode C. elegans 
to investigate the mechanism of action of nicotine on multiple levels. Research on C. elegans is 
relatively inexpensive, practical, and free of ethical concern. C. elegans is particularly attractive 
for transgenerational studies due to its small size (1 mm adult), short generation time (2-3 days) 
and lifespan (2-3 weeks) at 20
o
C, and superfluous offspring production (300 eggs/N2 
hermaphrodite) (Riddle et al.). C. elegans shares up to 80% homology with the human genome 
(Beitel, Clark, & Horvitz, 1990; S. Brenner, 1974). Thus, it has provided a wealth of information 
about biological and physiological processes over the last decade, the most recent of which 
involved the discovery of the microRNAs (miRNAs) (R. C. Lee et al., 1993).  
Serious research has been devoted to dissect the factors involved in gene regulation and 
has provided clues concerned with the environmental contribution in shaping physiological 
phenotypes. miRNAs are an extensive class of newly discovered small regulatory RNAs (B. 
Zhang et al., 2007). Over 200 and 1000 miRNAs have been sequenced in C. elegans and 
humans, respectively. Due to their conserved and pleiotropic roles in gene regulation processes 
(Ambros, 2003; Aukerman & Sakai, 2003; C. Z. Chen, Li, Lodish, & Bartel, 2004; V. N. Kim, 
2005; McManus, 2003), miRNAs are considered biomarkers of an innate response to 
environmental fluctuations. Nicotine altered miRNA expression levels in different biological 
systems (e.g. PDLSC, mouse fetal neuroepithelial precursors, rodents and PC12 cell model, 
canines, humans) (Balaraman, Winzer-Serhan, & Miranda, 2012; W. Huang & Li, 2009; Kassie 
et al., 2010; Ng et al., 2013; Shan et al., 2009; Shin et al., 2011). Some were linked to disruptions 




miR-16 and miR-21) (Shin et al., 2011; Baohong Zhang, Pan, Cobb, & Anderson, 2007). 
Nicotine also antagonized and upregulated ethanol-induced miRNAs (Balaraman et al., 2012). 
Interestingly, a study demonstrated the role of miR-140* in nicotine addiction using rodents and 
PC12 cells (W. Huang & Li, 2009). The research showed that miR-140* targeted dynamin, 
which is crucial for neuronal plasticity and hence addiction-related processes (W. Huang & Li, 
2009). Taken collectively, these studies showed a role for miRNAs in nicotine-dependent 
mechanisms. In this study, we systematically investigated the transgenerational impact of 
nicotine on miRNA expression and its implication on nicotine-induced health disorders. We took 
advantage on the wealth of data available on nicotine dose response curves. The latter are 
specific to each model organism and experimental design, yet are phenotypically comparable. 
Thus, we chose two nicotine doses associated with a stimulatory versus depressive effect on 
speed in our C. elegans model as reported by Sobkowiak and colleagues (Sobkowiak et al., 
2011). 
Material and Methods 
Nicotine exposure and sampling 
Nicotine exposure and worm sampling were based on our previous method (F. Taki et al., 
2013). Briefly, nicotine (Acros Organics, NJ, USA) was dissolved in phosphate buffer as 1 M 
and 0.001 M stocks. NaCl, peptone, agar and water mixture were first autoclaved, cooled and 
then kept at 55 °C. After the addition of cholesterol, CaCl2, MgSO4 and KPO4, the medium was 
divided into three flasks. The first flask was dedicated for control plates (no nicotine) and was 
left as is. Conversely, an equal amount of nicotine solution was added from each stock to the 




Thus, worms were exposed to nicotine uniformly distributed in solid agar medium. The selection 
of nicotine concentrations (20µM and 20mM) was based on previous reports (Matta et al., 2007; 
Sobkowiak et al., 2011) followed by a set of assays to confirm the dose-dependent biphasic 
phenotypes. Subsequently, we performed extensive analyses on the effect of nicotine on 
sinusoidal movement, body bends and reversals, as well as speed (F. Taki et al., 2013). The 
chosen concentrations were associated with a non-monotonic bell shaped response and thus 
agree with previous reports. So, 20µM and 20mM nicotine were considered suitable for our 
current and intended miRNA study. 
C. elegans hermaphrodite N2 Bristol wild type was used. Maintenance and worm transfer 
were done after NGM plates were seeded with OP50, and then kept at 20
o
C. Egg synchronization 
was done via bleaching method (J. Sulston & Hodgkin, 1988) with slight modifications. Bleach 
breaks down the worms allowing for eggs to be free in solution. The eggs were then washed 
several times and were left to be suspended in the last wash on a shaker in the 20
o
C incubator for 
about 14 hours. After hatching, all progeny were stuck at L1.  
L1 larvae of the parent (F0) generation were transferred to the three treatment groups 
which included the control group along with the low and high nicotine concentrations. Parent 
(F0) exposure lasted for about 30 hours until L3/L4 transition. Then, worms were washed off the 
plates into two eppendorf tubes and pelleted. We controlled for sample bias by collecting all 
worms on a plate. Thus each biological replicate included worms with variable sensitivities and 
covered the entire response spectrum within a plate. The bigger pellet was intermittently 
centrifuged two times at 2000 rpm then 3000 rpm with supernatant removal. Then, it was flash 
frozen in liquid nitrogen, and stored at -80
o
C for subsequent molecular studies. The eppendorf 




removal. The worms were then transferred to nicotine-free NGM plates seeded with OP50, left to 
dry, and were then sealed and placed back in the 20
o
C incubator to grow until second day of 
adulthood (egg laying peak). Worms were then collected for synchronization of isolated eggs. 
The whole procedure was repeated twice until F2 generation. 
miRNA expression profile 
Total RNA was extracted for all treated and control samples using mirVana™ miRNA 
Isolation Kit. Briefly, the sample was denatured using a lysis buffer. RNA was then separated 
from DNA and proteins via acid-phenol extraction. Then, ethanol was added to the sample 
followed by centrifugation to allow it to pass through a glass-filter. Several washes preceded the 
elution of the RNA with DNase/RNase-free water. RNA quantification and evaluation was done 
using the NanoDrop ND-1000 Micro-Volume UV/Vis Spectrophotometer (NanoDrop 
Technologies, Wilmington, DE).  
Reverse transcription was performed using TaqMan microRNA Reverse Transcription kit 
(Applied Biosystems, Foster City, CA) to reverse transcribe extracted RNA to cDNA for all 231 
miRNAs . A total of 200ng of RNAs was used for each RT reaction. The reactions were then run 
using thermal cycler for 16
o
C for 30 min followed by 42
o
C for 30 min, 85
o
C for 5 min and 
finally held at 4
o
C. The cDNAs were then diluted in 80µl DNase/RNase-free water for qRT-
PCR. 
The expression levels of miRNAs were analyzed after performing qRT-PCR on 384-
well-plates using the ViiA
TM
 Real-Time PCR System (Applied Biosystem). Briefly, each well 
carried a 15µl reaction of 5.5µl DNase/RNase free water, 7.5µl SYBR Green master mix, µl 




run for 10 min at 95
o
C for enzyme activation followed by denaturation for 15 sec at 95
o
C and an 
annealing/extension step for 60 sec at 60
o
C. The latter 2 steps were repeated for 40 cycles.  
The Ct values from the qRT-PCR were exported to an Excel file. The average of the total 
miRNA (231) Ct-values was used for normalization. The ∆Ct values were calculated as Ct(miRNA) 
-Ct(avg miRNAs). The ∆∆Ct was calculated as the difference in the ∆Ct values between control and 
treatment. Then the fold change was calculated as 2
(∆∆CT)
. Statistical analysis was based on t-test 
for independent samples via SPSS (20) to compare each of the nicotine treatments with control 
(i.e. low vs. control and high vs. control). Welch test correction was performed to account for 
unequal variance in each of the compared groups (control and treatment). In addition, to increase 
the statistical stringency, miRNAs differential expression was deemed significant only if it 
fulfilled two criteria: p value <0.05 and expression changed by at least 50% relative to control.  
Fold change values (2
(∆∆CT) 
-1) were used to construct heat maps coupled with non-
supervised hierarchical clustering using Euclidean distance and complete linkage analysis and 
included all miRNAs (vertical axis) and samples (six treatment groups on the horizontal axis). 
The latter approach was done for miRNAs with statistically significant expression alterations 
using MeV (MultiExperiment Viewer) (Saeed et al., 2006). 
Target prediction and pathway analysis 
Differentially altered miRNAs that were common to at least two generations were used to 
perform target prediction using mirSOM software (Heikkinen, Kolehmainen, & Wong, 2011). 
To prepare the input for analysis, duplicates were removed and thus only unique values of targets 
with a perfect seed match were used. The predicted targets were ranked according to the 
frequency of occurrence in the originally compiled gene list. Such a frequency reflects the 




Huang, Sherman, & Lempicki, 2009a, 2009b) for analysis. Gene ranking was based on 
functional annotation clustering (highest stringency) endpoint provided by DAVID. Target genes 
belonging to clusters with enrichment values ≥2 were used based on the order of the clusters to 
prepare a ranked list. The latter included 321 genes and was used as an input for GOrilla (process 
ontology) (Eden, Navon, Steinfeld, Lipson, & Yakhini, 2009) that provided DAG (directed 
acyclic graph) showing relationships among enriched processes. miRNA-target networks were 
constructed using Cytoscape (Smoot, Ono, Ruscheinski, Wang, & Ideker, 2011). Other specific 
analysis were performed and described in details in their corresponding result section.  
Results 
Analyzing the intra-generational effect of nicotine 
The effect of nicotine on the parent (F0) generation 
We studied the effect of nicotine on the expression levels of 231 miRNAs in L4 C. 
elegans (N2). The effect of nicotine on the F0 generation can be found in our previous study (F. 
A. Taki et al., 2013). To summarize the results, nicotine affected the expression of forty miRNAs 
(17.3%), in which three miRNAs (miR-79, miR-80 and miR-230*) were altered in response to 
the lower nicotine concentration (20µM). The expression of 37 miRNAs was changed after high 
nicotine concentration (20mM) treatment. About 78% of the altered miRNAs were upregulated 
with fold changes ranging from 0.5 to 3.0 folds. Twenty six miRNAs were upregulated by >0.5 
folds (p<0.05). The remaining 22% miRNAs were downregulated by the 20mM nicotine 
treatment. miR-80 was the only miRNA consistently upregulated in worms treated with low or 
high nicotine concentrations. Based on the miRNA profile changes observed in response to 




indirect transgenerational effect of nicotine treatment limited to the postembryonic-stages of the 
F0 generation.  
The effect of nicotine on the offspring (F1) generation  
The F0 generation was the only one with direct contact with nicotine, and such was 
limited to the 30-hour, post-embryonic period (i.e. L1 to L4). With this in mind, we investigated 
possible effects of nicotine on the genome-wide miRNA expression levels in L4 belonging to the 
F1 generation. As shown in Figure 2.1A, the expression of thirty one (13.4%) unique miRNAs 
was altered in response to parental nicotine exposure. The low and high nicotine concentrations 
affected nine and twenty six miRNAs, respectively. Three out of nine miRNAs were upregulated 
in offspring of worms exposed to the lower nicotine concentration (20µM) (Table 2.1). The 
highest increase was observed for miR-254 (3.5, p=0.006) followed by miR-793 (1.2, p=0.03) 
and miR-66 (0.7, p=0.04). On the other hand, the remaining six miRNAs were downregulated 
with the highest fold change observed for miR-253 (-1.0, p<0.001) followed by miR-255 (-0.7, 
p=0.001), miR-786 (-0.6, p=0.002), and miR-785, miR-794, and miR-41 (-0.5, p=0.036, 
p=0.029, and p<0.001, respectively) (Table 2.1).  As for offspring of parents exposed to the 
higher nicotine concentration (20mM), 32% of the differentially altered miRNAs were 
upregulated. The highest upregulation was observed for miR-254 (6.4, p=0.018) followed by 
miR-260 (5.6, p=0.023), miR-257 (4.8, p=0.034), miR-36 (2.9, p=0.014), miR-1019 (1.6, 
p=0.005), miR-236 (0.8, p=0.01), miR-353 (0.7, p=0.016), and miR-262 (0.6, p=0.014). 
Conversely, 68% of the miRNAs, altered after parental exposure to high nicotine concentration, 
were downregulated. With the highest fold change being for miR-253 (-1.0, p<0.001), others  
like miR-1829a (p=0.006) , miR-1829b (p=0.001),miR-2208a* (p=0.041), miR-56* (p=0.005), 




(p=0.002), miR-53 (p=0.001), miR-2212St (p=0.037), miR-2218a (p=0.044), miR-42 (p=0.013), 
miR-1828 (p=0.025), miR-242 (p=0.024), and miR-784* (p=0.022) decreased by more than 0.7 
folds (Table 2.1). Additionally, we observed that three miRNAs were affected by both nicotine 
concentrations when exposed during the parental post-embryonic stage. miR-254 was the most 
upregulated  in offspring of both treatment groups and as the concentration increased, the 
magnitude of the upregulation was more dramatic as it doubled from 3.0 folds to 6.0 folds. On 
the other hand, miR-785 (-0.5) and miR-253 (-1.0) were downregulated in response to both 
nicotine concentrations exposed to parents, but unlike miR-254, the magnitude was similar in 
offspring of parents exposed to both low and high nicotine concentrations (Table 2.1).  
The effect of nicotine on the grand-offspring (F2) generation  
We traced down the effect of nicotine until the F2 generation. Similarly, grand-offspring 
were never exposed to nicotine, but progressed from ancestors treated with nicotine during their 
post-embryonic period. In F2, sixteen unique miRNAs (6.9%) showed statistically significant 
alterations in their expression levels in response to grand-parental nicotine exposure (Table 2.2). 
Ten and twelve miRNAs were differentially expressed in grand-offsping of parents exposed to 
low and high nicotine concentrations, respectively. Among the affected miRNAs, 40:60% and 
50:50% were down and upregulated in grand-offspring originating from the parental low and 
high nicotine treatment groups, respectively (Table 2.2).  Interestingly, six of the sixteen unique 
miRNAs were commonly and similarly altered in both treatment groups progressing from grand-
parents exposed to low and high nicotine concentrations. miR-80 was the only commonly 
upregulated miRNA by 0.8 (p=0.027) and 0.6 (p=0.035) fold changes in grand-progenies of 
parents exposed to low and high doses, respectively. Oppositely, miR-239a (p(L)=0.006, 




downregulated in both groups by about 0.6 folds, while miR-53 and miR-244 were 
downregulated by about 1.0 folds with p(L) and p(H) <0.001. Other miRNAs were dose-dependent 
as their expression levels changed in one of the two groups, but not both. For example, miR-235 
(p=0.003), miR-51 (p=0.043), and miR-790 (p=0.041) were upregulated by >0.5 folds, while 
miR-255 was downregulated by about 0.5 folds (p=0.009) in grand-offspring of 20µM-treated 
parents. On the other hand, the highest upregulation was observed for miR-1 (2.0, p=0.005) 
followed by miR-2218a (0.9, p=0.013), miR-2220 (0.8, p=0.001) and miR-800 and miR-2212* 
(0.5, p=0.049 and p=0.001, respectively) leaving miR-1828 to be uniquely downregulated by 0.5 
folds (p=0.046) in grand-offpring of parents treated with high nicotine dose (20mM) (Figure 
2.1B; Table 2.2). 
Investigating the inter-generational effect of nicotine 
Fourteen miRNAs were affected in more than one generation (Figure 2.1C) 
We checked for miRNAs whose expression was altered in more than one generation and 
found that indeed some miRNAs were commonly affected. Four miRNAs were altered in both 
F0 and F1 worm populations in response to direct and indirect nicotine treatment, respectively.  
As shown in Figure 2.2, miR-242 and miR-1829b were upregulated (1.0 fold) in F0 worms 
exposed to high nicotine concentration, while both were downregulated (-0.5 folds) in their 
offspring. miR-794 was downregulated (0.5 folds) in F1 originating from the low nicotine 
treatment group without being affected in the parents, while it was upregulated (0.6) in the 
parents (F0) exposed to high nicotine concentration. Though the F0 parents exposed to 20µM 




F1 offspring. On the other hand, it reversed in response to the 20mM concentration as it was 
upregulated in F0 (1.0 fold) to become downregulated in their offspring by 0.5 folds.  
The parents and the grand-offspring also shared four altered miRNAs in response to 
nicotine. Both miR-2220 and miR-800 were altered in both F0 parents treated with the high 
nicotine dose and their grand-offspring. The extent seemed to decrease from 3.4 to 0.8 folds in 
the case of miR-2220, while it remained similar (0.5-0.6 folds) for miR-800. miR-80 on the other 
hand was upregulated (1.0 and 0.9 folds) in both F0 parents exposed to low and high nicotine 
concentrations and remained like so (0.8 and 0.6 folds)  in their grand-offspring, respectively. 
The F1 offspring and F2 grand-offspring were grown in nicotine-free environments. Our 
results showed that out of the total miRNAs differentially expressed across all generations, five 
were common to F1 and F2. miR-53 and miR-1828 were downregulated (-0.5) in the F1 
offspring of parents exposed high nicotine treatment group and continued to be so in the F2 
grand-offspring (-1.0 and -0.5, respectively). Opposite patterns were observed for miR-2212* 
and miR-1 which started as being downregulated in F1 20mM treatment group to become 
upregulated in F2. The expression of miR-1, miR-2218s and miR-2212* was increased by almost 
2.0 and 1.0 folds, respectively from F1 to F2generations, both of which originated from parents 
and grandparents exposed to the high nicotine concentration. No altered miRNAs were shared 
between F1 and F2 worms from parents and grandparents exposed to the low nicotine 
concentration.  
Interestingly, the expression of only one miRNA was computed to be statistically 
significant across all generations. It appears that miR-255 was upregulated by more than 1.0 fold 
in F0 parents exposed to the high nicotine concentration. Neither this pattern, nor its inverse was 




downregulated (-0.7 and -0.5 folds) in both F1 and F2 generations of parents and grandparents 
exposed to the lower nicotine concentration during its postembryonic development. Taken 
collectively, we report that fourteen miRNAs (6%) were differentially altered in response to 
nicotine in at least two generations.  
Seventy two miRNAs were differentially regulated across all generations 
We investigated the patterns of miRNA expression levels across all generations in 
response to post-embryonic nicotine exposure in C. elegans. We compiled a list of all miRNAs 
whose expression was altered by at least 0.5 folds (p<0.05) in at least one generation. As a result, 
the list included seventy two miRNAs which represent 31% of all miRNAs tested. We 
constructed a heat map based on the Mean Fold Change (MFC) values for both 20µM (Low) and 
20mM (High) nicotine treatment group across all generations (Figure 2.3). Different columns 
represent MFCs of six groups and are relative to control (0µM nicotine). Then, unsupervised 
hierarchical clustering based on Euclidean distance and complete linkage was performed and 
included six groups. For optimal visualization of the patterns, leaf ordering was done for both 
miRNAs and samples. As shown on the map, expression patterns for treatment groups belonging 
to the same generation were mostly similar to one another when compared to other generations. 
Thus, they were closely ordered next to one another. Also, we noticed another general pattern 
where worms exposed to the 20mM (high) nicotine treatment group as well as their F1 progeny 
had more altered miRNAs than those belonging to the lower nicotine concentration. Such was 
evident in the colored cells relative to those that were black (i.e. red: upregulated, green: 
downregulated, black: no change). However, the situation was different in the F2 generation 
where grand-offspring worms from parents exposed to high and low nicotine doses had similar 




concentration in F0 parents clustered with both F2 grand-offspring treatment groups. On the 
other hand, both groups in F1 had a different overall miRNA expression pattern and thus 
clustered separately from F0 and F2.  
The fold changes of the seventy two miRNAs were also subjected to unsupervised 
optimized clustering. With 8.6 as a cutoff distance, results showed two clusters, one that included 
four miRNAs (miR-254, miR-260, miR-257, and miR-36), while the other included sixty eight. 
Decreasing the cut-off distance by half to 4.3 resulted in one additional cluster of five miRNAs 
(miR-2220, miR-66, miR-90, miR-2216*, and miR-2218b*).   
For a more qualitative assessment of the expression changes across the three generations, 
we performed further analysis on the seventy two miRNAs that showed differential alteration in 
at least one generation. The exact values for the expression levels have been thoroughly 
discussed above. Hence, we provided further elaboration to study the effect of nicotine in a dose 
and generation-dependent manner. As shown in the radar graphs (Figure 2.4), each concentric 
ring represents respective fold changes with zero as no change. miRNAs were ordered 
alphabetically to allow for comparison between low and high treatment groups across 
generations. In F0, the direct nicotine effect was more dramatic in the high versus the low 
concentration treatment. As an overall, the pattern seen in response to the 20µM nicotine 
concentration was circular and generally uniform, bordering the zero-fold-rim, and did not 
exceed 1.0 fold change in either direction. On the other hand, the circular pattern was no longer 
uniform in worms treated with the 20mM nicotine dose. Much more miRNAs were increased by 
>1.0 folds, and the pattern borders mostly intersected with 1.0 fold-rim. In F1, though nicotine 
was no longer in direct contact, the progeny of worms exposed to the low nicotine concentration 




by dramatic up and downregulations that reached the 4
th
 rim in the positive direction, and the 1
st
 
rim in the negative direction, respectively. A more defined shape was observed in the offspring 
of parents exposed to the high nicotine concentration as it had a star-shaped pattern in the F1 
generation. The increase in the downregulated miRNAs was similar to offspring of the low 
nicotine concentration. However, the main shifts in expression levels were the doubled 
upregulations in three out of four miRNAs (miR-260, miR-254, miR-36, and miR-257).  Finally 
in F2, the pattern went back to become circular. Nonetheless, unlike the F0 generation, the 
circular pattern was similar in grand-offspring originating from grandparents treated with either 
nicotine doses. The circular pattern generally overlapped with the F0 20µM treatment group, and 
this was consistent with results shown in the heat map after hierarchical clustering. 
Investigating the nicotine potential effectors downstream of the altered miRNAs 
Most miRNAs have pleiotropic functions. It is known that one gene can be targeted by up 
to hundreds of miRNAs. Vice versa, one miRNA can target hundreds of genes. Therefore, to 
understand processes that are mostly affected by nicotine treatment, we limited our analyses on 
the fourteen miRNAs that showed differential expression in at least two generations (Figure 2.2). 
Thus, a list of genes predicted to be targeted by miR-242, miR-1829b, miR-785, miR-1, miR-
2218a, miR-53, miR-235, miR-80, miR-2220, miR-800, miR-255, miR-1828, miR-2212*, and 
miR-794 was compiled. The list included 2462 unique gene suspects. Two genes (rbc-1 and egl-
10) were predicted to be targeted by five miRNAs. Based on annotations from wormbase (Yook 
et al., 2012), rbc-1 might be involved in proton-pump translocation, while egl-10 has a role in 
egg laying and regulation of certain signaling pathways. Four miRNAs were predicted to 
regulate each of F10D2.10, miz-1(zinc-finger transcription factor), cyp-23A1 (xenobiotic 




348 were expected to be common to two miRNAs included in our analyses. The remaining genes 
were not considered as common targets to the fourteen miRNAs included in the target prediction 
analysis.  
To investigate whether each miRNA is involved in particular pathways, a gene list for 
each of the fourteen miRNAs was used as an input for DAVID analysis. Based on the percentage 
of genes belonging to a certain process, an enrichment value is computed coupled with p-values 
(Fold enrichment, p-value). Enrichments manifested in KEGG pathways were associated with 
only four miRNAs. miR-1828 might have a role in the Wnt-signaling pathway (3.3, p=0.058). 
miR-80 was predicted to target genes involved in Notch (6.0, p=0.025), MAPK (3.0, p=0.049), 
ErbB (4.0, p=0.082) signaling pathways. Also, MAPK (2.4, p=0.095) as well as endocytosis (3.1, 
p=0.006), and pyrimidine metabolism (2.9, p=0.016) might be regulated by miR-785. Finally, 
miR-1 was estimated to target signaling pathways such as the phosphatidylinositol system (5.7, 
p=0.003), lysosome (2.8, p=0.02), oxidative phosphorylation (2.2, p=0.027), Wnt (2.7, p=0.035), 
inositol phosphate metabolism (5.24, p=0.036), and mTOR signaling pathways (3.9, p=0.075). 
Since the miRNA annotation research is still in the juvenile stages, we were interested in 
investigating possible relationships between all the genes predicted to be targeted by the fourteen 
miRNAs. In order to do that, we used GOrilla software which provides a DAG (Directed Acyclic 
graph) that shows relationships among enriched pathways predicted to be regulated. The input 
for GOrilla was ranked. To prepare the ranked list, we performed functional annotation 
clustering for the 2462 genes through DAVID with highest stringency classification. The output 
from DAVID included 120 clusters arranged in decreasing order of enrichment values. Genes 
belonging to clusters with enrichment values greater than two were considered and were ranked 




genes and was used for input in GOrilla. The highest enrichments belonged to positive regulation 
of translation (10.9, p=10
-3
) followed by macromolecule modifications (6.67-10, p<10
-3
) (e.g. 
peptidyl-lysine and amino acid modification, protein metabolism). The fourteen miRNAs were 
computed to target metabolic and biosynthetic regulatory genes (4.6, p<10
-9
). Transcriptional 
control as well as RNA, nitrogen and nucleobase metabolism were also highly enriched (4.6, 
p<10
-9
). Processes like taxis and chemotaxis, axon guidance had an enrichment value of 2.9 with 
p<10
-7
.  Targeted processes like response to external (p<10
-5





) as well as phosphorylation (p<10
-3
) had enrichment values ranging 
from 2.1 to 2.7 (Figures 2.5 and 2.6A).  
Then, a bottom-top approach was followed starting with matching genes of every 
enriched pathway to their predicted regulatory miRNAs. Based on GOrilla predictions (Figures 
2.5 and 2.6AB), miR-242 was not involved in any of the enriched processes. miR-53 and miR-
1829b targeted genes involved in molting cycle and locomotion. In addition to these two 
processes, miR-800 might regulate cellular development, response to stimulus. Interestingly, 
targets of miR-785 were restricted to nitrogen, nucleobase, and RNA metabolic processes, 
biosynthesis, and transcriptional regulation. On the other hand, miR-235 covered many of the 
enriched processes, except for taxis, and other functions related to protein metabolism and 
modifications. Six of the remaining miRNAs (i.e. miR-2218s, miR-794, miR-255, miR-2212*, 
and miR-80) might be working redundantly as they covered all processes except for those related 
to protein metabolism and some modifications. Finally, the last two miRNAs were the most 
pleiotropic and were anticipated to fine-tune genes encoding of the enriched functions except for 





Pathways with the highest enrichment values and statistical significance 
We narrowed our analysis further by focusing on select pathways predicted by GOrilla to 
be altered in response to nicotine (Figure 2.7A). Enrichment values >3.0 and p-values <10
-9
 were 
used as cutoff criteria. Out of the fifty two overall pathways, only fourteen were then chosen for 
downstream analysis. 25 genes involved in those pathways were then extracted and used as input 
for gene functional annotation through DAVID. Such was run with highest stringency and 
resulted in two clusters. The first one, including unc-30, skn-1, nhr-49, fos-1, nfi-1, and vab-3, 
had an enrichment value of 21.4. The second one, including daf-4, daf-1, cmk-1, pek-1, and sma-
6, had a lower enrichment value of 11.3. As detailed in Table 2.3, their functions include 
response to stress, development and differentiation, behavior such as egg laying and locomotion. 
These results were consistent with the overall target prediction discussed in the previous 
paragraphs.  
Analysis through GOrilla provided a general idea about the enriched pathways across the 
three generations; however, it might have masked differences between individual generations. 
We wanted to investigate common effectors between only two generations. For F0-F1 pair, 
target prediction was done for five differentially altered miRNAs (miR-242, miR-785, miR-
1829b, miR-794, and miR-255). For F0-F2 pair, also five miRNAs were used (miR-255, miR-
2220, miR-80, miR-800, and miR-235). For F1-F2 pair, (miR-1, miR-2218a, miR-2212*, miR-
1828, miR-53, and miR-255) were used for target prediction. The resulting gene lists included 
1047, 1046, and 1149 genes for F0-F1, F0-F2, and F1-F2 pairs, respectively. The latter were 
individually run through DAVID for functional annotation clustering with highest stringency. 
Only clusters with enrichment values >3.0 were considered and the corresponding genes were 




enriched cluster (regulation of biosynthetic process, E=5.9) and included 16 genes. The F1-F2 
pair had three enriched pathways involved in the regulation of biosynthesis and transcription 
(Eavg=4.2) and included a total of 15 genes. The absence of enriched pathways from target genes 
predicted to be regulated by miRNAs common to the parents and their offspring in the F0 and F1 
generations suggests that different processes were altered in F0 versus F1 generations. This result 
is consistent with the hierarchical clustering where the distance between F0 and F1 was the 
highest, suggesting least commonalities in miRNA expression patterns.  
unc-30, fos-1, daf-4, daf-1, cmk-1, sma-1, and nfi-1 were common genes among the 
outputs from the above two approaches. Of the latter, only unc-30, fos-1, daf-1, daf-4, and cmk-1 
were targeted by differentially altered miRNAs in at least five of the six treatment groups across 
all generations. daf-4 was predicted to be targeted by twenty two miRNAs, daf-1 and fos-1 were 
predicted to be targeted by fourteen and twelve miRNAs, respectively, while cmk-1 and unc-30 
were targeted by eight and seven miRNAs, respectively (Figure 2.7A).  Figure 2.7B depicts these 
five genes targeted by one or more of the fourteen commonly altered miRNAs (Figure 2.7; Table 
2.3).  
Discussion 
Both genetics and environment determine the phenotype. Stress exposed during early 
development till adolescence has enduring effects (e.g. neuro-remodeling, sensitivity to drugs of 
abuse). A study showed that chronic nicotine exposure during adolescence but not adulthood 
lead to long-lasting alterations in the cognitive performance in rats (Counotte et al., 2009). 
Epigenetic modifications might be mediators of these short or long-term, and even 
transgenerational changes (Crews et al., 2012).  To be considered as truly transgenerational, 




exposure period. Those that occur in impregnated individuals should leave a mark on four or 
more generations, while experiences limited to ancestral postnatal period or non-gravid adults 
impact three or more generations (Skinner, 2008). In our study, post-embryonic nicotine 
exposure was restricted to F0 ancestors prior to their sexual maturity. This exposure was 
associated with an altered miRNA expression profile that remained evident in three generations. 
Therefore, it modeled a true transgenerational effect. 
Our results support the “two-hit” model proposed by Crews et al. (Crews et al., 2012). 
The first “hit” was the chronic nicotine exposure during the post-embryonic stage in C. elegans. 
The second “hit” was the withdrawal-associated stress experienced during gestation. Together, 
they caused alterations in the subsequent progeny (larvae) at the miRNA level, the focus of our 
study. Interestingly, some of the effects were shared while others were context dependent (e.g. 
nicotine dose, exposure vs. abstinence, acute vs. chronic, developmental period) (Figure 2.7C). 
Concentration specific patterns 
Chronic nicotine treatment was limited to about 30 hours from L1 to L4 in F0 generation 
worms. The subsequent generations were not in direct contact with nicotine. Despite that, 
nicotine affected miRNA profiles in a dose-dependent manner. In worms treated with the low 
nicotine concentration, the percentage of differentially expressed miRNAs remained similar 
across the generations (1-4% of miRNAs). However, a decreasing pattern was observed in 
worms treated with the high nicotine concentration as the generations progressed. 16.5% of the 
miRNAs had disparate expression in response to the direct exposure to the high nicotine 
concentration. The percentage decreased to about 11% in their F1 offspring. In the grand-




implies that nicotine treated chronically and strictly during the adolescent stages of the parent 
generation had a long lasting effect that was still detected in the third generation. Moreover, the 
dose-dependent effect was also passed along the generations as the severity of withdrawal was 
proportional to the nicotine dose and duration of exposure (Skjei & Markou, 2003). Unlike the 
high nicotine concentration, the low nicotine dose was pharmacologically active but 
asymptomatic. Such a dose-dependent effect decreased but remained evident in each generation. 
The F0-initiated nicotine ripple faded as the generations progressed to reach a baseline adaptive 
response observed in worms succeeding from the 20µM (low) nicotine treatment group.  
Generation versus nicotine concentrations  
Some miRNA expression alterations were specific to one nicotine dose, but not the other, 
while the expression of other miRNAs was altered in response to both nicotine concentrations. 
The difference was mostly evident in the F0 generation where worms were in direct contact with 
nicotine. Only 2.5% were commonly affected in response to the low and high nicotine 
concentrations. However, the miRNA response almost tripled in F1 offspring as 9.7% miRNAs 
were commonly responsive to both low and high nicotine concentrations. The percentage 
continued to increase in F2 grand-offspring as 37.5% of the miRNAs were commonly affected in 
response to both high and low grandparental nicotine exposures.  
Generation specific patterns 
31.2% of the miRNAs were totally altered in response to both nicotine concentrations. As 
the generations progressed, the number of totally altered miRNAs decreased from 17.3% in F0 to 
13.4% in F1 and finally became 6.9% in F2. Each generation had a pattern generally consistent 




However, most of the miRNAs (67%) were downregulated in F1, while almost half of them 
(55%) were upregulated in the F2 worm population. 
How can we explain the opposite miRNA patterns observed in F1 while both F0 and F2 were 
similar? 
Nicotine exposure was limited to the F0 generation. Similar miRNA profiles were 
observed in F0 and F2, while F1 had an opposite pattern as shown in the heat map, and radar 
graphs. Revisiting our experimental settings, L4 larvae belonging to the F0 generation were 
chronically exposed to nicotine and thus were desensitized to it. The L4 larvae of the F1 
generation were the progeny of F0 parents experiencing acute nicotine withdrawal. Finally, L4 
larvae grand-offspring (F2) progressed from parents (F1) experiencing protracted withdrawal. 
This is depicted in Figure 7C where all three time points are elucidated by arrows.   
It is crucial to recall two general nicotine-induced responses. The first is transient and 
results from either “acute” exposure or abstinence from nicotine. The second is adaptive and 
occurs after “chronic” treatment or abstinence from nicotine. Such might involve epigenetic 
modifications that stabilize gene expression in a dose and time-dependent manner in response to 
environmental changes. Thus, after adapting to a stimulus, an environmental shift back to 
“normality” is conceived as a new fluctuation. The system then responds transiently if the 
stimulus is temporary. Conversely, the response takes an adaptive, relatively permanent form in 
case the trigger is persistent. Thus, parent (F0) larvae model an adaptive state in response to 
chronic treatment. The perinatal period is vulnerable and sensitive to stress. It has been suggested 
that stress responses are transmitted through the germ line and are apparent in subsequent 




elegans maintains an epigenetic transcriptional memory through parental primordial germ cells 
(Furuhashi et al., 2010). Thus, grand-offspring (F2) larvae also model adaptation as they are the 
progeny of F1 parents experiencing chronic nicotine withdrawal. On the other hand, not only can 
chronic treatment followed by acute withdrawal disrupt a system, but contrasting symptoms can 
also arise after transitioning from acute to protracted withdrawal. With this in mind, the 
intermediate F1 generation does not model adaptation as their parents were experiencing acute 
withdrawal. Instead, they are sensitized and represent transience. This idea is clearly supported 
by an experiment done on rats where both direct nicotine exposure and chronic withdrawal were 
associated with a decrease in inhibitory control (i.e. addiction-related index). On the contrary, 
those rats undergoing acute withdrawal experienced improved inhibitory control (Kolokotroni, 
Rodgers, & Harrison, 2012). Collectively, the aforementioned scenarios can partly explain the 
similarities between F0 and F2 in contrast to F1 (Figure 2.7C).  
Functional annotation of miRNAs whose expression was altered in response to nicotine 
The miRNAs whose expression showed differential alterations in response to post-
embryonic nicotine treatment in F0 belonged to many families. However, miR-51 and miR-80 
families were more likely to mediate nicotine-induced effects. miR-51 family members are 
associated with a wide range of processes. Some of its members (i.e. miR-51, miR-52, and miR-
54-56) might regulate the developmental timing by antagonizing let-7 and lin-4. This family was 
also hypothesized to regulate miRISC activity which increased after the loss of miR-51 members 
and others like miR-239a and miR-244. The latter two were among the miRNAs that showed 
differential expression across generations. miR-51 family members are broadly and highly 
expressed (Lim et al., 2003). Therefore further upregulation might hinder other miRNA activities 




2010). Another abundant and constitutively expressed family is miR-58/80 family (Kato, de 
Lencastre, Pincus, & Slack, 2009; Lau, Lim, Weinstein, & Bartel, 2001; Lim et al., 2003). The 
deletion of all of miR-58 family members resulted in a sluggish worms with smaller body sizes. 
The miR-58 family members have a role in locomotion, body size and egg laying. Most of these 
traits are common with nicotine related phenotypes in C. elegans (e.g. paralysis in response to 
high nicotine concentration) (Matta et al., 2007). This might suggest a role of miR-58/80 family 
in nicotine molecular mechanism in the worm.  
Eight major functional hubs were mapped through GOrilla. These included locomotion, 
response to stimulus, multicellular organismal process, single-organism process, developmental, 
cellular and metabolic processes, and biological regulation. The highest statistically significant 
enrichment values belonged to the biological regulation hub. The latter included the regulation of 
transcription and gene expression, metabolism (e.g. RNA, nucleobase-containing compound), 
and biosynthesis pathways with enrichment values >3 and p-values <10
-9
. Similarities in 
pathway enrichment analysis were observed between F0 and F2, or F1 and F2 generations, but 
not F0 and F1.This is sensible when considering parents being under direct nicotine exposure, 
while their offspring originated from parents undergoing acute abstinence.  
Of course, response to environmental stimuli systematically alters a myriad of factors. 
However, we funneled down our analysis and focused on five genes predicted to have a role in 
nicotine’s mechanism of action across generations. The targets were regulated by the fourteen 
miRNAs whose expression levels were changed in more than one generation. We propose a 
model where daf-4, daf-1, fos-1, cmk-1, and unc-30 are regulated by most of the fourteen 
miRNAs in a context dependent manner across generations. Based on annotations from 




as it is expressed in the chemosensory neurons. fos-1 and cmk-1 mediate neuro-adaptation and 
remodeling in response to acute versus chronic exposure/withdrawal (Larson et al., 2011; Maze 
& Nestler, 2011; McPherson & Lawrence, 2007; Vonhoff, Kuehn, Blumenstock, Sanyal, & 
Duch, 2013). daf-4 might explain the downstream phenotypic changes as it is involved in exit 
from dauer larval stage, body size determination, male tail patterning, egg laying, chemosensory 
neuron specification, thermo-tolerance and reproductive ability. It is important to consider 
miRNAs as working as a system where synergistic, additive, as well as antagonistic effects arise 
and are affected by nicotine dose, duration of exposure, generation, as well as previous ancestral 
experiences. The net effect is a generation-specific phenotype, characterized by shared as well as 
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Table 2.1: The effect of parental post-embryonic nicotine exposure on miRNA expression 
levels in L4 worms belonging to the F1 generation. (* and β denote p-values<0.05 in 
comparison to control). 
 
 F1 Low F1 High 
 P value MFC ± SE P value MFC ± SE 
*miR1 0.813 0.12 ± 0.44 0.020 -0.60 ± 0.09 
*miR1019 0.321 0.92 ± 0.78 0.005 1.58 ± 0.29 
*miR1828 0.517 0.68 ± 0.93 0.025 -0.47 ± 0.11 
*miR1829a 0.637 -0.29 ± 0.53 0.006 -0.75 ± 0.06 
*miR1829b 0.009 -0.25 ± 0.04 0.001 -0.68 ± 0.06 
*miR1829c 0.025 -0.37 ± 0.11 0.027 -0.53 ± 0.09 
*miR2208aSt 0.883 0.12 ± 0.73 0.041 -0.66 ± 0.14 
*miR2212St 0.397 1.48 ± 1.50 0.037 -0.51 ± 0.17 
*miR2218a 0.581 0.37 ± 0.57 0.044 -0.50 ± 0.17 
*miR236 0.313 0.38 ± 0.28 0.010 0.81 ± 0.14 
*miR242 0.758 0.19 ± 0.53 0.024 -0.47 ± 0.07 
β*miR253 0.000 -0.97 ± 0.01 0.000 -0.97 ± 0.00 
β*miR254 0.006 3.47 ± 0.49 0.018 6.41 ± 0.87 
βmiR255 0.001 -0.71 ± 0.09 0.881 -0.10 ± 0.60 
*miR257 0.117 3.70 ± 1.69 0.034 4.81 ± 1.30 
*miR260 0.075 3.03 ± 1.13 0.023 5.58 ± 0.86 
*miR262 0.064 0.59 ± 0.20 0.014 0.58 ± 0.07 
*miR353 0.437 0.33 ± 0.39 0.016 0.67 ± 0.17 
*miR36 0.175 1.28 ± 0.72 0.014 2.90 ± 0.56 
βmiR41 0.000 -0.53 ± 0.01 0.586 0.18 ± 0.30 
*miR42 0.293 -0.30 ± 0.21 0.013 -0.48 ± 0.11 
*miR53 0.429 -0.24 ± 0.25 0.001 -0.52 ± 0.06 
*miR56St 0.531 -0.25 ± 0.33 0.005 -0.62 ± 0.05 
βmiR66 0.040 0.70 ± 0.20 0.091 1.01 ± 0.41 
*miR71 0.396 -0.29 ± 0.28 0.011 -0.62 ± 0.06 
β*miR785 0.036 -0.54 ± 0.10 0.002 -0.52 ± 0.03 
βmiR786 0.002 -0.65 ± 0.06 0.437 -0.21 ± 0.25 
*miR786St 0.700 0.18 ± 0.40 0.022 -0.45 ± 0.07 
βmiR793 0.031 1.21 ± 0.22 0.685 -0.07 ± 0.15 
βmiR794 0.029 -0.54 ± 0.14 0.242 -0.26 ± 0.16 





Table 2.2: The effect of parental post-embryonic nicotine exposure on miRNA expression levels 
in L4 worms belonging to the F2 generation. (* and β denote p-values<0.05 in comparison to 
control). 
 
 F2 Low F2 High 
 P value MFC ± SE P value MFC ± SE 
*miR1 0.636 0.24 ± 0.44 0.005 2.00 ± 0.35 
*miR1828 0.841 0.06 ± 0.26 0.046 -0.46 ± 0.10 
*miR2212St 0.696 0.10 ± 0.23 0.001 0.50 ± 0.02 
*miR2218a 0.843 0.07 ± 0.33 0.013 0.96 ± 0.11 
*miR2220 0.137 -0.40 ± 0.17 0.001 0.75 ± 0.09 
β*miR232 0.000 -0.61 ± 0.05 0.015 -0.59 ± 0.07 
*miR235 0.003 0.64 ± 0.10 0.921 0.03 ± 0.27 
β*miR239a 0.006 -0.57 ± 0.11 0.000 -0.69 ± 0.05 
β*miR240 0.012 -0.61 ± 0.07 0.001 -0.59 ± 0.02 
β*miR244 0.000 -1.00 ± 0.00 0.000 -1.00 ± 0.00 
βmiR255 0.009 -0.50 ± 0.05 0.970 0.00 ± 0.11 
βmiR51 0.043 0.55 ± 0.19 0.435 0.29 ± 0.29 
β*miR53 0.000 -1.00 ± 0.00 0.000 -1.00 ± 0.00 
βmiR790 0.041 0.48 ± 0.16 0.054 0.35 ± 0.08 
β*miR80 0.027 0.81 ± 0.14 0.035 0.57 ± 0.11 





Table 2.3: A summary of genes clustered with high enrichment using Gene functional annotation via 
DAVID. Worm annotations were obtained from WormBase (Yook et al., 2012). 
 






 a homeodomain-containing protein  
 orthologous to the Pitx family of homeodomain transcription factors  
 controls the terminal differentiation of all 19 type D GABA-ergic motor 
neurons during development 
skn-1  
(SKiNhead) 
 a bZip transcription factor orthologous to the mammalian Nrf (Nuclear 
factor-erythroid-related factor) transcription factors  
 required for specification of the EMS blastomere, a mesendodermal 
precursor that gives rise to pharyngeal, muscle, and intestinal cells during 
early embryogenesis  
 functions in the p38 MAPK pathway to regulate the oxidative stress 
response and in parallel to DAF-16/FOXO in the DAF-2-mediated 




 a nuclear hormone receptor (NHR) related to the mammalian HNF4 
(hepatocyte nuclear factor 4) family of NHRs 
 a key regulator of fat metabolism and lifespan by regulating induction of 
beta-oxidation genes upon food deprivation and activation of stearoyl-CoA 
desaturase in fed animals, respectively  
 activates transcription in conjunction with the MDT-15 mediator subunit 





 encodes two basic region-leucine zipper (bZip) transcription factors, FOS-
1A and FOS-1B, that are the sole C. elegans ortholog  of the fos bZip 
transcription factor family 
 required cell autonomously in the gonadal anchor cell for basement-
membrane removal and subsequent anchor cell invasion of the vulval 
epithelium  
nfi-1  
(Nuclear Factor I 
family) 
 encodes the C. elegans ortholog of the Nuclear Factor I (NFI) family of 
transcription factors in C. elegans,  






 a homeodomain protein (Pax-6 ortholog) 
 required for proper patterning of anterior (head) hypodermal cells  
 required for epidermal morphogenesis, epidermal cell fates, gonad cell 
migration and the development of sensory structures in the male tail  
 
 







 a transmembrane serine/threonine kinase (sole ortholog of the type II 
transforming growth factor-beta (TGF-b) receptors) 
 required for several biological processes, including entry into and exit from 
the dauer larval stage, body size determination, male tail patterning, egg 








 a TGF-beta type I receptor homolog  
 required for the regulation of dauer formation by environmental signals 
through the ASI chemosensory neuron  
cmk-1  
(CaM Kinase) 
 a Ca+2/calmodulin-dependent protein kinase I (CaMK1)  
 required, cell autonomously and downstream of the cyclic nucleotide-gated 
channel TAX-4, for several aspects of AFD thermosensory neuron 
differentiation, including expression of the gcy-8 guanylyl cyclase and nhr-
38 nuclear hormone receptor genes and morphology of the AFD sensory 
endings  
 required for normal thermosensory behavior  




 a predicted transmembrane protein kinase (orthologous  to human 
eukaryotic translation initiation factor 2-alpha kinase 3 (EIF2AK3))  
 strongly expressed in intestinal cells  
 required for the unfolded protein response (UPR) that counteracts cellular 
stress induced by accumulation of unfolded proteins in the endoplasmic 
reticulum (ER)  
 may phosphorylate eIF2alpha and inhibit protein synthesis in response to 
endogenous ER stress 
sma-6  
(SMAll) 
 a serine/threonine protein kinase (ortholog of type I TGF-beta receptors) 
 required for regulating body length and for proper development of the male 
tail  
 regulates reproductive aging  








Figure 2.1: Nicotine altered the miRNA expression profiles across generations in a dose-dependent 
manner. (a) Nicotine significantly altered the expression levels of 31 miRNAs in the F1 worm population. 
(b) Nicotine significantly altered the expression levels of 16 miRNAs in the F2 worm population. (c) A 
Venn diagram showing the number of the miRNAs with differentially altered expression levels shared in 
L4 larvae belonging to the three generations (F0, F1, and F2). P<0.05. [*, β denote statistically significant 
changes in response to high (20mM) and low (20µM) nicotine concentrations, respectively). All 




 (A)  
(B)  
Figure 2.2: Nicotine altered the expression levels of 14 miRNAs common to at least two generations. 
Different colors represent different treatment groups belonging to each of the three generations. From 
Left to right, bars represent Mean Fold Changes (MFC) for miRNAs belonging to (A) F0 L, F1 L, F2, L, 
and (B) F0 H, F1 H, and F2 H. L stands for low, and H stands for high nicotine dose. Data labels A, B, 





Figure 2.3:  Nicotine 
exposure limited to L4 of 
F0 generation caused 
differential clustering in 
three L4 generations in C. 
elegans (N2). 
Unsupervised hierarchical 
clustering based on 
Euclidean distance and 
complete linkage with 
optimization was 
performed for samples (3 
biological replicates per 
treatment group) and 
miRNAs. Each cell 
represents a MFC 
compared to control (Mean 
Fold Change: 2(∆∆CT) -1). 
In the figures, color red, 
green, and black represent 
up-regulation, down-
regulation and no change 
with respect to control, 
respectively. Graph was 
done using Mev software 






Figure 2.4: Radar 
graph showing 
general patterns of 
miRNA MFCs 
across generations in 
response to nicotine 
treatment limited to 
the post-embryonic 
stage of the parent 
F0 generations in C. 
elegans (N2). The 
MFCs of 72 miRNAs 
were used for the 
low treatment groups 
(20µM) (a) and high 
treatment groups 
(20mM) (b). Each 
concentric rim 
represents 1 fold 
increase or decrease 
(2(∆∆CT) -1) from 0. 
Different generations 
are presented by 
different colors. The 
input miRNA list had 
the same order 
among each 
treatment group (low 










Figure 2.5: Directed acyclic graph (DAG) performed by GOrilla. 14 miRNAs that were differentially expressed in at least 2 generations were used 
for target prediction. Only genes belonging to enriched clusters in DAVID were used to prepare the single gene ranked list for GOrilla input as 
described in the text. The Graph shows the relationships among the enriched pathways targeted by miRNAs altered in response to nicotine 











Figure 2.6: Analyzing the roles of the 14 commonly altered miRNAs in the enriched pathways. (a) A 
summary of the pathways predicted to be altered in response to nicotine treatment across the three 
generations. The data labels represent the respective p-values for each enriched process. (b) Variation in 
miRNA regulation. Some pathways are commonly regulated by 2 or more miRNAs while others are 
specific to 1 miRNA. On the other hand, there was an apparent difference in the % of pathways predicted 





Figure 2.7:  Nicotine exerts its 
transgenerational effect via 
five enriched gene candidates. 
(A) A network showing 
relationships between 
differentially altered miRNAs 
with gene candidates in each 
generation. Triangles denote 
worms of the F0 generations, 
while squares and circles 
denote worms of the F1 and 
F2 generations, respectively. 
The five genes candidates are 
in hexagons in the middle. 
The low concentration 
treatment groups are shown 
on the up-right side, while the 
high concentration treatment 
groups are shown in the left 
bottom side. (B) A simplified 
network showing interactions 
between only commonly 
altered miRNAs and the 
candidate genes. Candidate 
genes are in yellow. miRNAs 
targeting more than one gene 
are in green. (C) A 
hypothesized model to explain 
the nicotine-induced miRNA 
expression profiles and 
behaviors as a function of 
duration of exposure or 
abstinence and previous 








MS80-mediated resistance against nicotine-induced pharyngeal pumping inhibition 
Abstract 
Nicotine is the major addictive chemical in tobacco smoke of which exposure remains 
differentially yet highly prevalent during the neonatal and adolescent periods. This early 
exposure is associated with direct effects like delayed development, sudden infant death, and 
arrhythmias; however, the molecular mechanisms behind those health disparities remain 
unknown. Based on our prior transcriptomic data and bioinformatics analysis, we aimed to focus 
on the interplay of mpk-1, miR-80, and sir-2.1 (MS80) in nicotine-induced early onset diseases 
using the model organism C. elegans. Worms of different genetics backgrounds were treated 
with nicotine from L1 to early L4 larval stages prior to sexual maturity and then were used for 
growth and behavioral assays. Our length and seam cell count showed that nicotine arrested the 
worms at the L1 stage and this effect was not rescued with MS80. Nicotine also inhibited 
pharyngeal pumping in the worms yet this effect could be dissociated from the arrested 
development. Nicotine-induced pumping inhibition was mediated by MS80 as worms with loss-
of-function mutations in mpk-1, miR-80, or sir-2.1 were resistant to nicotine-induced reduction 
in pumping rate. On the other hand, pharyngeal mpk-1 overexpression mirrored the phenotype in 
N2 worms, while it sensitized miR-80 (lof) and sir-2.1 (lof) worms to nicotine-induced pumping 
inhibition. Interestingly, co-treatment with U0126 influenced pumping rate in miR-80 and sir-2.1 
backgrounds and this could be mediated by the increased activation of aak-2/AMPK downstream 
of nicotine-induced reduction in serotonin signaling. So, while the mechanism behind nicotine-
induced delay in development remains unknown, our study is the first to report a relationship 




neuromotor signaling and the consequential muscular tetanus during the early developmental 
periods.  
Keywords: Nicotine, MAPK, ERK1/2, mpk-1, sirtuins, SIRT1, sir-2.1, miR-80, C. elegans larvae, 












Nicotine, the major addictive component of tobacco, is associated with a wide spectrum 
of cardiac and respiratory arrhythmias (D'Alessandro, Boeckelmann, Hammwhoner, & Goette, 
2012). In addition, smoking altered respiratory sinus arrhythmia and heart rate in adolescents 
(Conrad, Gorka, & Kassel, 2015). However, the pathophysiological mechanisms for nicotine-
induced arrhythmias are poorly understood.  Here, we took advantage of the genetic tools and 
behavioral assays available for the model organism C. elegans. The C. elegans pharynx is an 
alimentary tissue that is considered a prototype to the human heart (Olson, 2006). Both have 
similar electrical activity that is the output of several action potentials induced by a myriad of 
physiological channels. Though evolved for a different function which is feeding, its proper 
function is required for proper growth and development. Normal pharyngeal function involves 
the right timing, pumping frequency, and downstream peristalsis (Avery & You, 2012). In wild 
type worms, the pharynx pumps rhythmically and rarely pauses and this behavior is impacted by 
certain environmental exposure (e.g. chemicals, food).Thus, we employed this phenotype as a 
proxy to study the molecular mechanism for nicotine induced arrhythmias. 
Previously, we profiled global microRNA expressions across three generations in 
response to post-embryonic nicotine exposure (F. A. Taki et al., 2014). We identified 14 
miRNAs that were impacted in at least two generations. Among them, we were interested in 
miR-80 which was upregulated in the parent (F0) generation as well as in the grand-offspring 
(F2) generation. Based on our previous bioinformatics analysis, fos-1 and cmk-1 were among the 
most common transcripts predicted to be targeted by the 14 transgenerational miRNAs (F. A. 
Taki et al., 2014). cmk-1 regulates CREB (cAMP responsive element). CREB interacts with its 




transcription and has been shown to be a target of miR-80 in global regulation of metabolism 
(Vora et al., 2013). More so, fos-1 is orthologous to the fos bZip transcription factor family. Both 
cFos and CREB have been reported to mediate responses to drugs of abuse like cocaine through 
sirtuin and miRNA dependent mechanisms (Ferguson et al., 2013; Gao et al., 2010; Robison & 
Nestler, 2011). In addition, cocaine reward and self-administration are partly promoted by SIRT1 
dependent activation of ERK in the MAPK pathway (Y. Li, Xu, McBurney, & Longo, 2008; 
Renthal et al., 2009). Both sirtuins and MAPK are highly conserved signaling molecules with 
pleiotropic roles (E. K. Kim & Choi, 2010; Vassilopoulos, Fritz, Petersen, & Gius, 2011). Here, 
we aim to study the interplay among sirtuin SIRT1, ERK1/2, and the nicotine-induced 
microRNA miR-80 in mediating nicotine-induced early onset diseases. 
To give a small background on our genes of interest, sir-2.1/SIRT1 belongs to the sirtuin 
family of proteins and is an NAD+-dependent protein deacetylase that is involved in 
transcriptional repression, stress response, lifespan (Bamps, Wirtz, Savory, Lake, & Hope, 2009), 
and apoptosis (Greiss, Hall, Ahmed, & Gartner, 2008). Meanwhile, mpk-1/ERK1/2 is the 
downstream effector of the MAPK pathway and is considered a central hub in C. elegans 
development, cell proliferation and differentiation, apoptosis, stress response (Sundaram, 2006), 
and lifespan (Okuyama et al., 2010). In addition, miR-80 belongs to the miR-58 family in C. 
elegans which is highly abundant and expressed at all developmental stages (Alvarez-Saavedra 
& Horvitz, 2010). Interestingly, members of the miR-58 family are orthologous to the bantam 
miRNA in Drosophila that controls cell proliferation and apoptosis (Brennecke, Hipfner, Stark, 
Russell, & Cohen, 2003). miR-80 mutants are long lived. Its loss of function prevented the age-
dependent decline of pharyngeal pumping and age-related pigments, decreased fecundity, and 




single miR-80 mutants did not have an abnormal phenotype, it rescued the sluggish, locomotory, 
as well as egg laying defect in miR-58 family multimutant (Alvarez-Saavedra & Horvitz, 2010). 
Based on our study, miR-80 was the only miRNA to be upregulated in response to both low and 
high nicotine doses (F. A. Taki et al., 2014; F. A. Taki et al., 2013). Based on benefits dependent 
on miR-80 deletion, we propose that its increased expression might contribute to physiological 
complications in response to nicotine.  
Material and methods 
Strains from CGC 
 N2 (lab WT strain), ga111 (ts and lof mpk-1), JK3929 (ga117), MT2124 (let-60 n1046), 
MT13949 (mir-80 (nDf53 III)), MT15563 (nDf53 III; mir-58 (n4640) IV; nDf54 X), FX863 
(acr-7(tm863 II), RM509  (ric-3(md158 IV), VC199 (sir-2.1(ok434 IV), JR667 (unc-
119(e2498::Tc1  III; wIs51 V), GR1366  (mgIs42 [tph-1::GFP + rol-6(su1006)]). 
Worm maintenance and treatment 
Worms were maintained on solid NGM (0.3% NaCl, 0.25% peptone, 1.7% agar, 0.5% 
cholesterol, 0.1% of 1M MgSO4, 0.1% of 1M CaCl2, and 2.5% of 1M KPO4) at 20°C. For 
treatment, we used two nicotine doses based on our previous studies (F. Taki et al., 2013; F. A. 
Taki et al., 2014; F. A. Taki et al., 2013; F. A. Taki & Zhang, 2013). Treatment plates as 
previously described (F. A. Taki et al., 2014) such that the final nicotine dose for the low and 
high treatment groups were 20µM and 20mM, respectively.  
Embryos were collected via the bleaching method before treatment ((70% water, 10% 




onto control and treatment plates that were seeded with the food source OP50 15-30 minutes 
prior to the experiment. The treatment period lasted for 30 hours only at 20°C unless otherwise 
noted (e.g. temperature sensitive worms grown at 22°C and 25°C were exposed for 28 and 22 
hours, respectively).  
Strains made 
 Ex myo-2 mpk-1 GFP was expressed in N2, miR-80 (nDF53), and sir-2.1 (ok434) 
backgrounds. IBI high speed mini plasmid kit was used for plasmid mini-preps. Plasmids 
pPD95_79 and L2531 were purchased from Addgene, PFU polymerase (MBL international) was 
used for all steps of construct construction; Platinum Taq polymerase 
(Invitrogen/Lifetechnologies) was used for screening; NheI and BglII (NEB) were used for 
sequential double digestion. All ligation reactions were performed overnight at 4 °C using NEB 
ligase (5µl reaction of 3.5µl fusion, 0.5µl TA vector, 0.5µl enzyme, 0.5µl buffer) (Supplementary 
figure 3.1). 
Plasmid construction  
GFP was amplified from pPD95-79 using forward and reverse primers 
5’-AATAATGGAGGGCAGAATCCTGTTATTGGCCAAAGGACC-3’and 5’-
GAAGATCTTCAAGTTGGTAATGGTAGCGACCG-3’, respectively. mpk-1a cDNA (gift 
from Lee lab) was amplified using the following forward and reverse primers 5’- 
CTAGCTAGCTAGATGGCCGACGGAGAAGCGGTTATC-3’, and 5’-
GGTCCTTTGGCCAATAACAGGATTCTGCCCTCCATTATT-3’, respectively. PCR products 
were purified by spin column purification and then used for fusion PCR. The latter was 





GAAGATCTTCAAGTTGGTAATGGTAGCGACCG-3’, respectively and was spin column-
purified before further steps. dA overhangs were added by incubating the fusion with taq 
polymerase reaction without primers for 30 minutes at 70°C. The fusion with sticky dA ends was 
then ligated to a pGXT vector (modified pGMET vector was a gift from the Zhu lab) and 
transformed into 50µl competent cells. Positive colonies were screened by colony PCR and 
sequential digestion with M-13-F and R primers, respectively.  
Both TA-fusion and L2531 plasmids (Addgene) were double digested with NheI at 37°C 
overnight. The digested product was spin-column purified and used for the BglII digestion at 
37 °C overnight following manufacturer’s protocol. Digested products were separated on 1% gel. 
Fragments with the correct sizes were excised at UV=365 nm in less than 30 sec and were used 
for the overnight ligation at 4°C. Ligated product (L2531-Fusion) was then transformed into 
DH5α E. coli competent cells, prepared according to published protocol (D. A. Wright et al., 
2006). 5µl of ligation solution was added to thawed cells and were left from 30 minutes on ice 
before being heat shocked for 90 seconds in a 42°C water bath. Cells were allowed to recover for 
2 minutes on ice before adding 300µl LB and were left for 1 hour on a shaker at 37°C. Then cells 
were spread on LB plates infused with 100ug/ml ampicillin and were left to grow overnight at 
37°C. 10 colonies were then grown and were used for plasmid isolation. Plasmids were then 
screened using forward and reverse primers 5’-ATTGGCCAAAGGACCCAAAGG-3’ and 5’-
TACGAATGCTGAGCGCTG-3’. Positive colonies were sequentially digested using NheI and 
BglII overnight at 37°C. The digested fragment was assessed on a gel relative to a DNA ladder. 
Positive plasmids were then Sanger sequenced for further validation before injecting to worm 




three worm strains: N2, miR-80 (nDf53), and sir-2.1 (ok434) worms. Positive worms with 
pharyngeal GFP expression were spotted using a fluorescence stereoscope. Worms were then 
transferred to individual plates and were grown for at least 8 generations before the experiment. 
Seam cell count 
GFP fluorescent seam cells were used as a marker to confirm the developmental stage of 
worms treated with nicotine relative to the no-treatment control. JR667 (unc-119(e2498::Tc1) III; 
wIs51 V) strain was used to visualize and count the number of seam cell in response to nicotine. 
Worms were treated for 30 hours until the L3/L4 molting stage. Worms were collected in an 
Eppendorf tube and then mounted on 2% agarose pads. Worms were paralyzed with 5mM 
levamisole, allowed to dry, and were then covered with a coverslip. Worms were then visualized 
using Zeiss inverted fluorescent microscope at 10X magnification. Pictures were taken, and the 
numbers of GFP fluorescent seam cells were counted per worm side (Figures 3.3BC; Table 3.1).  
Length measurements 
After worms were exposed to nicotine for 30 hours, worms were washed off the plate and 
mounted on 2% agarose slide. Worms were paralyzed with 5mM levamisole, dried, and covered 
with a coverslip. Worm images were taken using a camera mounted to Zeiss inverted microscope 
at 10X magnification. Length was measured for at least 30 worms per treatment group using 
imageJ software. One-way ANOVA was used to compare length measurements among treatment 
groups. Post-Hoc test was applied for pairwise comparisons and Bonferroni correction was 
applied. Statistical significance was based on p<0.05. 
Pharyngeal pumping assay 
Worms were transferred into a 12 well NGM plate with or without nicotine. Plates were 




hours before assessing their pumping rate. A minimum of 30 second -videos were taken per 
worm. At least 15 worms were tested per treatment group. One to three trials were performed per 
strain. Each trial was replicated three times. Videos were then played back at a slower speed to 
allow for manual pharyngeal counting to compute the pharyngeal pumps per minute for each 
worm. Data from all worms were pooled for statistical analyses. Residuals for raw data were 
checked for normality. Based on the latter, log transformation was done and was used as input 
for ANOVA in SPSS(20). Bonferroni correction was applied and statistical significance was 
based on p<0.05. 
Heat maps 
Mev was used to construct heat maps. Unsupervised hierarchical clustering was based on 




The relationship between miR-80, MAPK, and sir-2.1 
As previously mentioned, fos-1 and cmk-1 were transgenerationally enriched in response 
to parental nicotine exposure based on our predicted miRNA network (F. A. Taki et al., 2014). 
Previous studies showed that both factors promote substance use disorders via sirtuin and 
miRNA-dependent mechanisms (Fusco et al., 2012; Robison & Nestler, 2011). One of the 
members of the aforementioned miRNA network was miR-80. It was upregulated in both parent 
(F0) generation and grand-offspring (F2) generation worms (F. A. Taki et al., 2014; F. A. Taki et 




targets (Figure 3.1A; 3.2AC). This pathway is commonly and consistently implicated in nicotine-
induced disorders and responses (Figure 3.1A) (C. Y. Li et al., 2008) and was recently reported 
to be downstream of SIRT1(Y. Li et al., 2008; Renthal et al., 2009) (Figure 3.1A). Using the 
tissue-specific expression tool developed by Chikina et al. (Chikina, Huttenhower, Murphy, & 
Troyanskaya, 2009), we show the fos-1, cmk-1, sir-2.1, and mpk-1 are predicted to be co-
expressed in most tissues in the worm (Figure 3.1B) and could potentially work together in 
response to nicotine. Our analysis showed that miR-80 was the only transgenerational miRNA 
predicted to co-target both sir-2.1 and mpk-1 in the worm (Figures 3.2ABC). Therefore, in this 
study, we plan to investigate the interplay between miR-80, mpk-1, and sir-2.1 in response to 
post-embryonic nicotine exposure. 
Post-embryonic nicotine exposure negatively impacted growth and development 
L1 worms were transferred onto NGM plates with or without nicotine for a 30 hour 
exposure period. Two nicotine doses 20µM and 20mM were used based on our previous 
behavioral and genetic studies. After the period passed, we noticed that worms exposed to the 
high nicotine dose were smaller than both control and low treatment groups (Figure 3.3A). To 
accurately identify the developmental stage, we used the seam cell count as a biomarker for 
development. Seam cells are found laterally on both sides along the worm body. During the first 
three larval stages, the seam cells go through a stem cell-like division pattern. In L1, there are 10 
seam cells per worm side (H0, H1, H2, V1–6 and T). Before each molt, three events reiterate 
starting with, in most cases, asymmetric cell division, hypodermal fusion or cell differentiation, 
and reestablishment of contact between seam cells. The last cell division occurs at the L3/L4 
molt after which 16 seams cells terminally differentiate in the L4 stage per worm side, fuse in 




used the strain JR667 of which seam cells express GFP to facilitate counting seam cells in the 
worm and the inference of the developmental stage.  
Our results showed that about 50% of the control worms had around 28 cells per side. 
This number slightly decreased to 25 when worms were treated with the low nicotine dose. 
However, about 50% of the worms treated with the high dose only had up to 11 seam cells per 
side. As shown in the heat map (Figure 3.3B), the highest percentage of worms (14%) had 30 
seam cells per side in control, while the highest percentage of worms (20%) had 17 seam cells in 
response to the low nicotine dose. Meanwhile, the greatest majority of worms (36%) had 10 
seam cells after 30 hours of exposure to 20mM nicotine (Figure 3.3BC). The worms should 
range between late L3 to early L4 30 hours post-hatching. Typically, L4 worms have exactly 16 
unfused seam cells per side (Z.F. Altun & D.H.  Hall, 2009). Our results showed that about 12% 
of control worms had 16 seams cells per side, while 15% of the worms treated with the low 
nicotine dose had this number. As for the high treatment group, only 4% of the worms had 16 
seam cells per side. This data shows that the high nicotine dose delayed development of the 
worm population such that worms were arrested at the L1 stage [F(2,134)=93.55; p<0.001]. On 
the other hand, worms exposed to the low nicotine dose had fewer seam cells than control and 
may have finished the proliferative state concomitant with the molting stage (Monsalve, Van 
Buskirk, & Frand, 2011). This suggests that more control worms were still in the L3/L4 molting 
stage, while more worms progressed to early L4 in response to the low nicotine treatment (Figure 
3.3BC). 




We measured the worm length after 30 hours of nicotine exposure using imageJ software. 
Chronic early nicotine exposure significantly impacted worm length [F(2,141)=723.40; p<0.001]. 
Pairwise comparisons revealed that this was mainly due to the high nicotine dose which resulted 
in a 46% decrease in the worm length (p<0.001) (Figure 3.4A).  
We were interested in testing the effect of 30 hour nicotine exposure in different genetic 
backgrounds. In an mpk-1 sensitive background (ga111 grown at 20°C), the effect remained 
significant [F(2,100)=641.24; p<0.001]. This effect became stronger when mpk-1 was partially 
inactivated (ga111 grown at 22°C) [F(2,69)=1160.67; p<0.001] and completely inactivated 
(ga111 grown at 25°C) [F(2,92)=755.73; p<0.001]. This effect was similar when nicotine was 
exposed to miR-80 and sir-2.1 loss of function mutants [F(2,92)=643.40; p<0.001] and 
[F(2,96)=646.61; p<0.001], respectively. On the other hand, when MAPK was overactivated as 
in let-60 (n1046), the impact of early nicotine exposure was less severe [F(2,89)=386.65; 
p=0.001]. So, the high nicotine dose was associated with a significant decrease in the worm 
length in all the mutant backgrounds. The least decrease was in the miR-80 (nDf53) background 
(43%), followed by sir-2.1 (ok434) (45%), let-60 (n1046) (46%), ga111 at 25°C (47%), ga111 at 
20°C (51%), and ga111 at 22°C (59%) at p<0.001. Interestingly, the low nicotine dose increased 
the worm length in only ga111 background. The length increased by 8% when ga111 was grown 
at the permissive temperature 20°C (p<0.001) and by 6% at the restrictive temperature 25°C that 
results in complete deactivation of mpk-1 (Figure 3.4A). As a summary, the high dose treatment 
had similar impacts in almost all the tested genetic backgrounds and they all clustered together. 
This means regardless of the increase in length in their control and low counterparts relative to 




Since the weakest impact for nicotine exposure on worm length was in the let-60 (n1046) 
background with an overactivated MAPK pathway, we wondered if nicotine-induced mpk-1 in 
the pharynx would result in a similar effect on length. So, we generated three strains where mpk-
1 GFP fusion was overexpressed in the worm’s pharynx using the myo-2 promoter as described 
in the methods section. This construct was expressed in N2 worms and two loss of function 
mutants: miR-80 (nDf53), and sir-2.1 (ok434). We refer to these strains as N2Ex, miR-80Ex, and 
sir-2.1Ex. GFP fluorescent pharynxes were used as a marker to pick the worms of interest using 
a fluorescent stereoscope. As expected, the severity of nicotine-induced reduction in worm 
length was lower than N2, miR-80 (nDf53), and sir-2.1 (ok434) without pharyngeal mpk-1 
overexpression. The F-score in response to nicotine treatment dropped to [F(2,93)=89.01; 
p<0.001] in N2Ex, [F(2,108)=63.06; p<0.001] in miR-80Ex, and [F(2,109)=134.73; p<0.001] in 
sir-2.1Ex. In particular, the high nicotine dose decreased the length by 42%, 43%, and 50% 
(p<0.001) in N2Ex, miR-80Ex, and sir-2.1Ex, respectively (Figure 3.4A).  
When comparing the effect of each treatment per strain relative to the N2 background 
(e.g. each high group per strain was subtracted from the high group of N2), only let-60 (n1046), 
miR-80 (nDf53), and sir-2.1 (ok434) had a proportional increase in length in the control, low, 
and high groups (6-11%). However, the major difference was in the ga111 background when 
grown at 20, 22, and 25°C. The increase was no longer proportional when comparing control and 
low groups with the high groups. Worms in the high treatment group increased by only 6-10% 
relative to their N2 counterparts, while the controls and lows increased by 19-45% relative to N2. 
Interestingly, when mpk-1 was overactivated in miR-80Ex and sir-2.1Ex, neither the low nor the 
high groups were proportional to their controls. The low dose decreased the length by 9-10%, 




We took notice of the length patterns in three backgrounds: N2, miR-80 (nDf53), and sir-
2.1 (ok434) and focused on the impact of pharyngeal mpk-1 overexpression per treatment group. 
The first set of comparisons is shown in column (A) and the second set is shown in column (B). 
The top row (blue) is comparing control groups, the middle row (red) is comparing low treatment 
groups, and the bottom row (green) is comparing high treatment groups in different backgrounds, 
respectively. In column (A), we checked how pharyngeal overexpression of mpk-1 shifted the 
length per genetic background. We noticed that pharyngeal overexpression of mpk-1 decreased 
length in N2 (p=0.005) and miR-80 (nDf53) (0.001) backgrounds by 11%. The low dose didn’t 
further decrease the length in N2 background (11%, p=0.001) while it decreased the length by 18% 
from miR-80 to miR-80Ex (p<0.001). The high dose did not shift the length further after mpk-1 
overexpression in the pharynx in neither N2, nor miR-80 (nDf53) backgrounds. Interestingly, 
pharyngeal overexpression of mpk-1 in sir-2.1 (ok434) did not impact length in the control 
groups; however, both the low and high nicotine doses significantly decreased the length from 
sir-2.1 to sir-2.1Ex by 15% (p<0.001) and 17% (p=0.014), respectively (Figure 3.4C). This 
suggests that (i) mpk-1 is inversely proportional with length, (ii) mpk-1 is downstream of miR-
80 and sir-2.1, (iii) the low dose further increased mpk-1 activation, which in turn decreased the 
length, (iv) the high dose did not further increase mpk-1 activation in N2 and miR-80 (nDf53) 
backgrounds, and (v) sir-2.1 (lof) mutation had lower mpk-1 activation which increased upon 
low and high nicotine exposure and consequently decreased length. 
In column (B), we looked into the impact of miR-80 (nDf53) and sir-2.1 (ok434) on 
length as a function of pharyngeal mpk-1 overexpression and nicotine exposure. In the absence 
of nicotine (i.e. controls, first row), miR-80 loss of function increased the length by 10% relative 




80Ex. Interestingly, sir-2.1Ex length remained 13% higher than N2Ex (p=0.003). This is 
consistent with the previous propositions where sir-2.1 loss of function had lower levels of 
endogenous mpk-1. The low nicotine dose did not alter the increase in length in miR-80 (nDf53) 
background (11%, p=0.003); however, the pattern shifted once mpk-1 was overexpressed in the 
pharynx such that it reversed and decreased by 10% (p=0.01). In addition, sir-2.1 (ok434) loss of 
function could no longer increase the length in the presence of exogenous pharyngeal mpk-1. 
Finally, similar patterns were observed in the high treatment groups though they were not 
statistically significant suggesting that the high nicotine activates mpk-1 to a high level such that 
the inhibitory effect on length finally plateaus and is no longer impacted by further activation of 
exogenous mpk-1, even in sir-2.1 (ok434) loss of function background (Figure 3.4C).  This 
suggests that (i) miR-80 and sir-2.1 are inversely proportional with length  (ii) miR-80 and sir-
2.1 have a positive relation with mpk-1 (iii) mpk-1 contributes to the 10% increase in length in 
miR-80 (nDf53) background, and (iv) the low and high nicotine doses activate mpk-1 and impact 
worm length even in miR-80 and sir-2.1 loss of function backgrounds. 
Is nicotine-induced developmental delay a consequence of pharyngeal pumping inhibition? 
High doses of nicotine have been shown to cause muscular paralysis through over-
activation of neuromotor signaling pathways (Matta et al., 2007). C. elegans is a filter feeder that 
depends on autonomous rythmic pharyngeal pumping action to swallow and ingest their food. 
This pumping action depends on neuronal input to function efficiently (Avery & You, 2012) and 
is affected by the mechanochemical signals associated with the presence of food (Bargmann, 
2006; Goodman, 2006). Taken collectively, we hypothesized that the observed developmental 
delay is a side-effect of nicotine-induced inhibition of pharyngeal pumping. Perhaps pumping 




development. To test this hypothesis, we measured the pharyngeal pumping rate in response to 
the low and high nicotine doses and compared the rate to their untreated control as described in 
the methods section.  
Our results showed that nicotine dramatically inhibited pharyngeal pumping 
[F(3,145)=33.77; p<0.001]. This significant effect was mainly due to the high nicotine dose that 
decreased pumping by 67% (p<0.001). To determine if this decrease was due to developmental 
delay rather than a direct effect of nicotine exposure, we compared the pharyngeal pumping with 
size matched larvae that were not exposed to nicotine. Based on our seam cell count and mean 
length measurements, we deduced that most of the worms treated with the high nicotine dose are 
similar to L1 larvae. Worms were synchronized and left to hatch for about 18 hours as described 
in the methods section. Hatched L1 were plated onto NGM seeded with OP50 and left to 
acclimate and adapt for up to three hours before the pumping assay. The pumping rate for L1 
control was 68% higher than the high treatment group (p<0.001) (Figure 3.5A). This suggests 
that the decrease in the pumping rate is a direct effect of nicotine rather than a side-effect of 
developmental delay. We also exposed the worms to nicotine in the absence of food. Even 
though all worms including control and low groups arrested in development, the same pumping 
inhibition trend was observed and was proportional to the nicotine dose. Due to the low pumping 
rate in the absence of food, the overall effect was not statistically significant [F(2,74)=1.48; 
p=0.234] (Figure 3.5A). 
We were intrigued to identify some of the molecular contributors of nicotine-induced 
pumping inhibition. We decided to examine the effect of nicotine on pharyngeal pumping in 
worms of which MAPK pathway is sensitive or altered. mpk-1 (ga111) is a temperature sensitive 




due to complete inactivation of mpk-1). As shown in Figure 3.5A, nicotine inhibited the 
pumping rate in a dose dependent manner in mpk-1 (ga111) grown at 20°C [F(2,42)=17.50; 
p<0.001]. Pairwise comparisons revealed that the low dose was sufficient to decrease the 
pumping rate by 36% (p=0.008), while the high dose decreased the pumping rate by 77% 
(p<0.001). The effect remained evident when mpk-1 (ga111) worms were grown at 25°C 
[F(2,31)=10.89; p<0.001], but that was only due to the high nicotine dose of which rate 
decreased by only 42% (p=0.003). Interestingly, when this strain was grown at 22°C, the effect 
of nicotine on pharyngeal pumping was no longer evident [F(2,44)=0.39; p=0.678]. The same 
recovery was observed in mpk-1(ga117) [F(2,33)=1.441; p=0.251] where mpk-1 is reported to be 
completely inactivated (Lackner & Kim, 1998). Then we wondered what would happen if we 
exposed nicotine to worms with overactivated MAPK pathway. For that, we used let-60 (n1046) 
strain and noticed that nicotine did impact the pumping rate [F(2,42)=15.50; p<0.001]. 
Interestingly, the low nicotine dose slightly increased the pumping rate by 34% (p=0.046) while 
the high dose consistently decreased the pumping rate by only 42% (p=0.009) (Figure 3.5A).  
We repeated the experiment by exposing worms with a loss of function mutation in miR-
80 (nDf53) with nicotine. Our results showed that nicotine could no longer significantly impact 
pumping rate in this genetic background [F(2,42)=1.77; p=0.183]. miR-80 is a member of the 
miR-58 miRNA family that is highly abundant and expressed throughout development in C. 
elegans. This family is orthologous to bantam miRNA in Drosophila which is involved in cell 
proliferation and apoptosis (Alvarez-Saavedra & Horvitz, 2010). The rescue phenotype was not 
as evident, but was also observed after nicotine was exposed to worms lacking the entire miR-58 




control.  In addition, the recovery of the nicotine-induced pumping inhibition was observed in 
worms with loss of function mutation in sir-2.1 (ok434) [F(2,86)=4.104; p=0.02] (Figure 3.5A) .  
Nicotine was reported to delay development of skeletal muscle growth in cell lines via 
nAChR-α7 signaling (Kawakita A et al., 2008) along with secondary spinal motor neurons 
(Svoboda et al., 2002). To test the role of nAChR- α7 in C. elegans, we found the pumping rate 
was only slightly impacted, but was no longer severely impacted in worms with dysfunctional  
acr-7 (tm863) after nicotine exposure [F(2,42)=3.38; p=0.043]  which is consistent with previous 
reports using a much lower (1mM) nicotine dose (Saur et al., 2013). Interestingly, worms which 
lost the function of ric-3 (md158) still showed a severe inhibition of pharyngeal pumping 
[F(2,42)=11.062; p<0.001] and especially in response to the high nicotine dose which resulted in 
a 77% decrease in the pumping rate (p<0.001). ric-3 is responsible for the maturation and 
function of  a number of nAchRs and was previously reported to mediate resistance against 
nicotine-induced paralysis (Halevi et al., 2002). A possible reason for the discrepancy is the 
much lower concentration used in their study (100µM) relative to our high dose (20mM) (Figure 
3.5A).  
Taken collectively, our data failed to show a strong correlation between nicotine-induced 
developmental delay and size retardation with inhibited pharyngeal pumping. In other words, the 
smaller size and delayed development could be dissociated from the reduced pumping rate. For 
example, mpk-1 (ga111) grown at 20°C exposed to the low nicotine dose had a lower pumping 
rate yet was larger in length than the control. In addition, mpk-1 (ga111) grown at 22°C was 
resistant to nicotine-induced pharyngeal paralysis yet the worms exposed to the high nicotine 
dose resulted in the most severe worm shortening. More so, let-60 (n1046) worms exposed to the 




Lastly, miR-80 (nDf53) and sir-2.1 (ok434) still showed great size retardation despite having an 
improved pumping rate relative to their control.  It is noteworthy that ga117 control had 
significantly lower pumping rate than the N2 control (p<0.001) (Figure 3.5A). 
The effect of nicotine in the presence of mk-1 inhibitor (U0126) 
As mentioned earlier, both mpk-1 and sir-2.1 are predicted targets for miR-80. We were 
interested in testing a possible functional feedback among them in response to early nicotine 
exposure. So, U0126 was diluted in DMSO solvent and was mixed with the worm OP50 food 
source after which they were spread on the media and left to dry for 1 hour. The final 
concentration for U0126 was 50µM based on previous reports (F. Chen, Mackerell, Luo, & 
Shapiro, 2008).  Synchronized L1 worms were transferred to NGM plates seeded with OP50 and 
DMSO, U0126, or U0126 on 20mM nicotine (high dose) NGM plates. Worms were left to for 30 
hours on treatment before the pharyngeal pumping rate was assessed. Our results showed that 
U0126 partially negated the effect of nicotine on pharyngeal pumping in N2 worms 
[F(2,110)=12.06; p<0.001].  The pharyngeal pumping was only reduced by 25% (p=0.015) 
instead of the 67% reduction in response to the high nicotine dose in N2 worms. Interestingly, 
miR-80and sir-2.1 loss of function mutations could no longer rescue nicotine-induced pumping 
inhibition in the presence of U0126 with overall impacts of [F(2,96)=37.03; p<0.001] and 
[F(2,86)=31.13; p<0.001], respectively. This combination treatment decreased the pumping rate 
by 32% (p<0.001) in miR-80 (lof) and by 49% (p<0.001) in sir-2.1 (lof) backgrounds (Figure 
3.5B).  





Since partial inhibition of mpk-1 by U0126 alleviated nicotine’s inhibitory effect on 
pharyngeal pumping, we deduced that nicotine-induced pumping inhibition could be partly due 
to the overactivation of mpk-1. We planned to validate this hypothesis by testing the effect of 
nicotine in a hyperactivated mpk-1 background. For that, we generated three strains where mpk-
1 GFP fusion was overexpressed in the worm’s pharynx using the myo-2 promoter as described 
in the methods section. This construct was expressed in N2 worms and two loss of function 
mutants: miR-80 (nDf53), and sir-2.1 (ok434). We refer to these strains as N2Ex, miR-80Ex, and 
sir-2.1Ex. GFP fluorescent pharynxes were used as a marker to pick the worms of interest using 
a fluorescent stereoscope.   Nicotine treatment altered the pumping rate in N2Ex [F(2,131)=24.96; 
p<0.001], miR-80Ex [F(2,137)=43.25; p<0.001], and in sir-2.1Ex [F(2,87)=6.44; p=0.002]. In all 
strains, the pumping inhibition was due to the high nicotine dose while the low dose had no 
effect. Similarly to the N2 background, the high nicotine dose reduced the pumping rate by 68% 
(p<0.001). On the contrary, the high nicotine dose reduced the pumping rate by 46% in miR-
80Ex strains despite having no effect in miR-80 (lof) mutants without mpk-1 overexpression in 
the pharynx. Similarly, sir-2.1 (lof) worms were no longer resistant to nicotine’s inhibitory effect 
when mpk-1 was overexpressed in the pharynx such that the pumping rate decreased by 50% 
(p=0.002) (Figure 3.5C). As a summary, our results suggest that (i) the high nicotine dose 
inhibits pharyngeal pumping through the overactivation of pharyngeal mpk-1, miR-80, and sir-
2.1, (ii) mpk-1 works downstream of miR-80 and sir-2.1, and (iii) that miR-80 and sir-2.1 are 
positively correlated with mpk-1. 
Discussion 
In this study, we aimed to understand the role of miR-80 in response to direct nicotine in 




development. This resulted in two noticeable effects: inhibited development and reduced 
pharyngeal pumping. We showed that mpk-1, sir-2.1 and miR-80 contribute to the pharyngeal 
pumping phenotype and that the latter can be dissociated from the developmental delay. 
MS80: mpk-1, sir-2.1, and miR-80 
Our previous expression and bioinformatics analyses highlighted cmk-1 and fos-1 
(fosbZip transcription factor family) as transcripts downstream of nicotine-responsive 
microRNAs like miR-80 (Figure 3.1). cmk-1, predicted to be a direct target of miR-80, activates 
crh-1/CREB (cyclic AMP-responsive element-binding protein) transcription (Kimura et al., 
2002). crh-1/CREB promote long term memory (Lakhina et al., 2015; Sugi, Ohtani, Kumiya, 
Igarashi, & Shirakawa, 2014), cell survival and proliferation, apoptosis, differentiation, 
metabolism, and immune response (Mayr & Montminy, 2001). crh-1/CREB binds promoters and 
recruit co-activators or co-repressors to genes responsive to drugs of abuse like cocaine 
amphetamine, opiates (Robison & Nestler, 2011), and nicotine (Brunzell, Mineur, Neve, & 
Picciotto, 2009). CBP is a histone acetyltransferase CBP (CREB-binding protein) that is a co-
activator of CREB (Kwok et al., 1994). The histone acetylase activity of cbp-1 and crh-1 
dependent transcriptional activation was perturbed in a C. elegans neurodegenerative model 
(Bates, Victor, Jones, Shi, & Hart, 2006). Interestingly, cbp-1 was repressed by miR-80 in C. 
elegans, and the expression levels of both were reversed with dietary restriction (Vora et al., 
2013). Meanwhile, sir-2.1/SIRT1 was predicted as a target for miR-80 and our data brought to 
light a potentially positive relationship between them. Contrary to cbp-1/CBP, sir-2.1/SIRT1 is a 
histone deacetylase that can serve as a corepressor (Xie et al., 2009) as well as an activator 




in response to nicotine and this suggests that it might induce crh-1/CREB mediated gene 
regulation through sir-2.1/SIRT1.  
sir-2.1/SIRT1 sirtuins are conserved class III histone deacetylases that not only impact 
the chromatin states, but are also members of transcriptional repressive complexes and have also 
been shown to result in posttranslational modifications of non-histone proteins like transcription 
factors (Robison & Nestler, 2011). SIRT1 is crucial for the orchestration of transcriptional 
programs relative to the stress and energy states in an organism (Noriega et al., 2011) and have 
been shown to have roles in neurodegenerative diseases, oxidative and environmental stress 
response, caloric restriction, ageing, lipid metabolism, DNA damage response, apoptosis, cell 
survival, and cancers (Rahman & Islam, 2011). Recently, SIRT1 was shown to promote reward 
and self-administration in response to cocaine and morphine (Ferguson et al., 2013; Ferguson et 
al., 2015; Renthal et al., 2009) and this response involved ERK1/2 activation downstream of 
SIRT1 (Y. Li et al., 2008; Renthal et al., 2009). Since then, SIRT1 and MAPK were shown to 
have a synergic relationship in promoting neuronal apoptosis after TBI (Zhao et al., 2012) and 
were positively correlated in response to oxidative stress in ischemic-reperfused cardiomyocytes 
(Becatti et al., 2012) and in vitiligo skin (Becatti et al., 2014). This positive relationship was also 
deduced from our data using mpk-1/ERK2 inhibitor U0126 and mpk-1/ERK2 overexpression in 
the pharynx. 
mpk-1/ERK1/2 is a part of the mitogen-activated protein kinase (MAPK) pathway. The 
latter are evolutionarily conserved kinases that relay extracellular signals and affects cellular 
processes such as growth, proliferation, differentiation, migration and apoptosis (Cargnello & 
Roux, 2011; Dhillon, Hagan, Rath, & Kolch, 2007). Given their pleiotropic roles, MAPK 




PD, and ALS (E. K. Kim & Choi, 2010). It is also enriched for drugs of abuse and particularly 
nicotine (C. Y. Li et al., 2008). Interestingly, MAPK was enriched for miR-80 regulated 
pathways (Figure 3.1A) and mpk-1/ERK2 was predicted to interact with miR-80 (Figure 3.2). 
Therefore, this study is the first to investigate the interplay among miR-80, MAPK, and sirtuin 
signaling in response to nicotine.  
Developmental arrest 
Response to stress and developmental arrest is systematic and involves cell non-
autonomous signaling. The most studied cases of C. elegans developmental L1 arrest is in 
response to starvation is recognized as L1 quiescence (Baugh, 2013).  Our results showed that 
the exposure to the high nicotine dose was associated with an L1-arrest like state (Figure 3.3). 
Was nicotine a direct cause for this phenotype? Alternatively, was this developmental arrest due 
to nicotine-induced starvation as a result of pharyngeal pumping inhibition? We argue that the 
phenotype is only partially mediated by nicotine-induced altered feeding rate; however, we were 
able to dissociate worm growth from pharyngeal pumping rate. This suggests that there is also a 
direct effect of nicotine on worm growth and this mechanism remains unknown. For example, 
ga117 (mpk-1 lof), ga111 grown at 22°C, miR-80 (lof), sir-2.1 (lof) were resistant to nicotine’s 
effect on pharyngeal pumping (Figure 3.5A), but those worms were still arrested suggesting that 
other factors are involved. Candidate factors include insulin-signaling factor daf-16 and miR-235 
of which loss of function mutants are defective in starvation induced arrest. Starvation activates 
daf-16 which upregulates miR-235 in the worm. miR-235 was actually downregulated in 
response to our nicotine exposure (F. A. Taki et al., 2013) and miR-235 (lof) mutants did not 
rescue nicotine-induced developmental arrest (data not shown). Also, if left on nicotine, some of 




produce much fewer eggs (data not shown). This does not happen in starving worms that remain 
arrested. Another support is that miR-80 (nDf53) (lof) mutants had a decreased survival rate in 
response to starvation-induced L1 arrest (X. Zhang, Zabinsky, Teng, Cui, & Han, 2011). On the 
contrary, miR-80 (nDf53) worms were resistant to nicotine’s effect on pumping which suggests 
that nicotine’s impact on growth is not a side-effect of starvation. miR-80 (lof) was associated 
with a dietary restriction (DR)-like global metabolism (Vora et al., 2013). So, if miR-80 loss of 
function mirrors caloric restriction in the worm, then we would expect the opposite with miR-80 
gain of function as was observed after nicotine treatment (F. A. Taki et al., 2014; F. A. Taki et al., 
2013). Recently, de Lucas et al. showed that miR-58 family, which included miR-80, interacts 
with TGFβ signaling pathway to regulate worm growth and stress resistance (de Lucas, Saez, & 
Lozano, 2015); however,  disruption of TGFβ is linked to dauer phenotypes and did not affect 
the survival of starvation-arrested L1 worms (Baugh, 2013). Taken together, we conclude that 
there is a direct effect of nicotine on worm’s development which can be dissociated from its 
effect on pharyngeal pumping and that the mechanisms behind this effect remain elusive.  
The roles of sir-2.1 and miR-80 in nicotine induced pharyngeal pumping inhibition 
Only the high nicotine dose inhibited pharyngeal pumping in N2 background (Figure 
3.3A). This effect was rescued in miR-80 (lof) and sir-2.1 (lof), and was partially rescued in acr-7 
(lof) and ric-3 (lof). miR-80 (lof) was associated with better pumping at old age (Day 11) relative 
to N2 worms (Vora et al., 2013) and this provides support for miR-80’s role in improving 
pumping in different conditions (e.g. nicotine, ageing). Does this recovery involve an 
upregulation of MAPK? 




Nicotine has been shown to cause hypercontraction in dissected pharynxes through MC 
motor neuron neurotransmission which activates downstream nAChR eat-2 with eat-18 (McKay, 
Raizen, Gottschalk, Schafer, & Avery, 2004). Nicotine causes pharyngeal tetanus defined as 
contractions lasting more than 30 seconds as opposed to less than 1 second in normal pumps 
(Avery & Horvitz, 1990). We treated worms of different mpk-1 backgrounds and checked their 
pumping rates as discussed below. 
ga111 is a weak loss of function allele that affects MEK binding site and its 
consequential phosphorylation of mpk-1 and its activation. This mutation is associated with a 
germ line sterility phenotype at higher temperatures which are restrictive for mpk-1 activity. 
ga111 worms are superficially wild type when grown at 20°C (Lackner & Kim, 1998) and might 
be partially non-functional as it could rescue the IR-induced apoptosis phenotypes in let-60 (gof) 
and lip-1 (lof) worms (Rutkowski et al., 2011). However, ga111 remain sensitive to stimuli that 
activate mpk-1. Though at a lower rate, IR was still able to activate MAPK in ga111 worms 
grown at 25°C (Rutkowski et al., 2011). This means that mpk-1 (ga111) allele is sensitive and 
reversible and we used this feature to test the effect of nicotine on the pumping rate. We would 
expect that ga111 worms grown at 20°C to be the most sensitive and most reversible, and for the 
sensitivity and reversibility to decrease as the temperature increases. Indeed, ga111 worms 
grown at 20°C were very sensitive to nicotine. Our data showed that both the high and even the 
low nicotine dose could significantly recover mpk-1 activation which in turn negatively affected 
pumping in this sensitive background (Figure 3.5A). When grown at 22°C and 25°C, the 
sensitivity and recovery decreased such that nicotine could no longer hyperactivate mpk-1 
resulting in a close to normal pumping rate as observed at 22°C, or alleviated the inhibition by 




due to the stress of the high temperature with the high nicotine dose, but it could still recue the 
inhibition in response to the less stressful low nicotine dose. For example, worms grown at 23-
33°C accelerated paralysis in response to aldicarb (Kalinnikova T.B. et al., 2013). In addition, 
miR-80 was reported to be responsive to 25°C (Nehammer, Podolska, Mackowiak, Kagias, & 
Pocock, 2015) and that could have prevented the complete rescue observed when grown at 22°C. 
Lastly, the inhibition was also reduced by 42% when nicotine was co-treated with U0126 (Figure 
3.5B). These data confirm previous reports that nicotine activates mpk-1 and that the 
hyperactivation of this pathway results in hypercontraction and consequently pumping inhibition. 
You et al generated N2 worm lines with mpk-1 overexpressed in the pharynx and these 
lines had a severe feeding defect, slower growth rate, starvation phenotype and arrested at L1. 
They concluded that this hyperactive mpk-1 kinase phenocopied the grinder defect in cases of 
hyperactivated muscarinic signaling (You, Kim, Cobb, & Avery, 2006). This was not completely 
the case in our strains overexpressing mpk-1 in the pharynx. The difference could be attributed to 
the technical approach such that the lines generated by You et al were based on the injection of 
PCR fusion fragments (You et al., 2006). On the other hand, our construct was integrated into a 
plasmid and then injected to the worm’s gonads. Transgenic lines were based on 
extrachromosomal mpk-1 and were characterized with low penetrance. Worms were transferred 
and grown and enriched over several generations before exposure to nicotine. GFP was fused 
downstream of mpk-1, therefore worms with pharyngeal mpk-1 overexpression were fluorescent 
and could be picked using a fluorescent stereoscope. Positive worms were shorter and grew 
slightly slower; however, they did not arrest at L1 and proceeded till adulthood to lay eggs and 
were superficially wild type. This was probably due to mpk-1 being expressed at a level that was 




those worms with pharyngeal mpk-1 overexpression with low and high doses of nicotine. This 
overexpression did not increase the severity of inhibition by the high nicotine dose, while it 
slightly increased the sensitivity of worms exposed to the low dose. Since it mirrored the original 
phenotype in N2 worms, it further confirmed that that the high nicotine did result in the 
hyperactivation of mpk-1 which locked the pharyngeal grinder and hindered normal pumping 
(You et al., 2006). 
The relationship between miR-80, sir-2.1, and mpk-1 in nicotine-induced pumping response 
We also overexpressed mpk-1 GFP fusion in the pharynx of miR-80 (lof) and sir-2.1 (lof) 
worms and checked the pumping rates in response to nicotine. We had established that mpk-1 
hyperactivation results in pharyngeal pumping inhibition. If mpk-1 is downstream of miR-80 or 
sir-2.1, then overexpression of mpk-1 in the pharynx will reconstitute nicotine-induced pumping 
inhibition. Indeed, this is what we observed as pumping decreased in those backgrounds 
confirming that mpk-1 is downstream of either or both factors (Figure 3.5C).We then co-treated 
miR-80 (lof) and sir-2.1 (lof) worms with nicotine and the mpk-1 inhibitor U0126. We expected 
that this co-treatment would affect the pumping in neither of those backgrounds. Interestingly, 
the pumping slightly did decrease in response to the high nicotine dose in both backgrounds 
(Figure 3.5B). As a side note, U0126 nicotine co-treatment recovered nicotine-induced 
pharyngeal pumping inhibition by 42%. What about the remaining 25% inhibition? Either that 
U0126 concentration was insufficient to overcome the entire nicotine-induced mpk-1 
hyperactivation or it could be that other factors might account for the remaining 25% inhibition.  
We checked the function of U0126 and found that it is a specific non-competitive 




2/MEK1/2’s ability to phosphorylate (Favata et al., 1998). By affecting the ATP ratio, U0126 
was also shown to activate aak-1/2/AMPK (Dokladda, Green, Pan, & Hardie, 2005). The authors 
suggested the need for caution when interpreting experiments conducted with U0126, and this 
helped us in understanding our results. aak-2/AMPK is inhibited by serotonin from the ADF 
neurons which results in glutamate release and consequent increase in pumping rate. In aak-1/2 
loss of function worms, pumping increased and its over-activation decreased pumping 
(Cunningham et al., 2012). aak-2/AMPK.is also activated by nicotine (S. Wang et al., 2012). 
This means that nicotine and U0126 potentiated the activation of aak-2/AMPK and that would 
explain the incomplete recovery we observe in N2 background (25% inhibition) and miR-80 (lof) 
(26% inhibition) (Figure 3.5B). Meanwhile, there was a 43% inhibition when sir-2.1 (lof) worms 
were co-treated with nicotine and U0126 (Figure 3.5B). Why was this reduction more severe? It 
could be that (i) aak-2/AMPK is higher, or (ii) mpk-1 activation is lower in sir-2.1 (lof) 
background.  aak-2/AMPK activation is less likely to be hyperactivated in sir-2.1 (lof) because 
aak-2 and sir-2.1 activate each other (Ruderman et al., 2010). The second possibility is more 
likely and suggests that sir-2.1 is an upstream regulator. This is supported by our data such that 
the percent inhibition in sir-2.1 (lof) (43%) was similar to the percent recovery of N2 (67%-
25%=42%) when mpk-1 was inhibited my U0126 (Figure 3.5B). Therefore, nicotine might 
activate sir-2.1 which in turn activates mpk-1 directly and indirectly through miR-80. Whether or 
not nicotine-induced aak-2/AMPK activation is sufficient to contribute to 25% of pumping 
inhibition remains unconfirmed and this could be tested by treating temperature sensitive aak-2 
(lof) mutants with nicotine without U0126. Interesting, serotonin production was reduced by 33% 




high nicotine dose decreases serotonin signaling which increases aak-2/AMPK and further 
inhibits pumping. 
In conclusion, this is the first report to show sir-2.1 and miR-80 as upstream positive 
regulators of mpk-1 hyperactivation in response to early nicotine exposure. While none of those 
effectors could rescue nicotine-induced developmental delay, our results unexpectedly brought to 
light aak-2/AMPK as a potential candidate which is activated when energy production is 
compromised or when energy consumption increases like in cases of increased muscle 
contraction (Jager, Handschin, St-Pierre, & Spiegelman, 2007; Wallace & Fan, 2010). The latter 
is considered a metabolic master switch that prevents ATP consumption and activates ATP 
production (Beale, 2008). aak-2/AMPK mutants were L1 arrest defective such that they initiated 
post-embryonic development even in the absence of food (Baugh & Sternberg, 2006). aak-
2/AMPK was also required for inhibition of germline stem cell division during L1 arrest 
(Fukuyama et al., 2012). Nicotine activated aak-2/AMPK and consequently increased abdominal 
aortic aneurysms in mice (S. Wang et al., 2012). Therefore, aak-2/AMPK might be a potential 
contributor to nicotine-induced developmental arrest.  In addition, the cytochrome P450 might be 
involved in mediating the developmental delay. For example, loss of function mutation of cyp-
35A partially rescued the developmental delay in response to high caffeine doses (Min, 
Kawasaki, Gong, & Shim, 2015). Therefore cytochromes homologous to mammalian CYP2A6 
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Table 3.1: The effect of 30 hour post-embryonic nicotine exposure on seam cells per worm 
side in JR667 strain.  
 








SD Min Max 
Control 43 25.44 0.87 28.00 5.70 16 35 
Low 39 23.21 0.90 25.00 5.63 16 32 






















Figure 3.1: (A) Rational for MS80 (mpk-1, sir-2.1, miR-80). (B) Predictions for protein expression in 









Figure 3.2: TargetScanWorm (6.2)-based predictions for miRNA targets sites in (A) mpk-1, and (B) sir-
2.1. (C) Predicted miR-80 MREs (miRNA response elements) in mpk-1and sir-2.1(Jan, Friedman, Ruby, 


















Figure 3.3: (A) Postembryonic nicotine exposure inhibited development in C. elegans N2. (B; C) Nicotine 
affected the normal timing of seam cell division in C. elegans (JR667 strain). (B) Heatmap: From left to 
right: Control (1
st
 column), Low (2
nd
















Figure 3.4: (A) The effect of post-embryonic nicotine exposure on worm length in different genetic 
backgrounds. (*) denotes statistically significant differences at p<0.05 relative to control per strain. (B) 
Heat map of the worm lengths in different genetic backgrounds normalized to the control group of the N2 
lab strain and presented as percentages. Unsupervised hierarchical clustering was based on Euclidean 
distance and average linkage as described in the methods section. (C) Left column: The effect of 
pharyngeal overexpression of mpk-1 on worm length in each treatment group: control, low, high. Right 
column: comparisons of the nicotine-induced length patterns in N2, miR-80 (nDf53), sir-2.1 (ok434) with 






(B)  (C)  
 
Figure 3.5: (A) The effect of postembryonic nicotine exposure on pharyngeal pumping in different genetic backgrounds. (B) The effect of U0126 
(mpk-1 inhibitor) co-treatment on pharyngeal pumping in N2, miR-80 (NDf53), and sir-2.1 (ok434). (C) The effect of postembryonic nicotine 
exposure on N2, miR-80 (nDf53), and sir-2.1 (ok434) with pharyngeal-specific overexpression of mpk-1. Comparisons were done to the control of 







Figure 3.6: Postembryonic to the high nicotine exposure decreased serotonin synthesis in ADF neurons, 
but not NSM neurons at p<0.05. GR1366 worms have tph-1 tagged with GFP. tph-1 is the rate limiting 
enzyme for serotonin synthesis. Expression was based on GFP expression and was measured by imageJ 














Supplementary figure 3.1: pharyngeal specific mpk-1 overexpression in adult worms (first row taken at 







MS80: Fasting-induced resistance against late-onset nicotine-induced germ line apoptosis 
Abstract 
Nicotine remains the most socially accepted drug of abuse worldwide. This results in children 
and adolescents being exposed to nicotine either through active smoking or through second and 
even third hand smoking sources. This early exposure does not only impact the young 
individuals, but can also impact their future health. Unfortunately, the developmental molecular 
origins of the related late-onset diseases remain elusive. Therefore, in this study we were 
interested in investigating the contributions of mpk-1, sir-2.1, and miR-80 (MS80) to nicotine-
induced enduring impacts using the model organism C. elegans. Worms were exposed to 
nicotine prior to sexual maturity and were then washed and transferred to grow on nicotine-free 
NGM plates until adulthood to examine their reproductive success, germ line apoptosis rate, and 
their average lifespan. One-way ANOVA and post-hoc test were used to test the impact of 
nicotine on reproduction and germ line apoptosis while Kaplan-Meier curves and Chi-square 
tests were used for lifespan analysis. Statistical significance was based on p<0.05 after applying 
Bonferroni corrections. Our results showed that early nicotine exposure delayed the onset of 
reproduction, but it did not decrease the fertility. In addition, this early exposure decreased mean 
worm lifespan by 5% and this effect was lost in miR-80 (lof) worms. Post-embryonic treatment 
with either the low (20µM) or the high (20mM) nicotine doses also increased adult germ line 
apoptosis rate and this was completely recovered in miR-80 (lof) worms and partially recovered 
in sir-2.1 (lof) worms. The apoptosis rate also went back to normal after treating worms with 
mpk-1 inhibitor (U0126). Interestingly, starvation concurrent with nicotine treatment made the 
worms resistant to nicotine-induced adult germ line apoptosis. Similarly, modeling a DR-like 




nicotine exposure. This was supported by epidemiological observations where annual fasting 
habits could explain the discrepancies between lower death rates in spite of the higher smoking 
prevalence. Our study is the first to show that MS80 mediate nicotine-induced late-onset germ 
line apoptosis and that manipulating this pathway can enhance an organism-level response that 
may boost the antioxidant system in a DR-like similar mechanism. This can prevent the 
susceptibilities of late-onset health disparities like neurodegenerative diseases related to early 
nicotine exposure.  
Keywords: Nicotine, MAPK, ERK1/2, mpk-1, sirtuins, SIRT1, sir-2.1, miR-80, C. elegans larvae, 
neonates, adolescents, late-onset, lifespan, germ line apoptosis, ROS, oxidative damage, 







Though it is variable in different cultures, nicotine remains the most socially accepted 
drug of abuse worldwide (Goriounova & Mansvelder, 2012).  For example, smoking rates among 
11 year olds in Lebanon is above 60% (WHO, 2013). Smoking rates among adolescents are also 
increasing in the US due to the spread of waterpipes (i.e. hookas) and other nicotine products 
(Soule et al., 2015). Also, about 16% of women smoke during and after pregnancy or use 
nicotine replacement therapy in the US (Smith et al., 2010) and this subjects their developing 
embryo as well as the lactating neonates to nicotine through breast milk. Unfortunately, smokers 
remain unaware of the severity of their habit on their health as well as their family or continue to 
relapse due to the addictive nature of nicotine (Zhou et al., 2014). This results in children and 
adolescents being exposed to nicotine either through active smoking or through second and even 
third hand smoking sources (Martins-Green et al., 2014). Second hand smoke was linked to 
increased risks of neurodevelopmental delays and poor neurocognitive performances when 
experienced during the postnatal period (R. Chen et al., 2013). On a cellular level, nicotine 
exposure negatively impacted the survival of hippocampal progenitor cells in developing as well 
as adult brains (Berger, Gage, & Vijayaraghavan, 1998) and increased the apoptotic markers in 
the developing piglet brains (Machaalani, Waters, & Tinworth, 2005). This early exposure does 
not only impact the young individuals, but can also impose catastrophic impacts on their future 
health (Cuthbertson & Britton, 2010). Epidemiologic studies linked smoking with increased risks 
of neurodegenerative diseases like Parkinson’s (Hernan et al., 2002) and Alzheimer’s (Durazzo 
et al., 2014). In addition, the prevalence of Attention Deficit Hyperactivity Disorder (ADHD) 
autism cases has increased in the last years. Both neurologic diseases have an apoptotic 




onset with exposure to parental smoking (James, 2013; Smith et al., 2010; Zhou et al., 2014). 
Recently, there has been an increased interest in and emphasis on understanding the mechanisms 
contributing to late-onset diseases in response to chemical and environmental exposures during 
sensitive developmental windows (Haugen et al., 2015; Wadhwa, Buss, Entringer, & Swanson, 
2009). Interestingly, both DOHaD and epigenetics are prioritized areas of research in the NIHES 
strategic plan and include DNA and histone methylation as well as regulatory RNA molecules 
like microRNAs (Haugen et al., 2015). In this study, we were interested in investigating the role 
of microRNAs in mediating late-onset diseases in response to post-embryonic exposure in C. 
elegans.  
Previously, we showed that early nicotine exposure was associated with changes in 
behavior and microRNA profiles across generations (F. Taki et al., 2013; F. A. Taki et al., 2014; 
F. A. Taki et al., 2013). We identified miR-80 as a potential transgenerational biomarker for 
early parental nicotine exposure. In chapter III, we showed that miR-80 alleviated nicotine-
induced pharyngeal tetanus. Our results suggested a potential relationship between miR-80, mpk-
1, and sir-2.1 in response to direct nicotine exposure. We were intrigued to test if this 
relationship mediates nicotine-induced late-onset diseases in C. elegans. In this study, we study 
the role of miR-80, mpk-1, and sir-2.1 in late-onset diseases in response to early nicotine 
exposure. 
Material and methods 
Strains from CGC: N2 (lab WT strain), MT2124 (let-60 n1046), MT13949 (mir-80(nDf53)III), 
MT15563 (nDf53 III; mir-58(n4640) IV; nDf54 X), VC199 (sir-2.1 (ok434) IV); FX863 (acr-




MD701(bcIs39 [lim-7p::ced-1::GFP + lin-15(+)]. In addition, N2Ex, miR-80(nDf53)Ex, and sir-
2.1(ok434)Ex were generated as previously described.  
Worm maintenance and treatment 
Worms were maintained on solid NGM (0.3% NaCl, 0.25% peptone, 1.7% agar, 0.5% 
cholesterol, 0.1% of 1M MgSO4, 0.1% of 1M CaCl2, and 2.5% of 1M KPO4) at 20°C. For 
treatment, we used two nicotine doses based on our previous studies (F. Taki et al., 2013; F. A. 
Taki et al., 2014; F. A. Taki et al., 2013; F. A. Taki & Zhang, 2013). Nicotine was diluted in the 
same KPO4 buffer used in NGM. A serial dilution was done to two nicotine stocks of 1M and 
1mM. The latter were added during the making of the treatment plates such that the final nicotine 
concentrations in the media were 20mM (high dose) and 20µM (low dose) (F. A. Taki et al., 
2014). Plates were left to dry, sealed, and stored at 4°C until use.  
Worms used for experiments were first mixed with a freshly prepared synchronization 
solution ((70% water, 10% NaOH, 20% bleach), eggs were collected and were left to hatch for 
about 18 hours in M9 buffer. In the absence of food, the L1 larvae remain arrested at that stage 
and thus enabled starting all treatments on age-synchronized worms. Before transfer, OP50 food 
was spread on the control and treatment plates 15-30 minutes and were left to dry. Then, 
approximately equal numbers of L1 larvae were transferred to the seeded control and treatment 
plates. The treatment period lasted for 30 hours only at 20°C unless otherwise noted (e.g. 






After treatment, worms were left to grow till late L4/young adult stage on NGM plates. 
Then, six centimeter NGM plates were prepared and were labeled by treatment. The plates were 
seeded with a 10µl drop of OP50 bacteria and left to dry. From each treatment group, four 
worms were transferred to their corresponding plate. Once the egg laying started, adult worms 
were then transferred to a new NGM plate every 24 hours, while the older plate was sealed and 
placed at 4°C.  This allowed for easier counting as larvae were sessile and the eggs were 
preserved. The process was repeated for a total of two days. Four replicates were used for each 
treatment group with four worms per replicate and the progeny count was normalized per worm. 
Worms that burrowed in the agar or were lost during transfer were excluded from the analysis on 
the respective days. 
Apoptosis assay 
Nicotine treatment was only limited to the L1-L4 period, afterwards, worms were 
transferred to fresh NGM to grow to first day of adulthood during which the apoptosis assay was 
performed. To visualize the apoptotic cells, SYTO12 (Gumienny, Lambie, Hartwieg, Horvitz, & 
Hengartner, 1999) or acridine orange staining (Lant & Derry, 2014) were used for easier 
distinction of apoptotic cells in the gonad loop region (i.e., death zone) (Supplementary figure 
4.1). Briefly, worms were collected and stained with ~30µM SYTO12 (Invitrogen) for 2 hours or 
0.075mg/ml acridine orange for 1.5 hours. Afterwards, they are washed with M9 and transferred 
to a seeded NGM plate for 1.5 hours to regurgitate the dye from their intestine. Worms were then 
mounted on 2% agarose pads onto Zeiss inverted fluorescence microscope to count apoptotic 
cells in gonadal death zone. As a negative control, we used the apoptosis defective mutant 





After worms were exposed to nicotine for 30 hours, they were collected, washed with M9 
buffer, and transferred to nicotine free NGM plates until late L4/early adulthood. Then, an 
average of 200 worms were transferred to a labelled 6 cm NGM plate seeded with OP50 from 
each of the control, low (20µM), and high (20mM) treatment groups, respectively. Every other 
day, all worms were counted and categorized as dead or alive or lost. Living worms were 
transferred to a new NGM plate and the process was repeated until all worms died. Worms were 
considered dead when they didn’t move upon gentle touch and with a 5µl drop of M9 buffer. 
Worms that were stuck in the agar or on the plate wall were censored. Two to four trials were 
performed for each strain. 
Data analysis 
One way ANOVA was used for reproduction and apoptosis assays in SPSS (20). Post-
hoc test was performed for pairwise comparisons. Bonferroni correction was applied to compute 
statistical differences between treatment groups at p<0.05. Lifespan assays were organized in 
excel sheets and were inputted into OASIS which is a free user-interface software for lifespan 
analyses (J. S. Yang et al., 2011). Kaplan Meier curves were constructed and chi square test was 
used to compute statistically significant differences. 
Results 
Post-embryonic nicotine exposure did not affect reproduction 
While the low nicotine dose did not hinder worm growth, we noticed that development 




checking if this delay was associated with a negative effect on reproductive success. The 
reproduction assay was performed as described in the methods section. A delay in development 
is not necessarily associated with a smaller progeny size. Thus, the assay started once the worms 
started laying eggs to control for the delay in development. Fertile progeny included larvae and 
fertile eggs after a 48 hour period. As shown in Figure 4.1A, postembryonic exposure to either 
low or high nicotine doses did not impact the worms’ fertility [F(2,9)=1.28; p=0.324]. 
Post-embryonic nicotine exposure altered lifespan 
We were interested in the effect of 30 hour larval nicotine exposure on the mean lifespan 
in adult N2 worms. Exposure to the low nicotine dose did not impact the mean lifespan [χ2=0.09; 
p=1]. On the other hand, the high nicotine dose significantly decreased the mean lifespan by 
more than 5% relative to the control worms [χ2=10.26; p=0.0027]. This effect was lost in the 
miR-80 (nDf53) loss of function mutant [χ2=0.24; p=1] where the mean lifespan of the low and 
high treatment groups was similar to the control group (12 days) (Figure 4.1B). This suggests 
that the decrease in lifespan associated with exposure to the high nicotine dose was at least 
partially dependent on miR-80 and that the latter is pro-ageing. 
Post-embryonic nicotine exposure increased germline apoptosis 
We wanted to check how early nicotine exposure can have an enduring effect on the 
germ line in the worm. So, after the 30 hour larval exposure, worms were washed off treatment 
and transferred to NGM plates seeded with OP50 as a food source. Worms were left to grow till 
after egg laying had started in the first day of adulthood. Worms were then stained with either 
SYTO12 or acridine orange as described in the methods section. Our results showed that nicotine 




comparisons revealed that both the low and high doses increased the number of apoptotic cells 
by 119% and 90% (p<0.001), respectively (Figure 4.2). To rule out possible technical biases or 
errors associated with staining, we used the MD701 strain with ced-1 GFP fusion protein in the 
sheath cells. No staining is required to visualize apoptotic germ cells in this strain; instead, 
apoptotic cells appear as hollow circles with a fluorescent rim. Consistent with our results in the 
lab strain N2 background, both nicotine doses increased the apoptotic rate in the worms 
[F(2,155)=6.40; p=0.002] (Figure 4.2). In Chapter III, we showed that nicotine alters the worm’s 
feeding rate. To rule out the possibility that the observed apoptosis is not due to starvation, we 
starved the worms on NGM plates without OP50 throughout the 30 hour nicotine exposure 
period. Then, worms were transferred to seeded NGM to grow till adulthood. Interestingly, the 
low and high nicotine doses could no longer impact the apoptotic rate of starved worms (Figure 
4.2). This suggests (i) that exposure to nicotine through feeding was a prerequisite for long term 
effects, and (ii) that the apoptosis phenotype was specific to nicotine. To confirm that those cells 
are apoptotic, we repeated the procedure using an apoptosis defective mutant ced-3 (n717) and 
inspected the gonadal death zone. We failed to observe any stained apoptotic cells in this 
background, which confirmed that early nicotine exposure had an enduring effect on the 
germline physiology as it increased the apoptotic rate (Figure 4.2).  
Candidate molecular mediators for nicotine-induced apoptosis 
The treatment and staining procedure was repeated in different genetic backgrounds. The 
loss of function of p53-like protein cep-3 (gk138) recovered the germline apoptotic rate to 
normal physiological levels (Figure 4.2). This suggests that early nicotine exposure was 
associated with cellular DNA damage that lasted until adulthood. Interestingly, the loss of 




and high nicotine doses. The same effect was observed with loss of function mutations in the 
entire miR-58 family (nDf53 III; mir-58(n4640) IV; nDf54 X) (Figure 4.2).  
In other genetic backgrounds, the recovery from the increased apoptosis was dose-
dependent. For example, nicotine had a significant effect on apoptosis in let-60 (n1046) 
background [F(2,294)=10.54; p<0.001]. This effect was due to the low nicotine dose which 
increased apoptosis by 80% (p<0.001) (Figure 4.2). On the contrary, loss of function mutations 
in sir-2.1 (ok434), acr-7 (tm863), and ric-3(md158) were resistant to the low nicotine dose only 
and were rather sensitive to the high nicotine dose. For example, apoptosis was significantly 
increased in sir-2.1 (ok434) worms [F(2,147)=17.98; p<0.001] and that effect was specific to the 
high nicotine dose which increased the apoptotic rate by 272% relative to the control. Similarly, 
acr-7 (tm863) and ric-3 (md158) worms were impacted by nicotine exposure [F(2,140)=5.99; 
p=0.003] and [F(2,147)=21.51; p<0.001], respectively. This was due to exposure to only the high 
nicotine dose resulting in a 102% and 214% increase in apoptosis in acr-7 (tm863) and ric-3 
(md158), respectively (Figure 4.2). Taken collectively, this suggests that different combinations 
of molecular factors are responsive and dependent on the nicotine dose.  
Co-treatment with nicotine and U0126 
The C. elegans mpk-1is homologous to ERK2 (MAPK1) and is the most downstream 
kinase in the MAPK pathway (Y. Wu & Han, 1994). We wanted to check how the inhibition of 
mpk-1 would impact the increase in apoptosis in response to early nicotine exposure. Each 
replicate was comprised of two nicotine-free NGM plates and one 20mM nicotine infused NGM 
plate. One batch of OP50 food was mixed and then divided to three falcon tubes. DMSO was 




other OP50 tubes resulting in a final concentration of 50µM (F. Chen et al., 2008). Fifteen 
minutes before the start of exposure, DMSO-OP50 mix was spread on NGM plates for vehicle 
control, U0126-OP50 mix was spread on either nicotine-free NGM, or NGM infused with 20mM 
of nicotine, respectively. After the plates dried, equal amounts of synchronized L1 larvae were 
transferred onto the plates and were left to grow for 30 hours under those conditions. Then, 
worms were washed off treatment and transferred to NGM free of both U0126 and nicotine and 
allowed to grow until adulthood. Once egg laying started, adult worms were collected, stained, 
and inspected as described in the methods section. Our results showed that the high nicotine dose 
could no longer increase the apoptotic rate in the presence of U0126 in the N2 background 
[F(2,267)=2.84; p=0.06] (Figure 4.3A). The same pattern was observed in miR-80 (nDf53) 
background with or without U0126. Interestingly, sir-2.1 (ok434) were resistant to the 
proapoptotic effects of the high nicotine dose when co-treated with U0126 [F(2,267)=0.11; 
p=0.898] (Figure 4.3A). This suggests that the 272% increase in germline apoptosis in sir-2.1 
(lof) mutants (Figure 4.2) was due to nicotine-induced upregulation of mpk-1. From this data, we 
deduced that (i) nicotine induced apoptosis was due to the overactivation of mpk-1, (ii) the loss 
of function of sir-2.1 sensitized the worms to nicotine’s proapoptotic effects and that this was 
due to hyperactivation of mpk-1, and (iii) mpk-1 overactivation could be a direct or a side-effect 
of nicotine’s effect on sir-2.1.  
The role of pharyngeal mpk-1 on nicotine-induced germ line apoptosis 
In chapter III, we showed that nicotine overactivated mpk-1 in the pharynx. We were 
intrigued to see the effect of early nicotine exposure on worms with an extrachromosomal 
overexpression of mpk-1 GFP fusion in the pharynx. Using the same treatment and staining 




pharyngeal GFP. Unexpectedly, neither nicotine dose resulted in an increased apoptotic rate 
when mpk-1 was constitutively overexpressed in the pharynx in N2 background [F(2,136)=0.01; 
p=0.99] (Figure 4.3B). Worms with miR-80 loss of function were consistently not impacted with 
mpk-1 pharyngeal overexpression [F(1,138)=2.95; p=0.055]. On the contrary, sir-2.1 loss of 
function was initially sensitized to the high nicotine dose and this effect was lost when mpk-1 
was constitutively expressed in the pharynx [F(1,118)=0.62; p=0.542] (Figure 4.3B). These 
results suggest that (i) there is cell non-autonomous signaling that links pharyngeal 
overexpression of mpk-1 with germ line apoptosis, (ii) mpk-1 overexpression in the pharynx 
protected the worms against nicotine’s late onset cell death, (iii) constitutive mpk-1 
overexpression in the pharynx potentially negated nicotine-induced adult germ line apoptosis 
either through inhibition of germ line mpk-1 aberrant activation or through mpk-1independent 
mechanisms, and (iv) miR-80 is a possible mediator of this protective effect or acts through a 
parallel mechanism.  
Discussion 
Early nicotine exposure impacted mean lifespan, but not reproductive success in C. elegans 
In Chapter III, we showed that exposure to the high nicotine dose was associated with a 
developmental delay. This effect was reversible since the worms resumed growth at the normal 
rate when washed off of treatment onto nicotine-free treatment plates with food. Those worms 
progressed to sexual maturity and started laying eggs12-24 hours after the control and low 
treatment groups (data not shown). Despite the delayed onset, reproduction was not impacted by 
either nicotine dose. This is consistent with previous reports on nicotine-induced delay in 




inconsistent with previous reports linking early nicotine exposure to reduced fertility (Bruin et al., 
2010; CDC, 2010b). Toxicology studies employing reproduction as a sub-lethal endpoint usually 
expose C. elegans worms between the last larval stage L4 and adulthood. Spermatogenesis starts 
during late L4 and oocytes differentiate in young adults. Thus during this developmental period, 
the number of mature germ cells is maximal which makes the reproduction assay more sensitive 
to assessing fertility while controlling for growth retardation side effects (Boyd, McBride, Rice, 
Snyder, & Freedman, 2010). Our treatment procedure ended at early L4 stage before any germ 
cells had differentiated which might have impacted the sensitivity to nicotine’s effects on 
reproduction. This is also supported by the fact that C. elegans worms arrested at L1 develop 
increased stress resistance which is a feature used when freezing worm stocks for long term 
storage at -80°C (J. A. Lewis & Fleming, 1995). Consistent with this point, when worms were 
left to grow on nicotine, some worms reached sexual maturity though at a much slower pace and 
produced much fewer viable progeny (data not shown).  
In spite of L1 resistance, this early nicotine exposure decreased mean worm lifespan by 
about 5% and this effect was lost in miR-80 loss of function mutant (Figure 4.1B). In C. elegans, 
the genes involved in L1 arrest and stress resistance are also implicated in adult lifespan (Baugh, 
2013). Interestingly, in spite of this resistance property, early nicotine exposure still negatively 
impacted adult lifespan and this effect could be at least partially promoted by the overexpression 
of miR-80 in response to nicotine ((F. A. Taki et al., 2014; F. A. Taki et al., 2013). This is 
consistent with previous reports that showed that miR-80 loss of function prolonged lifespan 
through the regulation of the Dietary Restriction (DR) metabolic program (Vora et al., 2013). 
Indeed, our results also showed that miR-80 (nDf53) loss of function increased mean lifespan by 




Post-embryonic nicotine exposure increased adult germ line apoptosis 
Nicotine is both pro and anti-apoptotic and this bivalent effect is context-dependent (e.g. 
dose, development, duration, organ) (Zeidler et al., 2007). Based on our preliminary data, 
exposure to both the low and high nicotine concentrations increased germ cell apoptosis in C. 
elegans. The low dose (20µM) is 1000 times lower than the high dose (20mM) yet it resulted in 
similar apoptotic rates (Figure 4.2). This reinforces the idea that no tobacco and nicotine 
exposure level is risk free (CDC, 2014; Zhou et al., 2014). 
Both mpk-1 isoforms were shown to interact with cep-1 in the apoptotic pathway 
(Rutkowski et al., 2011). Our data showed that cep-1/p53 like loss of function rescued apoptosis 
in response to both doses (Figure 4.2), which suggests that it could be downstream of mpk-1 
activation. cep-1/p53 activation usually reflects the occurrence of DNA damage. Therefore, early 
nicotine exposure impacted DNA integrity which is a trigger for cell apoptosis.  
The main and direct targets of nicotine are the nicotinic and muscarinic acetylcholine 
receptors. C. elegans has around 29 nAChR subunits classified into 5 different families (Jones, 
Davis, Hodgkin, & Sattelle, 2007). acr-7 is a member of the acr-16 like family and is 
homologous to the alpha 7-10 subunit in vertebrates (Jones & Sattelle, 2004). Previously it was 
reported that acr-7 (lof) conferred resistance against the delay in development induced by 1-2mM 
of nicotine (Saur et al., 2013). Here, we report that acr-7 partially rescued apoptosis in response 
to the low nicotine dose; however, it was insufficient to rescue apoptosis in response to the high 
dose (Figure 4.2). Similarly, the same effect was observed with ric-3 loss of function (Figure 4.2). 
ric-3 is necessary for the maturation of at least 4 acetylcholine receptors and therefore its loss of 




resistance against nicotine paralysis (Halevi et al., 2002). Both acr-7 and ric-3 loss of functions 
could not recover apoptosis back to normal levels with the high nicotine dose. This suggests that 
nicotine induces apoptosis via different mechanisms depending on the dose. acr-7 and ric-3 could 
be part of a nicotine-specific response as was observed in response to the low dose. Meanwhile, 
apoptosis induced by the high nicotine dose could be a side-effect of organism level signaling.  
Revisiting apoptosis in different mpk-1 backgrounds 
let-60 (n1046) results in constitutive activation of Ras/MAPK yet is not associated with 
increased apoptosis (Gumienny et al., 1999) and that was also evident in our data as let-60 
(n1046) control did not differ significantly from N2 control (Figure 4.2). let-60 (n1046) did not 
rescue apoptosis induced by the low nicotine dose; however, it rescued apoptosis induced by the 
high nicotine dose (Figure 4.2). let-60 (n1046) doesn’t increase the protein levels of mpk-1, but 
instead alters its phosphorylation levels (M. H. Lee et al., 2007). In particular, let-60 (n1046) is 
associated with hyper-phosphorylation of mpk-1a isoform and hypo-phosphorylation of mpk-1b 
isoform. mpk-1b is the predominant isoform in the germline (M. H. Lee et al., 2007). This 
suggests that the low nicotine dose is associated with an increase of phosphorylation of mpk-1b 
in the germline resulting in increased apoptosis (Figure 4.2). Why was this effect lost in response 
to the high nicotine dose in let-60 (n10460) (Figure 4.2)? To answer this question, we consider 
the case with N2 worms with mpk-1a overexpression in the pharynx. When the same nicotine 
treatment procedure was applied onto these worms, apoptosis was no longer higher than control 
(Figure 4.2). Why does the hyperactivation of mpk-1a in the pharynx rescue the apoptosis 
phenotype in response to nicotine? We suggest that the increase of mpk-1a in the pharynx and 
body alters the feeding rate and models dietary restriction in the worm. This is supported by the 




overexpression in the pharynx (Figure 4.4). It is important to note that this mpk-1 induced 
dietary restriction is not starvation as growth was not arrested and worms laid viable eggs. 
Dietary restriction activates many antioxidative signaling pathways that could have protected and 
masked nicotine-induced apoptosis. With this in mind, this could have been the case in let-60 
(n1046) worms treated with the high nicotine dose which hyperactivates mpk-1a isoforms in the 
pharynx and body prior to the germline development and shifts global metabolism to dietary 
restriction mode. Worms are removed off of nicotine after 30 hours, by then dietary restriction 
had been established and it prevented the nicotine-induced hyperphosphorylation of mpk-1b in 
the germline once fully developed. This might have also been the case for exposing worms to 
nicotine without a food source as starvation activated mpk-1 in the pharynx (You et al., 2006). 
Control, low, and high groups were all arrested at L1 for the entire 30 hour period and resumed 
growth once washed and transferred onto OP50 seeded NGM plates. This starvation scenario 
made the worms resistant to nicotine’s effect on apoptosis which could be through DR-like 
mechanisms as described above.  
Are mpk-1 and sir-2.1 inversely proportional? 
Since sir-2.1 loss of function enhanced nicotine-induced apoptosis and that effect was 
lost when nicotine was co-treated with U0126 (Figure 4.3A), then sir-2.1 (lof) resulted in further 
hyperactivation of mpk-1 which increased apoptosis. Based on this data, we would conclude that 
sir-2.1 and mpk-1 are inversely proportional; however, this was only observed in response to the 
high nicotine dose and not the low dose. As shown in Figure 4.2, sir-2.1 loss of function rescued 
the apoptotic effect of the low nicotine dose, so this shows that sir-2.1 and mpk-1 are positively 
correlated. This positive relationship is also previously reported where SIRT1 activated ERK1/2 




of sir-2.1 in response to the high nicotine dose could be a side-effect of organism level response 
to the high dose.  
ROS: a candidate signaling molecule for nicotine-induced molecular memory 
Nicotine exposure started at the L1 post-embryonic stage and ended around the L3/L4 
molt in C. elegans. Worms were then washed off treatment and allowed to grow on a nicotine 
free medium until sex maturation and the onset of adulthood. To recap germ line development in 
C. elegans, germ cells differentiate around the four-cell stage during embryogenesis. However, 
further differentiation of the somatic gonad is coupled with that of germ cells and occurs post-
embryonically. Those germ cell precursors require signaling and nutrients from the developing 
somatic gonad for subsequent steps. The process starts in mid-L1 until L3 stage where a somatic 
“niche” is formed from 12 cells: 2 distal tip cells (DTCs) and 10 proximal cells. This represents 
the backbone for subsequent bursts in germ and somatic cell proliferation and marks the 
beginning of sex determination. As worms grow till L4 and young adult stages, events continue 
to be spatiotemporal starting from DTC-dependent germ cells mitosis which then transition to 
meiosis around gonad loop region. This is the site of apoptosis and is known as the death loop. 
Until this point, germ cells are syncytial and share a cytoplasm during the pachytene stage. This 
basal level of apoptosis is considered a normal physiological phenomenon that does not only 
eliminate faulted germ cells, but it also provides nutrients to the qualified cells through the 
shared cytoplasm (Hubbard & Greenstein, 2005). It is important to note that apoptosis does not 
always correlate with fertility, and in fact has been reported to be inversely proportion in some 
situations (Gartner A. et al., 2008).  This was also observed in our data as nicotine increased the 
apoptotic rate (Figure 4.2), but did not impact fertility in this model organism (Figure 4.1A). In 




beyond pachytene as well as the apoptosis rate. Thus, decreased MAPK signaling is proportional 
to pachytene arrest, decrease in apoptosis, as well as a decrease in fertility. Based on our results, 
we concluded that both nicotine doses increased apoptosis through different mechanisms that 
converged on MAPK signaling and cep-1/p53 as a likely downstream candidate to promote cell 
death. Our apoptosis assay is usually done on the first day of adulthood after which F1 embryos 
have been laid. The apoptosis assay is concerned with the loop region of the adult gonad which is 
comprised of both oocyte progenitor and non-progenitor cells. It is important to note that 
nicotine exposure preceded the differentiation of sperms or oocytes. So how come do we still see 
an increase in apoptosis in meiotic oocytes? Is apoptosis in this region at that time a consequence 
of direct nicotine exposure? One can argue that nicotine could directly have impacted the mitotic 
progenitor cells that migrated after nicotine was removed and eventually died. We argue that this 
observed apoptosis response is not due to direct nicotine exposure, but instead due to a nicotine-
induced molecular memory that persisted until at least adulthood. Below, we provide a rationale 
for this proposition.  
Did those pachytene cells in the loop arise from the meiotic cells directly exposed to 
nicotine that migrated to the loop during development? The answer to this question is two folds: 
For worms treated with the low nicotine dose, apoptosis increased in a manner similar to those 
exposed to the high dose (Figure 4.2). Those worms were similar to control in growth rate and 
reproductive onset and showed no signs of a delay. We argue that those apoptotic cells were not 
due to direct contact with nicotine, and that nicotine induced a stress response that was enduring. 
This is supported by the fact that hermaphrodite germ cells are first seen in the pachytene stage 
during the late-L3 stage and those cells enter meiosis to become sperm during the L4 stage. On 




in adults (Kimble & Crittenden, 2007). Therefore, the only exposed meiotic cells were sperm 
progenitors, while the progenitors for oocytes did not coincide with nicotine exposure. For 
worms treated with the high nicotine dose, apoptosis also increased (Figure 4.2). Those worms 
were developmentally delayed. In other words, for the entire nicotine exposure period, most of 
the worms remained in the L1 stage as confirmed with our seam cell counts (Figure 3.3). As we 
recall from the timeline of germline development, the gonad has not undergone any cell division 
or expansion at this point. Therefore, the only exposed cells were the two germ stem cells. Taken 
together, this suggests that there is intragenerational inheritance of a nicotine-induced signal. 
What could this signal be?  
ROS are great candidates for nicotine induced intragenerational signaling molecule 
What make ROS (Reactive Oxygen Species) a highly likely candidate are their chemical 
properties. They bind covalently to their targets, and in most cases can be reversed. Targets 
include ROS-sensitive transcription factors and signaling molecules that can result in cellular and 
organism level responses (Ray, Huang, & Tsuji, 2012). ROS can diffuse through membranes via 
aquaporins and anion channels (Fisher, 2009) and mediate intercellular signaling. Sensors of 
ROS levels include cep-1/p53 which in addition to its canonical role as a tumor suppressor, it is 
also known as an antioxidant (D'Autreaux & Toledano, 2007) which can respond to ROS in a 
dose-dependent manner (i.e. antioxidant activation vs. apoptosis (Rutkowski et al., 2011)). ROS 
results in oxidation of the Cys residues on proteins and their inactivation. The hyperactivation of 
mpk-1 in adult germ line despite the absence of nicotine could be due to the ROS-mediated 
inactivation of the phosphatases (e.g. lip-1 in C. elegans) that inactivate the kinases as an 
autoregulatory feedback loop to keep signaling under control (Ray et al., 2012; Schieber & 




apoptosis, especially in sir-2.1 (lof) mutants as observed in our study. This is consistent with the 
role of sirtuin homologs like SIRT1in enhancing the organisms antioxidant responses 
(Berdichevsky, Viswanathan, Horvitz, & Guarente, 2006; Olmos et al., 2013; Tissenbaum & 
Guarente, 2001). 
Epidemiological evidence 
When considering epidemiological data concerned with mortality rates relative to 
smoking prevalence, some countries like Lebanon stand out. Lebanon has a significantly high 
level of smokers and has the highest rates among adolescents yet has one of the lower death rates 
in the region in the Middle East and Europe (Figure 4.5). There are around 18 religious groups in 
Lebanon (USDOS, 2011) and they all have one form of an annual fasting habit (Trepanowski & 
Bloomer, 2010). Fasting is in some ways similar to dietary restriction especially in boosting the 
anti-oxidant system (Trepanowski & Bloomer, 2010). This common cultural and religious habit 
could be the reason for the discrepancies between smoking and death rates in the country.  
Applications of MS80 (mpk-1, sir-2.1, and miR-80 network) 
In our study, loss of function of sir-2.1 further sensitized the worms to apoptosis in 
response to the high nicotine dose. Interestingly, the human homolog SIRT1 induced 
antioxidants that rescued smoking-induced inflammation, DNA damage and apoptosis in aortic 
endothelial cells and thus promoted vasoprotection (Rutkowski et al., 2011). This suggests the 
high nicotine dose is associated with higher levels of reactive oxygen species that could result in 
oxidative stress and DNA damage and eventually cellular apoptosis. This is supported by the 
recovery of apoptosis levels in cep-1/p53 (lof) worms (Figure 4.2). Protection from oxidative 




In addition, apoptosis levels went back to normal in miR-80 loss of function mutants (Figure 4.2) 
as well as treatment with mpk-1/ERK2 inhibitor U0126 (Figure 4.3A).  miR-80 loss of function 
has previously been implicated with the regulation of a DR-metabolism in C. elegans (Vora et al., 
2013). By doing so, miR-80 (lof) could enhance the anti-oxidant system in the worms which 
confers resistance against nicotine-induced enduring effects. This could be done by delivering 
specific anti-miR molecules into patients with smoking enhanced neurodegenerative diseases as 
well as other diseases with an apoptotic component. For example, smoking has been shown to 
increase the apoptosis rates of beta-islet cells (Bruin, Gerstein, et al., 2008; Bruin et al., 2007) as 
well as cardiomyocytes (L. Wang et al., 2014). Therefore, anti-miR delivery could help in 
treating smoking related diabetes and cardiovascular dysfunction. In addition, smoking related 
cancer treatments would also benefit from this drug. Cancer cells can tolerate very high levels of 
ROS and evade apoptosis. Providing patients with antioxidants that scavenge the ROS makes the 
cancer more detrimental. Meanwhile, an anti-miR molecule that shifts the body’s metabolism to 
a DR mode would enhance the antioxidant defense system in the body such that high ROS levels 
would activate p53 to induce apoptosis in the cancer cells while low ROS levels in normal levels 
would activate p53 antioxidant property (Schieber & Chandel, 2014) which makes this approach 
much more selective.  
Another promising application is the delivery of anti-miR ‘vaccine’ to neonates and 
adolescents in the form of transdermal patches throughout those early stages would be sufficient 
to confer long term resistance. This idea is supported by the observation that treatment with 
MAPK inhibitor only during the first 30 hours of the worms’ life was sufficient to prevent 
nicotine-induced late-onset apoptosis. Also, Li et al where showed that sir-2.1/SIRT1 sensitized 




We propose a model for nicotine-induced late-onset apoptosis. Early exposure to high 
doses of nicotine results in high ROS levels. ROS act as signaling molecules that mediate the 
intragenerational inheritance of nicotine-induced damage even after growing in nicotine free 
environments. In turn, ROS signaling molecules activate germline mpk-1 which interacts with 
cep-1 to promote cellular apoptosis. With this in mind, our data bring to light potential 
microRNA candidate molecules for the development of preventative medicine for 
neurodegenerative diseases triggered by early exposure to nicotine. By targeting human 
microRNAs that are functionally similar to cel-miR-80 (Chapter V), we could boost a DR-
metabolic and antioxidant response in patients without changes in their diets which could 
alleviate the enduring complications. More so, our findings could potentially explain 
discrepancies in long lived smokers such that their smoking habits might have been associated 
with a decreased appetite and reduced food intake. The latter could induce a DR-like similar 
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Figure 4.1: (A) The effect of postembryonic nicotine exposure on worm fertility. (B) The effect of 
postembryonic nicotine exposure on adult mean lifespan in N2 versus miR-80 (nDf53) (lof) worms.  (*) 







Figure 4.2: The effect of postembryonic nicotine exposure on adult germ line apoptosis in the lab strain N2 and in different genetic backgrounds 
(described in the text). Comparisons were done per genetic background. Differences were considered statistically significant at p<0.05 and are 









Figure 4.3: (A) The effect of U0126 co-treatment on late-onset germ line apoptosis in response to post-
embryonic exposure to the high nicotine dose. (B) The effect of pharyngeal mpk-1 overexpression on 










Figure 4.4: mpk-1 overexpression in the pharynx was associated with reduced intestinal bacteria in N2, 

















Figure 4.5: Prevalence of tobacco users among adults aged 15 or older among (A) females and (B) males 
in 2012 (WHO, 2015). (C) Rates of non-communicable disease (NCD) in both sexes, age standardized, 







Supplementary figure 4.1: The effect was early nicotine exposure on adult germ line apoptosis was 





A hypothesized model and promising applications of nicotine-induced MS80 
Abstract 
Our study added more evidence to the concept of “there is no safe threshold nicotine dose below 
which an effect is not observed”. We showed that early exposure to the high nicotine dose 
delayed development and the onset of reproduction, inhibited pharyngeal pumping, and 
decreased mean worm lifespan. Meanwhile, even the low nicotine dose during post-embryonic 
stage was sufficient to increase adult germ line apoptosis and that effect was similar if not 
slightly higher than the high dose. Our study is the first to report a possible relation among mpk-
1/ERK1/2, sir-2.1/SIRT1, and miR-80 in nicotine-induced pharyngeal pumping inhibition and 
adult germ line apoptosis. Interestingly, we also found potential functional homologs (hsa-miR-
3150a-3p, hsa-miR-3150b-3p, hsa-miR-4683, hsa-miR-4769-3p) for cel-miR-80 in humans using 
Clustal omega alignments and IntaRNA programs. After performing pathway enrichment 
analysis using DIANA-miRPath, we found that MAPK and nicotine addiction clustered together 
and were commonly predicted to be regulated by hsa-miR-3150b-3p. The latter could serve as 
cel-miR-80 counterpart in humans and an important nicotine-responsive microRNA. Based on 
the post-embryonic cell lineage in the worm and the exposure timeline, we suggest that the head 
neurons could be the major site of nicotine-induced reprogramming that could be relayed to the 
other tissues in the body resulting in an orchestrated and synchronized response that is triggered 
by ROS and mediated by MS80. Finally, we revisit the importance of epigenetic microRNA 
changes that precede the onset of disease which is a property that can be used as a biomarker for 
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MS80: A hypothesized molecular network 
As mentioned earlier, the prevalence of passive and active nicotine exposure among 
neonates, children and adolescents remains relatively high and varies among cultures and 
countries. Currently, there is ample evidence that a safe nicotine dose or level does not exist. For 
that, early exposure to any nicotine product is considered “catastrophic” to the children’s future 
and wellbeing (Cuthbertson & Britton, 2010). Previously, we showed that this early parental 
exposure altered behavior in three generations using the C. elegans model (F. Taki et al., 2013). 
Here, we showed that post-embryonic nicotine exposure in the parent generation was sufficient 
to induce systemic alterations in microRNA profiles till at least the grand-offspring (F2) 
generation (F. A. Taki et al., 2014; F. A. Taki et al., 2013). This exposure was associated with an 
inhibition in growth and development (Figures 3.3; 3.4) via an unidentified molecular 
mechanism that potentially involved aak-2/AMPK and/or CYP2A6 homologs. Based on our 
results, the high nicotine dose inhibited pharyngeal pumping and that effect was promoted by 
mpk-1 hyperactivation which was downstream of sir-2.1 and miR-80 (MS80) (Figure 3.5). Co-
treatment with U0126 showed that the effect on pumping effect is not exclusively regulated by 
MS80, but also involved others like serotonin (Figure 3.6) and possibly aak-2/AMPK signaling. 
The higher sensitivity of sir-2.1 mutants to nicotine U0126 co-treatment (Figure 3.5B) suggested 
that sir-2.1 is an upstream transducer and results in mpk-1 hyperactivation through miR-80 
dependent and independent mechanisms. Consistent with Cuthbertson and Britton’s statement, 
this early exposure was associated with enduring effects on worm mean lifespan (Figure 4.1B) 
and adult germline apoptosis (Figure 4.2), but not fertility. The mean worm lifespan decreased 
by 5% and this effect was lost in the long lived miR-80 loss of function mutants (Figure 4.1B). 




upregulation. As for nicotine-induced adult germ line apoptosis, our data suggests that it is ROS-
dependent upregulation of the antioxidant system via MS80, cep-1/p53, ced-3 caspase signaling. 
Finally, our findings showed that boosting the innate antioxidant system during early 
development through starvation or dietary restriction-like metabolism rescues the enduring 
effects of early nicotine exposure (Figures 4.3B, 4.4). Due to the conservation of MAPK and 
sirtuin signaling in living systems, we propose that MS80 is a promising target to ‘vaccinate’ 
children and adolescents against nicotine. Targeting this pathway would shift metabolism and 
enhance the innate antioxidant system and increase resistance against harmful ROS levels 
without risking the reduction of normal ROS signaling.  
Are there cel-miR-80 functional homologs in humans? 
We downloaded the sequences of all 35858 miRNAs in miRBase and looked for human 
and C. elegans miRNAs with the miR-80 six base pair sequence GAGAUC. Thirteen matches 
were found, five of which were for humans and were hsa-miR-3150a-3p, hsa-miR-3150b-3p, 
hsa-miR-4683, has-miR-4768-3p (Table 5.1). None of the human microRNAs were functionally 
annotated. Six of the remaining C. elegans microRNAs belonged to the miR-58 family as 
expected (Ibanez-Ventoso et al., 2008). This leaves two microRNAs cel-miR-1018 and cel-miR-
1021 in which the sequence started in the fourth and fifth position, respectively (Table 5.1). The 
canonical microRNA seed sequence is usually from position 2 to 7 in the 5’end of the microRNA. 
Interestingly, a recent study used an approach called CLASH to study microRNA-target 
interactions and found that most of the targets did not base pair to the microRNA seed region 
which suggested that other sites in the microRNAs are also involved in target recognition. They 
added that miRNA-target interactions that depended on the seed sequence had a stronger 




presence of the GAGAUC sequence in other microRNAs can also potentially contribute to the 
fine tuning of the targets.  
Previously, miR-80 was reported to be more than 70% similar to the human homologue 
hsa-miR-450b-3p (Ibanez-Ventoso et al., 2008). We performed multiple sequence alignment 
using mature microRNA sequences for cel-miR-80-3p and the aforementioned human 
microRNAs hsa-miR-450b-3p, hsa-miR-3150a-3p, hsa-miR-3150b-3p, hsa-miR-4683, and hsa-
miR-4768 using Clustal Omega program (Sievers et al., 2011). We confirmed that hsa-miR-450-
3p was 71% similar to cel-miR-80-3p. Interestingly, cel-miR-80-3p was at least 50% similar to 
the remaining microRNAs: hsa-miR-4683 (57%), hsa-miR-3150a-3p and hsa-miR-3150b-3p 
(56%), and hsa-miR-4768-3p (53%) (Table 5.2). 
Identifying potential miRNA-target interactions 
We used IntaRNA (Busch, Richter, & Backofen, 2008; P. R. Wright et al., 2014) to check 
for possible significant interactions for sir-2.1/SIRT1 or mpk-1/MAPK1 with the mature 
sequences of cel-miR-80-3p, hsa-miR-450b-3p, hsa-miR-3150a-3p, hsa-miR-3150b-3p, hsa-
miR-4683, hsa-miR-4769-3p. MAPK1, also known as ERK2 has more than 80% sequence 
identity with the C. elegans mpk-1 (Y. Wu & Han, 1994) and sir-2.1 is homologous to the 
mammalian SIRT1 (Bamps et al., 2009; Frye, 2000). IntaRNA computes an energy score that 
doesn’t only depend on the hybridization energy, but also incorporates the accessibility of the 
interaction site in both RNAs as a function of their folds and lengths. We combined results from 
IntaRNA with the criterion of a 5’ seed sequence in the 2-7 position, and found five candidate 
interactions for MAPK1 which could interact with hsa-miR-3150a-3p between position 1 and 11 




candidate MAPK1 interaction was with hsa-miR-4768-3p along the first 1-11 bases starting with 




 base (-12.47 Kcal/mol). hsa-miR-3150b-3p was predicted to 
interact with MAPK1 using the bases from 1-17 with 1-7 for the seed sequence (-10.85 Kcal/mol) 
(Table 5.3). Similarly, MAPK1 was predicted to interact on multiple sites ranging from position 
1 to 20 on hsa-miR-4683-3p starting with the seed sequence from 1-7 ( -8.78 Kcal/mol). MAPK1 
could also interact with hsa-miR-450b-3p from position 1 to 19 with a similar seed sequence 
from 1-7 (-5.17 Kcal/mol). On the other hand, fewer interactions that met our criteria were found 





 base with the seed sequence from 2-8 (-7.62 Kcal/mol). As a side note, the lowest 
energy score was for a possible interaction between hsa-miR-4683 (-13.85 Kcal/mol). A lower 





 position; however, the seed sequence was from 5-11 (Table 5.3). As mentioned 
earlier, non-canonical miRNA-target interactions are more common than originally thought and 
could serve a fine-tuning function rather than an extreme effect on protein levels. Our IntaRNA 
analysis showed a possible interaction with both MAPK1 and SIRT1 (Table 5.3). The predicted 
functional role for this interaction is discussed below.  
Unsupervised enrichments: MAPK and nicotine addiction 
We were interested in identifying the pathways enriched for those human microRNAs. 
DIANA-miRPath was used and was based off of microT-CDs to find microRNA-target sites in 
both coding and 3’UTR regions (Vlachos et al., 2012). The p-value threshold was 0.05 and the 
default MicroT threshold was 0.8. The program identified the pathways enriched for each 
miRNA and then merged them together through “Pathway Union”. A summary of the results is 




which was enriched for hsa-miR-4683, hsa-miR-3051b-3p, and hsa-miR-4768. Interestingly, 
nicotine addiction was also enriched and was predicted to be regulated by hsa-miR-3051b-3p 
(p=0.007). In addition, MAPK and nicotine addiction were clustered together (Figure 5.2). 
Therefore, we suggest that hsa-miR-3150b-3p could be cel-miR-80 counterpart in humans and an 
important nicotine-responsive microRNA. Despite having the highest similarity with cel-miR-
80-3p (71%) (Table 5.2), hsa-miR-450b-3p did not show enrichment for MAPK signaling 
(Figure 5.2). These results are encouraging and suggest a potential conserved seed sequence 
responsive to nicotine-induced disorders in humans.  
All for one and one for all 
Is there a central alarm center in the worm? Nicotine resulted in a systemic effect in the 
worm which was evident by the endpoints analyzed in this study: behavior, developmental arrest, 
and microRNA profiles. We can assume that this systemic response is triggered by a molecular 
alarm signal from either (i) a specific sensitive cell/tissue or (ii) multiple cells/tissue that are 
directly exposed. In either situation, the consequent response is synchronized and that is mainly 
evident in the developmental arrest. 
Examples of non-autonomous signaling in C. elegans include HIF-1-dependent inhibition 
of p53-induced germ line apoptosis through the secretion of tyrosinase from ASJ head sensory 
neurons (Sendoel, Kohler, Fellmann, Lowe, & Hengartner, 2010). More so, larval neuronal 
mitochondrial perturbation was sufficient to induce the mitochondria-specific unfolded protein 
response (UPRmt) in the intestines. This response was maintained until adulthood and resulted in 
increased lifespan (Durieux, Wolff, & Dillin, 2011). The authors suggested that epigenetics 




stress (Durieux et al., 2011). In addition, tissue-specific rescue of microRNA biogenesis 
machinery (PASH-1) showed that miRNAs promote longevity in cell autonomous and non-
autonomous mechanisms in C. elegans. So, microRNAs might not necessarily be signaling 
molecules by themselves, but they regulate gene expression in a cell and consequently alter its 
function. In turn, intra and extracellular signaling is impacted as a side-effect (Lehrbach et al., 
2012). That was the case with miR-71 neuronal regulation which resulted in increased lifespan 
through endocrine daf-16/FOXO signaling in the intestine (Boulias & Horvitz, 2012). In addition, 
by using tissue-restricted RNAi and aversion response as an endpoint, Melo and Ruvkun showed 
that neuroendocrine signals could be relayed between neuronal and non-neuronal peripheral 
tissue as a result of the sensation and response to cellular exposure and stress (Melo & Ruvkun, 
2012). Their findings supported the DAMP (damage-associated molecular pattern) hypothesis 
which involves the cellular recognition of small molecules released into the extracellular 
environment following pathogen-induced cell damage and lysis of their neighbors (Matzinger, 
1994; Melo & Ruvkun, 2012).  
Interestingly, we mentioned in chapter I that extracellular miRNAs could be carried in 
exosomes, apoptotic bodies, RNA binding proteins, and lipoproteins (Boon & Vickers, 2013; H. 
J. Lee, 2014; Rayner & Hennessy, 2013) and that this is not limited to leakage from a damaged 
cell, but it can actively be excreted (Bala et al., 2012). For example, neuronal PDGF-B regulation 
required an exosome-dependent shuttling of miR-29b from astrocytes (G. Hu et al., 2012). Thus, 
miRNAs can mediate organism-level signaling to synchronize communications and processes. 
Intercellular miRNA circulation has not been documented in C. elegans; however, in vitro 
expression of C. elegans cel-miR-67 in rat gliosarcoma cells was associated with intercellular 




microRNAs can also mediate signaling indirectly by influencing the intracellular ROS levels 
(Magenta, Greco, Gaetano, & Martelli, 2013). Indeed, ROS are required for normal signaling. 
For example, ROS are required for the activation of RTK/MAPK signaling to mediate normal 
cellular function (Finkel, 2011). An increase in ROS levels can also activate the redox-sensitive 
aak-2/AMPK which activates sir-2.1/SIRT1 (Salminen, Kaarniranta, & Kauppinen, 2013) and 
alter cell signaling and gene expression to enhance oxidative resistance (Brunet et al., 2004) or 
induce cellular apoptosis (Jin et al., 2007; Y. Li et al., 2008). The two main sources of ROS are 
membrane-bound enzymes that rely on NAPDH oxidases activity and mitochondrial cytochrome 
complexes (I, III) which release electrons from NADH and FADH2. Electrons can then interact 
with oxygen and give rise to superoxide anions (Finkel, 2011). miRNAs can act as antioxidants 
by activating antioxidant enzymes like GSH directly (J. M. Wang et al., 2014) or indirectly 
(Howell et al., 2013) or by suppressing ROS-producing enzymes like NADPH (Varga et al., 
2013). Meanwhile, they can also act as pro-oxidants by increasing ROS-producing enzymes 
(Oenarto et al., 2016; Shilo, Roy, Khanna, & Sen, 2008). Nicotine is notorious for increasing 
ROS levels in mesencephalic cells (Barr et al., 2007), offspring arteries (Xiao, Huang, Yang, & 
Zhang, 2011), fetal and neonatal pancreatic cells (Bruin, Petre, et al., 2008), and therefore this 
could be mediated in part by influencing the expression levels of microRNAs. 
With this in mind, we propose that nicotine causes intracellular damage. The latter 
includes elevated ROS levels which might be released from cells directly exposed to nicotine: 
neurons and the intestines (Durieux et al., 2011) (Figure 5.1). Neurons like ASG secrete a signal 
that results in a synchronized organism level response (i.e. developmental arrest). Worms 
exposed to the high nicotine dose were arrested at L1 yet had an increased germline apoptosis 




adulthood. This growth is associated with a 350% increase in neuronal cells in the lateral 
hypodermis, 170% increase in neuronal cells of the ventral cord, 70% increase in intestinal cells, 
and only a 2% increase in neuronal cells of the head (Figure 5.3) (J. E. Sulston & Horvitz, 1977). 
The increase in all the neuronal cells is contributed by the postembryonic lineage, while the 
increase in the intestinal cells is due to a single duplication of about 70% of the cells present at 
L1 (J. E. Sulston & Horvitz, 1977). The intragenerational inheritance of ROS induced by direct 
nicotine exposure is unlikely to be in neurons of the lateral hypodermis or ventral cord as it is 
more likely to be diluted due to the dramatic increase in cell count. The intestine also duplicates 
but for a lesser extent, so ROS remnants may, but are less likely to, result in an enduring effect. 
The most noticeable tissue was the head region where the neuronal cell count almost remains the 
same from L1 till adulthood (Figure 5.3). On a separate note, worms exposed to the low nicotine 
dose did not arrest at L1 and yet also had an increase in the apoptotic rate in their adult germlines. 
The neural head count is common to L1, L3, L4, and adult worms and therefore could be the site 
of enduring ROS-induced damage or signaling. This suggests that ROS in head neurons could 
trigger an oxidative stress response that is communicated to the remaining body tissue via miR-
80 and endocrine signaling as the worms grow.  
Promising potential for MS80 
If the long term effects of early nicotine exposure are mediated by ROS, then would not 
antioxidant supplements be sufficient? The answer to this argument is two folds: (i) ROS is a 
signaling molecule critical for normal physiological processes and molecular signaling and a 
reduction in ROS below normal levels could disrupt the homeostasis and result in toxicity, and 





In addition, there is some evidence about the temporal sequences of epigenetics factors 
that suggests that it precedes the onset of the disease and can in turn be influenced by the disease 
itself (Relton & Davey Smith, 2012). With this in mind, we showed that miR-80 could serve as a 
transgenerational biomarker for early parental nicotine exposure and we showed its roles in 
mediating nicotine-induced early and late-onset diseases in the worm. This could imply that the 
upregulation of miR-80 in the grand-offspring generation increases the susceptibility of those 
individuals to the enduring effects such as cell apoptosis and therefore predisposes them to 
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Table 5.1: C. elegans and humans microRNAs with GAGAUC sequence. 
 
Position microRNA 5'->3' mature sequence 
2 cel-miR-58a-3p UGAGAUCGUUCAGUACGGCAAU 
2 cel-miR-80-3p UGAGAUCAUUAGUUGAAAGCCGA 
2 cel-miR-81-3p UGAGAUCAUCGUGAAAGCUAGU 
2 cel-miR-82-3p UGAGAUCAUCGUGAAAGCCAGU 
4 cel-miR-1018 AGAGAGAUCAUUGGACUUACAG 
5 cel-miR-1021 AAGUGAGAUCAUGUGAAAUCCUCGG 
2 cel-miR-58b-3p AGAGAUCAACCAUUGAGAUCCAA 
2 cel-miR-2209a-3p AGAGAUCAGCGGUUACACUACA 
6 hsa-miR-3150a-3p CUGGGGAGAUCCUCGAGGUUGG 
5 hsa-miR-3150b-3p UGAGGAGAUCGUCGAGGUUGG 
3 hsa-miR-4683 UGGAGAUCCAGUGCUCGCCCGAU 
5 hsa-miR-4768-3p CCAGGAGAUCCAGAGAGAAU 
















Table 5.2: Homology between cel-miR-80-3p and five human miRNAs based on Clustal omega. 
Percent Identity  Matrix 
(Clustal2.1)  
cel-miR-80-3p hsa-miR-450b-3p hsa-miR-3150a-3p hsa-miR-3150b-3p hsa-miR-4683 hsa-miR-4768-3p 
cel-miR-80-3p 100 71.43 55.56 55.56 57.14 52.94 
hsa-miR-450b-3p 71.43 100 38.89 38.89 47.62 35.29 
hsa-miR-3150a-3p 55.56 38.89 100 90.48 66.67 55 
hsa-miR-3150b-3p 55.56 38.89 90.48 100 61.11 55 
hsa-miR-4683 57.14 47.62 66.67 61.11 100 61.11 







Table 5.3: Predicted microRNA-target interaction using IntaRNA (Busch et al., 2008; P. R. Wright et al., 2014). 
 





SIRT1 918 -- 935 hsa-miR-4683 2 -- 20 -13.8472 5 to 11 0 0 
 
MAPK1 1189 -- 1206 hsa-miR-3150a-3p 1 -- 18 -12.8174 1 to 7 1 1 
 
MAPK1 1448 -- 1458 hsa-miR-4768-3p 1 -- 11 -12.468 1 to 7 2 0 
 
SIRT1 922 -- 936 hsa-miR-4768-3p 3 -- 17 -11.4264 7 to 13 0 0 
 
MAPK1 1350 -- 1366 hsa-miR-3150b-3p 1 -- 17 -10.8541 1 to 7 0 0 
 
MAPK1 1619 -- 1641 hsa-miR-4683 1 -- 20 -8.78021 1 to 7 3 1 
 
SIRT1 986 -- 1005 hsa-miR-3150b-3p 2 -- 19 -7.61717 2 to 8 3 2 
 
SIRT1 861 -- 867 hsa-miR-3150a-3p 16 -- 22 -6.58482 6 to 22 1 0 
 
MAPK1 435 -- 447 hsa-miR-450b-3p 1 -- 19 -5.16529 1 to 7 0 0 
 








Figure 5.1: Hypothesized model for MS80 in response to postembryonic nicotine exposure. (A) The hypothesized tissue distribution of MS80 in 
response to nicotine based on previous reports. (B) The hypothesized sequential roles of MS80 in nicotine-induced disorders. (C) Western blots to 






detect the activated mpk-1/ERK (phosphorylated) relative to total mpk-1 (You et al., 2006) in Ex myo-2 mpk-1 backgrounds. ImageJ was used for 













Figure 5.3: The percent increase in the number of cells from L1 to adult stage in neuronal and intestinal 
tissue. The number of cells was based on data from Sulston et al (J. E. Sulston, Schierenberg, White, & 
Thomson, 1983). 
 
 
 
 
 
 
 
 
 
